{"meta":{"query_hash":"a3fa8339d393","filters":{"venue":"International Clinical Psychopharmacology"},"cohort_total":107,"direct_labels_cover":0,"predictions_cover":107,"exported":107,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a3fa8339d393","api":"https://metacan.xera.ac/api/v1/cohort?venue=International+Clinical+Psychopharmacology"},"results":[{"id":"W1601971109","doi":"10.1097/yic.0b013e3283597678","title":"Adherence to escitalopram treatment in depression","year":2012,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"National Institute of Mental Health","keywords":"Escitalopram; Dosing; Discontinuation; Regimen; Interpersonal psychotherapy; Pharmacotherapy; Depression (economics); Medicine; Psychiatry; Citalopram; Pill; Psychology; Internal medicine; Randomized controlled trial; Pharmacology; Anxiety; Antidepressant","score_opus":0.09389593227981391,"score_gpt":0.5073609288943141,"score_spread":0.41346499661450015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601971109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730942,0.00087337923,0.000089428824,0.0025406072,0.0040528122,0.00049829,0.000010997282,0.000035874124,0.018804379],"genre_scores_gemma":[0.99461347,0.00027941348,0.0008018539,0.0022550353,0.00066309737,0.00014887314,0.00002293802,0.000012008755,0.0012033373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884623,0.000070133356,0.00042280488,0.00026057163,0.0001496942,0.00025054123],"domain_scores_gemma":[0.99925864,0.00019860105,0.000053389034,0.00013366742,0.000047039575,0.00030866676],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021953315,0.00012122301,0.00023438204,0.00012204747,0.00001767152,0.000005317679,0.0001037495,0.000110518435,0.0014189035],"category_scores_gemma":[0.00008239238,0.00009386633,0.00010342616,0.0001028621,0.000038432314,0.00007021598,0.000039457926,0.00016649581,0.00095955277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011908951,0.0032735106,0.8671962,0.0000022543684,0.00012486387,0.000013719026,0.000093025556,0.0000022723157,0.00075250934,0.000066646426,0.0015700591,0.12571403],"study_design_scores_gemma":[0.00645447,0.0010969206,0.8672612,0.00001641853,0.00004865359,0.000030796364,0.000014056707,0.000032978154,0.00028575375,0.000090084446,0.12458862,0.00008005128],"about_ca_topic_score_codex":0.000074383126,"about_ca_topic_score_gemma":0.00008101339,"teacher_disagreement_score":0.12563398,"about_ca_system_score_codex":0.0001487302,"about_ca_system_score_gemma":0.000042471594,"threshold_uncertainty_score":0.9998183},"labels":[],"label_agreement":null},{"id":"W1969712323","doi":"10.1097/yic.0b013e32830cebed","title":"Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial","year":2008,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Tolerability; Placebo; Internal medicine; Hamilton Anxiety Rating Scale; Major depressive disorder; Nausea; Medicine; Hamilton Rating Scale for Depression; Adverse effect; Population; Psychiatry; Anxiety","score_opus":0.04528260503552192,"score_gpt":0.4316187127020481,"score_spread":0.38633610766652615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969712323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880168,0.00061424414,0.000298915,0.0047803787,0.0016233072,0.00400331,0.000049875944,0.000027133849,0.0005860702],"genre_scores_gemma":[0.99621046,0.00078348524,0.0009282428,0.0005664852,0.00046843768,0.0003984317,0.000039252405,0.00002239152,0.0005828174],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99726593,0.00033856637,0.001343347,0.0005780675,0.00025184365,0.00022225795],"domain_scores_gemma":[0.99399287,0.0051044184,0.0003768244,0.00018838036,0.00015626274,0.00018124272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009012061,0.00021424987,0.0009883649,0.00017600204,0.000058991904,0.0000054728644,0.00015249365,0.00024805573,0.00032391647],"category_scores_gemma":[0.0019351217,0.00017017234,0.00023533082,0.00007131053,0.00040441615,0.00007650208,0.00010090639,0.00033155095,0.000005014192],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83398867,0.0039596246,0.1487701,0.000028607305,0.0005220746,0.00004757565,0.00008488591,0.00001847522,0.0012548078,0.000038631155,0.001085655,0.010200892],"study_design_scores_gemma":[0.65953207,0.0018104812,0.33397543,0.000045618686,0.00020020384,0.000044126195,0.0000065667678,0.00077509397,0.00008315614,0.00027633595,0.0031418637,0.00010905243],"about_ca_topic_score_codex":0.00003351903,"about_ca_topic_score_gemma":0.000029707895,"teacher_disagreement_score":0.18520536,"about_ca_system_score_codex":0.000055334247,"about_ca_system_score_gemma":0.00010039667,"threshold_uncertainty_score":0.6939426},"labels":[],"label_agreement":null},{"id":"W1971130967","doi":"10.1097/yic.0b013e3281c61b28","title":"Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting","year":2007,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Discontinuation; Encephalopathy; Medicine; Adverse effect; Pediatrics; Urea cycle; Psychiatry; Delirium; Internal medicine","score_opus":0.22630111614812712,"score_gpt":0.5704658701246423,"score_spread":0.34416475397651525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971130967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016061523,0.9808383,0.0000042608535,0.0032911918,0.005246523,0.0025957215,0.00005602474,0.0000381769,0.006323649],"genre_scores_gemma":[0.0029060491,0.9741342,0.00014846222,0.02029242,0.0020151,0.00028213198,0.000086357046,0.00003896442,0.00009632504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934818,0.0013470313,0.003223966,0.00079162675,0.00068903086,0.000466555],"domain_scores_gemma":[0.9894216,0.008460805,0.001277412,0.00035205868,0.00032617763,0.00016193616],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0053111403,0.0005277335,0.0029774732,0.0004279225,0.00006244054,0.000010375704,0.0009612502,0.0005568877,0.0005706559],"category_scores_gemma":[0.0030437496,0.00031401217,0.0014089536,0.00083798525,0.0002694024,0.000053557822,0.00017290686,0.0023833467,0.00012054633],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034913773,0.001599561,0.00051998434,0.029152878,0.00077597226,0.0010095913,0.000019237898,1.6295401e-7,0.000007085251,0.00005649904,0.020260867,0.946249],"study_design_scores_gemma":[0.0023495632,0.0008519133,0.0007868226,0.021642402,0.0021189344,0.0007579661,0.0000103400125,0.000005704939,0.0000013053451,0.00007362432,0.97111094,0.00029046158],"about_ca_topic_score_codex":0.0000153936,"about_ca_topic_score_gemma":0.00000425347,"teacher_disagreement_score":0.95085007,"about_ca_system_score_codex":0.00014563322,"about_ca_system_score_gemma":0.00035454912,"threshold_uncertainty_score":0.9999312},"labels":[],"label_agreement":null},{"id":"W1977708183","doi":"10.1097/01.yic.0000137184.64610.c8","title":"Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study","year":2004,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Discontinuation; Agomelatine; Paroxetine; Placebo; Medicine; Double blind; Randomized controlled trial; Internal medicine; Psychiatry; Psychology; Antidepressant; Alternative medicine; Anxiety","score_opus":0.029635700189344815,"score_gpt":0.40005410824838994,"score_spread":0.37041840805904513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977708183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987695,0.00015639585,0.0025226153,0.002129055,0.0006920466,0.0058078794,0.000038757276,0.00005396906,0.0009042886],"genre_scores_gemma":[0.99749213,0.000114375645,0.0008106764,0.000107555104,0.0002831158,0.00073302176,0.00015374357,0.000029219527,0.00027615723],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99566346,0.00041772082,0.0019823608,0.0007655695,0.00090612855,0.00026473397],"domain_scores_gemma":[0.99542123,0.0015968931,0.0018153604,0.0003432808,0.0006460094,0.00017722172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001682673,0.0003931278,0.0016344957,0.00034614716,0.00005839912,0.00002980522,0.00025263167,0.00017213436,0.00014503444],"category_scores_gemma":[0.0004877793,0.00024911633,0.00024531066,0.00026481022,0.0007348259,0.00036714438,0.000077109806,0.0004136109,0.000008725763],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76449424,0.006507814,0.21936552,0.000024991788,0.0019794083,0.000028981678,0.000501295,0.0004669853,0.00084653206,0.00030123105,0.000035726203,0.0054472797],"study_design_scores_gemma":[0.8901592,0.00630137,0.09919767,0.00048042575,0.0015541264,0.000034854485,0.00017971375,0.0010334192,0.00063597277,0.00014963443,0.00002167406,0.00025196982],"about_ca_topic_score_codex":0.00010716161,"about_ca_topic_score_gemma":0.00010972313,"teacher_disagreement_score":0.12566493,"about_ca_system_score_codex":0.00008430604,"about_ca_system_score_gemma":0.00018694413,"threshold_uncertainty_score":0.9999961},"labels":[],"label_agreement":null},{"id":"W1979180758","doi":"10.1097/yic.0b013e328314e2cb","title":"Assessing the efficacy of 2 years of maintenance treatment with venlafaxine extended release 75–225 mg/day in patients with recurrent major depression: a secondary analysis of data from the PREVENT study","year":2008,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Center for Advancing Translational Sciences; National Institute of Mental Health","keywords":"Venlafaxine; Placebo; Major depressive disorder; Venlafaxine Hydrochloride; Medicine; Internal medicine; Population; Maintenance therapy; Depression (economics); Randomized controlled trial; Fluoxetine; Antidepressant; Chemotherapy","score_opus":0.07622204376022716,"score_gpt":0.45497734628346664,"score_spread":0.37875530252323947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979180758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997245,0.00029497806,0.00006880319,0.0005443504,0.00034858292,0.0011185214,0.00026808912,0.000008845257,0.000102805],"genre_scores_gemma":[0.99869317,0.00016624162,0.0004354172,0.0001430083,0.00009327337,0.000049601247,0.0003458631,0.000017019407,0.000056378663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970163,0.000588612,0.0010620309,0.0005571804,0.00062365684,0.00015219953],"domain_scores_gemma":[0.99551463,0.0024464342,0.0008587885,0.0008712238,0.00023160079,0.00007729291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005609614,0.00018474781,0.0007127807,0.00016269858,0.00003478843,0.0000049378164,0.0005997541,0.00007187808,0.00033643635],"category_scores_gemma":[0.00025711217,0.000091131275,0.00016257993,0.00039475484,0.00034852666,0.00014576476,0.00017174154,0.000318702,0.000002263028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014657132,0.018495934,0.9231961,0.000006169403,0.005298176,0.00011504296,0.00033637742,0.00009028594,0.000117027674,0.0000010938428,0.0004680452,0.037218634],"study_design_scores_gemma":[0.031365428,0.0027351864,0.9622141,0.0001908485,0.0024596408,0.0000040516165,0.000099693156,0.00053003855,0.000057806283,0.000007903166,0.0002590068,0.000076301425],"about_ca_topic_score_codex":0.00021113823,"about_ca_topic_score_gemma":0.0001339527,"teacher_disagreement_score":0.039018016,"about_ca_system_score_codex":0.00008720706,"about_ca_system_score_gemma":0.00017881757,"threshold_uncertainty_score":0.37162253},"labels":[],"label_agreement":null},{"id":"W1979879412","doi":"10.1097/00004850-200607000-00034","title":"The Japanese version of the Screen for Cognitive Impairment in Psychiatry: a preliminary study","year":2006,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cognitive impairment; Psychiatry; Medicine; Psychology; Cognition","score_opus":0.02794339153818813,"score_gpt":0.4520431467233027,"score_spread":0.42409975518511456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979879412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794106,0.000098005745,0.000017390737,0.01140431,0.0028010476,0.0026498118,0.000046134573,0.000010053343,0.0035626756],"genre_scores_gemma":[0.9962518,0.000032170174,0.000034018085,0.0011273798,0.0004883054,0.00029752564,0.000025535186,0.000011703275,0.00173154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979982,0.00032179832,0.0007081797,0.00029660034,0.00044172505,0.00023354118],"domain_scores_gemma":[0.9978172,0.0014107148,0.00019519139,0.00014071463,0.0003799,0.000056271416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014162405,0.00011186004,0.0002136178,0.00009341038,0.0000942576,0.000011258694,0.0003284821,0.00007418312,0.00021840347],"category_scores_gemma":[0.0002679074,0.00006572052,0.00023964429,0.00017738131,0.0002751097,0.000039468014,0.00013432247,0.00032630804,0.000018933184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022451956,0.006470868,0.9450121,0.000012583695,0.00031239467,0.0000094725565,0.000056300636,0.0000026696393,0.00010847527,0.00007355534,0.022591772,0.002897847],"study_design_scores_gemma":[0.021798644,0.0043858094,0.96920335,0.000058860023,0.00016344771,0.000007993571,0.00078431785,0.00027235926,0.00006765782,0.0006304052,0.002567144,0.000060007722],"about_ca_topic_score_codex":0.00010389858,"about_ca_topic_score_gemma":0.00011120126,"teacher_disagreement_score":0.024191247,"about_ca_system_score_codex":0.000055857927,"about_ca_system_score_gemma":0.00013719908,"threshold_uncertainty_score":0.26800048},"labels":[],"label_agreement":null},{"id":"W1979892910","doi":"10.1097/yic.0b013e3282ffdedc","title":"Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials","year":2008,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Escitalopram; Duloxetine; Duloxetine Hydrochloride; Tolerability; Venlafaxine; Internal medicine; Major depressive disorder; Reuptake inhibitor; Randomized controlled trial; Medicine; Psychology; Psychiatry; Adverse effect; Anesthesia; Antidepressant","score_opus":0.089783870356015,"score_gpt":0.4951104557882556,"score_spread":0.4053265854322406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979892910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924635,0.0012435276,0.000057909183,0.0044290307,0.0004659435,0.00061029097,0.00006654981,0.000010179561,0.00065303914],"genre_scores_gemma":[0.99556684,0.0030043551,0.00038007068,0.0005534464,0.00017270802,0.000083968545,0.000065093525,0.000008691098,0.00016481445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974141,0.0004987248,0.0013066892,0.0003290781,0.00032581054,0.00012558336],"domain_scores_gemma":[0.9956217,0.0033992361,0.0005514109,0.00022188308,0.00013278263,0.00007297636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078606105,0.00014696785,0.0010216446,0.0003954419,0.000025399402,0.0000031251454,0.00018386716,0.000100399266,0.00046448523],"category_scores_gemma":[0.00060522364,0.0000876592,0.00046651126,0.00033489344,0.0002797912,0.00003715466,0.000028065357,0.00012973469,0.000004607352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067125745,0.007574767,0.95848536,0.000009334397,0.0069253645,0.00018709648,0.00037474046,0.00006679261,0.0053493283,0.00008147563,0.0006926302,0.013540537],"study_design_scores_gemma":[0.042624764,0.0019514684,0.945361,0.000024636753,0.0055464003,0.0000430518,0.000044845165,0.0009991815,0.0011724026,0.00024304705,0.0019067671,0.00008241804],"about_ca_topic_score_codex":0.00016264671,"about_ca_topic_score_gemma":0.0000936179,"teacher_disagreement_score":0.03591219,"about_ca_system_score_codex":0.000036126978,"about_ca_system_score_gemma":0.00004782535,"threshold_uncertainty_score":0.5085788},"labels":[],"label_agreement":null},{"id":"W1985243621","doi":"10.1097/01.yic.0000080803.87368.01","title":"Migraine headache prophylaxis and treatment with low-dose mirtazapine","year":2003,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Mirtazapine; Migraine; Medicine; Migraine Disorders; Anesthesia; Psychiatry; Antidepressant","score_opus":0.053906987452666984,"score_gpt":0.436928140555989,"score_spread":0.383021153103322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985243621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95999116,0.0009953737,0.000032043154,0.015904462,0.00035141618,0.0005546319,0.000013985792,0.00004977634,0.022107162],"genre_scores_gemma":[0.9757111,0.002011053,0.0019239307,0.005153506,0.00062387454,0.000095705436,0.00001983368,0.000022756276,0.014438205],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984565,0.000121570505,0.0005128583,0.00046443712,0.0002028944,0.00024176284],"domain_scores_gemma":[0.9988822,0.00036344238,0.00011138613,0.0002214059,0.00018960879,0.00023198988],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031033438,0.00021360001,0.00045284894,0.00010559441,0.00006219547,0.000010031686,0.00010184512,0.00012602778,0.00091883994],"category_scores_gemma":[0.0002844206,0.00014323049,0.00015718794,0.00011180945,0.0003082508,0.000041019863,0.000030963234,0.00029692592,0.00007659103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020345517,0.0099775875,0.6914325,0.00013662221,0.005958505,0.001051417,0.0008864172,0.0000041269604,0.009030982,0.0034976436,0.21625686,0.041421883],"study_design_scores_gemma":[0.026933203,0.011134548,0.12791769,0.00005982133,0.0002987002,0.00040957791,0.00013202928,0.000074911295,0.00041785868,0.000409952,0.8319325,0.00027920064],"about_ca_topic_score_codex":0.00003565725,"about_ca_topic_score_gemma":0.00010598478,"teacher_disagreement_score":0.6156757,"about_ca_system_score_codex":0.00006392402,"about_ca_system_score_gemma":0.00011129175,"threshold_uncertainty_score":0.99999446},"labels":[],"label_agreement":null},{"id":"W1986626492","doi":"10.1097/yic.0b013e32834309fc","title":"A multicenter, double-blind, placebo-controlled study of sildenafil citrate in Canadian men with erectile dysfunction and untreated symptoms of depression, in the absence of major depressive disorder","year":2010,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Centre Hospitalier de l’Université de Montréal; University Health Network; Hôpital Saint-Luc; University of Toronto","funders":"","keywords":"Sildenafil; Erectile dysfunction; Placebo; Depression (economics); Multicenter study; Medicine; Internal medicine; Depressive symptoms; Double blind; Psychiatry; Randomized controlled trial; Anxiety; Pathology","score_opus":0.030563976504769157,"score_gpt":0.3953721313042803,"score_spread":0.3648081547995111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986626492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443775,0.000081161,0.000012688828,0.00051849964,0.0010684014,0.0015662222,0.000008779487,0.000007691102,0.0022987935],"genre_scores_gemma":[0.9990275,0.000068094974,0.0000155187,0.0003350834,0.000086465865,0.00023365632,0.000008360614,0.000009841592,0.00021551643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813896,0.00019849598,0.0009104967,0.00031784418,0.00027072412,0.00016348607],"domain_scores_gemma":[0.9978633,0.0011000626,0.0003843914,0.00016560704,0.00038315594,0.00010350679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061037566,0.00014253879,0.0005210777,0.0003777617,0.000033527587,0.0000053995427,0.00014451367,0.00012814622,0.0002850197],"category_scores_gemma":[0.0003391244,0.0000897757,0.000057651985,0.00027621258,0.00021007896,0.000063668056,0.000028595685,0.00046240888,0.0000023395264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16088273,0.0021543382,0.832775,0.00001671238,0.00048303136,0.000021823374,0.0005877969,0.000048976308,0.001950641,0.000020786234,0.00027373945,0.0007844086],"study_design_scores_gemma":[0.25957906,0.0015142793,0.73578924,0.000044343833,0.00016801269,0.000016918897,0.0014729534,0.00087167585,0.00016232768,0.000012032584,0.0002928316,0.00007633534],"about_ca_topic_score_codex":0.03240398,"about_ca_topic_score_gemma":0.12048978,"teacher_disagreement_score":0.098696336,"about_ca_system_score_codex":0.000024854993,"about_ca_system_score_gemma":0.0001147347,"threshold_uncertainty_score":0.9740393},"labels":[],"label_agreement":null},{"id":"W1986838837","doi":"10.1097/01.yic.0000139342.22133.77","title":"Evidence based review of escitalopram in treating major depressive disorder in primary care","year":2004,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"H. Lundbeck A/S","keywords":"Escitalopram; Citalopram; Placebo; Venlafaxine; Major depressive disorder; Medicine; Internal medicine; Randomized controlled trial; Depression (economics); Meta-analysis; Psychiatry; Adverse effect; Psychology; Antidepressant","score_opus":0.11029778439425995,"score_gpt":0.5137643946306977,"score_spread":0.4034666102364377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986838837","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052731816,0.9919342,0.000013511861,0.00090452377,0.0015987351,0.0025571396,0.00008081434,0.000031645846,0.002352102],"genre_scores_gemma":[0.0008393147,0.994685,0.001056852,0.0017998351,0.00028435132,0.00059816317,0.00056230224,0.00006317253,0.000110988236],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9943897,0.0007523929,0.0030010063,0.0009610692,0.00058714807,0.00030865523],"domain_scores_gemma":[0.9946431,0.0031964853,0.001284926,0.00045160347,0.0002708262,0.00015307682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079261843,0.0004868882,0.00293075,0.0006014923,0.00001719884,0.0000068218105,0.00060609396,0.0005824137,0.00074494234],"category_scores_gemma":[0.0017185835,0.00038789515,0.0009454798,0.00047453225,0.00018958875,0.00014147496,0.00016289434,0.0012759073,0.00006913754],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063253095,0.0015219154,0.025104435,0.13098827,0.00027366288,0.0005328752,0.000011794757,0.0000067390565,0.0000025804347,0.000006782957,0.00037297202,0.8405454],"study_design_scores_gemma":[0.012623525,0.00048345487,0.015262694,0.80373204,0.0015185336,0.000057270885,0.000005230205,0.0000073407455,0.0000020724667,0.000023976805,0.16595104,0.00033281514],"about_ca_topic_score_codex":0.000063913896,"about_ca_topic_score_gemma":0.00002415376,"teacher_disagreement_score":0.84021264,"about_ca_system_score_codex":0.0010197047,"about_ca_system_score_gemma":0.0012955618,"threshold_uncertainty_score":0.9998573},"labels":[],"label_agreement":null},{"id":"W1988500223","doi":"10.1097/00004850-200307000-00005","title":"Risperidone in acute and continuation treatment of mania","year":2003,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia; McGill University","funders":"","keywords":"Young Mania Rating Scale; Risperidone; Mania; Mood stabilizer; Internal medicine; Bipolar disorder; Bipolar I disorder; Psychology; Randomized controlled trial; Psychiatry; Mood; Medicine; Hamilton Rating Scale for Depression; Antipsychotic; Extrapyramidal symptoms; Brief Psychiatric Rating Scale; Psychosis; Schizophrenia (object-oriented programming); Major depressive disorder","score_opus":0.0442284188970842,"score_gpt":0.45578171978774457,"score_spread":0.4115533008906604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988500223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870252,0.0010247899,0.00005149134,0.0018197048,0.00087673677,0.0002759754,0.000011611783,0.000009212776,0.008905248],"genre_scores_gemma":[0.99511635,0.0033256172,0.0005628144,0.0003086651,0.00006531661,0.000029327253,0.00001685703,0.0000069190555,0.0005681056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991305,0.00007931132,0.00041514714,0.0001982765,0.00008715164,0.00008961131],"domain_scores_gemma":[0.999567,0.00015357659,0.00008475857,0.00007318252,0.00005707739,0.00006443451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013817743,0.000082578204,0.00025351753,0.000086344466,0.000008882965,0.0000025629076,0.000031453936,0.000080515194,0.0005095017],"category_scores_gemma":[0.00003947028,0.000067919624,0.000066060275,0.000053002208,0.00008308095,0.000026345371,0.0000061765118,0.000074078824,0.000022351642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017422711,0.0027914902,0.9557204,0.0000049578366,0.0006591895,0.000037222122,0.00010133485,8.497895e-7,0.0036491747,0.0010338866,0.00019670314,0.034062505],"study_design_scores_gemma":[0.024805201,0.0018527942,0.92394334,0.000011417577,0.00022051061,0.00007640125,0.00002020556,0.00010362337,0.0013630314,0.0007714972,0.04676064,0.00007132557],"about_ca_topic_score_codex":0.00002033833,"about_ca_topic_score_gemma":0.00004309242,"teacher_disagreement_score":0.046563935,"about_ca_system_score_codex":0.000047830945,"about_ca_system_score_gemma":0.000027260961,"threshold_uncertainty_score":0.55786866},"labels":[],"label_agreement":null},{"id":"W1991193159","doi":"10.1097/01.yic.0000224782.83287.3c","title":"Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?","year":2006,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Duloxetine; Fibromyalgia; Antidepressant; Analgesic; Placebo; Medicine; Major depressive disorder; Anesthesia; Neuropathic pain; Chronic pain; Duloxetine Hydrochloride; Psychology; Internal medicine; Psychiatry; Anxiety; Mood","score_opus":0.08980493269877934,"score_gpt":0.5331173373544522,"score_spread":0.4433124046556729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991193159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03969378,0.9481759,0.00006359554,0.0002433411,0.005770602,0.003303392,0.00019794477,0.00010381416,0.0024476293],"genre_scores_gemma":[0.007304363,0.98877186,0.00033062845,0.0004801076,0.0013059536,0.00020849484,0.00073265686,0.00008267091,0.0007832761],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99471784,0.0011718154,0.0024497455,0.0008838125,0.00041576524,0.00036104763],"domain_scores_gemma":[0.9948372,0.0034147487,0.000929781,0.00044221524,0.00013456111,0.00024149507],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015847188,0.0005187761,0.0029806483,0.0005822283,0.000022015756,0.000011123432,0.00052411645,0.0006723542,0.0011416076],"category_scores_gemma":[0.000643948,0.0003525123,0.00093293434,0.00035471396,0.00018218368,0.000060768874,0.000097603115,0.00092161744,0.000112927555],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004504051,0.005380877,0.010596057,0.0025237277,0.0019730276,0.001600728,0.0000053426593,0.0000030811298,0.0000066100056,0.00007203919,0.0024896923,0.97084475],"study_design_scores_gemma":[0.029487403,0.0047230837,0.02305525,0.007435447,0.0033316303,0.00023939436,0.0000014892272,0.00014616708,0.0000066151283,0.000103967584,0.93098974,0.00047983212],"about_ca_topic_score_codex":0.000057524998,"about_ca_topic_score_gemma":0.000020246584,"teacher_disagreement_score":0.9703649,"about_ca_system_score_codex":0.00015129324,"about_ca_system_score_gemma":0.0002771505,"threshold_uncertainty_score":0.9998927},"labels":[],"label_agreement":null},{"id":"W1991997150","doi":"10.1097/00004850-200211000-00009","title":"Dysphoric mania induced by high-dose mirtazapine: a case for ???norepinephrine syndrome????","year":2002,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Mirtazapine; Mania; Norepinephrine; Serotonin syndrome; Medicine; Anesthesia; Bipolar disorder; Internal medicine; Psychiatry; Serotonin; Antidepressant; Receptor; Dopamine; Serotonergic; Anxiety; Lithium (medication)","score_opus":0.06827330872237859,"score_gpt":0.4393751703315637,"score_spread":0.3711018616091851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991997150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95683736,0.00088915497,0.00011533767,0.034888048,0.004354333,0.0012229409,0.00009673562,0.00013375179,0.0014623685],"genre_scores_gemma":[0.9760827,0.0011177857,0.0010789289,0.014929331,0.0012119042,0.00044757844,0.000071330476,0.00006105652,0.0049994015],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973398,0.00012503842,0.0010926803,0.0007062606,0.00027737702,0.000458861],"domain_scores_gemma":[0.99758595,0.0010100129,0.0003092276,0.000366257,0.00045699617,0.00027156874],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043317076,0.000307954,0.0006870464,0.00019524925,0.00010739777,0.000015856784,0.00040322752,0.0002452319,0.0034802863],"category_scores_gemma":[0.0006323389,0.00028426628,0.00031213195,0.0002192479,0.00017655955,0.000086107895,0.000106407206,0.000617058,0.00036398825],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008051004,0.0043261773,0.0055679674,0.00007987296,0.0043764324,0.0059883664,0.00010469364,0.0000016485529,0.083396606,0.0005765079,0.85986674,0.027663961],"study_design_scores_gemma":[0.14243098,0.022255257,0.046545193,0.0001363525,0.0016157604,0.034830794,0.0001134237,0.0027837094,0.003844619,0.0040290467,0.7396835,0.0017313753],"about_ca_topic_score_codex":0.000041687683,"about_ca_topic_score_gemma":0.000018349521,"teacher_disagreement_score":0.13437997,"about_ca_system_score_codex":0.00015117662,"about_ca_system_score_gemma":0.00002962923,"threshold_uncertainty_score":0.99996096},"labels":[],"label_agreement":null},{"id":"W1992547531","doi":"10.1097/01.yic.0000277959.60604.d1","title":"High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder","year":2007,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"VGH and UBC Hospital Foundation","keywords":"Depression (economics); Medicine; Psychosocial; Quality of life (healthcare); Internal medicine; Sexual dysfunction; Psychology; Psychiatry","score_opus":0.08221312398091613,"score_gpt":0.47471126675328484,"score_spread":0.3924981427723687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992547531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017115263,0.9636008,0.0009603434,0.00067320437,0.008768356,0.0064852643,0.0009293938,0.00007535923,0.0013920194],"genre_scores_gemma":[0.0119761145,0.9740702,0.0061432426,0.0006988155,0.0022273713,0.000636299,0.0019626387,0.00016478739,0.0021205465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954603,0.0004046841,0.0020474745,0.0009160145,0.0008486523,0.0003229222],"domain_scores_gemma":[0.9953715,0.001343908,0.0018608237,0.00058151205,0.0006245304,0.00021773438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063928275,0.0004961291,0.0019505054,0.00018220444,0.000095919975,0.00001043833,0.00075379066,0.00081061583,0.00030964898],"category_scores_gemma":[0.0004125808,0.0002667684,0.0012227474,0.000213257,0.00035124677,0.00005969269,0.00023622147,0.00089554937,0.0000115382445],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008730319,0.008274579,0.014453784,0.0036502825,0.0050693825,0.000012332079,0.000008435846,0.00005977304,0.0000029730945,0.0003479555,0.006386135,0.95300406],"study_design_scores_gemma":[0.046934128,0.0014575489,0.067058384,0.0053614764,0.010709933,0.00006125634,0.0000044840435,0.000030511343,0.000018195959,0.00017329422,0.8675297,0.00066108187],"about_ca_topic_score_codex":0.000011802894,"about_ca_topic_score_gemma":0.0000014135959,"teacher_disagreement_score":0.952343,"about_ca_system_score_codex":0.00011292366,"about_ca_system_score_gemma":0.00022412097,"threshold_uncertainty_score":0.9999784},"labels":[],"label_agreement":null},{"id":"W1993305638","doi":"10.1097/yic.0b013e328013f89d","title":"Lamotrigine in the treatment of recurrent brief depression","year":2007,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Lamotrigine; Venlafaxine; Depression (economics); Suicidal ideation; Antidepressant; Anticonvulsant; Psychiatry; Bipolar disorder; Psychology; Medicine; Reuptake inhibitor; Fluoxetine; Psychotic depression; Internal medicine; Epilepsy; Poison control; Psychosis; Suicide prevention; Lithium (medication); Serotonin","score_opus":0.06425131639068486,"score_gpt":0.492688439523282,"score_spread":0.42843712313259713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993305638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97714156,0.0027523022,0.00013922196,0.003999275,0.0020807341,0.00043977748,0.000008633742,0.000013536305,0.013424988],"genre_scores_gemma":[0.99565804,0.0025321366,0.0002050964,0.000911582,0.0004242927,0.000022812867,0.00002719319,0.0000067611554,0.00021211161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987772,0.00008289294,0.0005846007,0.00021250006,0.00019926639,0.0001435174],"domain_scores_gemma":[0.9990314,0.00057992735,0.00011062351,0.00014500749,0.00006732499,0.00006567355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049679744,0.00009665238,0.00022495836,0.00010434104,0.000014863536,0.0000027286137,0.0001305539,0.00009105191,0.0003516119],"category_scores_gemma":[0.000042724143,0.00005806963,0.0001458331,0.00010890214,0.000088748835,0.000020225065,0.000010022529,0.0001557301,0.000029206303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041883807,0.008974025,0.74976695,0.000006752421,0.00022123026,0.00006844383,0.00016314653,0.0000013477054,0.0004445267,0.00023085448,0.0011424118,0.23479193],"study_design_scores_gemma":[0.010843344,0.0018432246,0.7984746,0.000017194403,0.00008022053,0.000037613525,0.000020978709,0.00004215947,0.00037236922,0.00022403542,0.18800108,0.000043169726],"about_ca_topic_score_codex":0.00004226661,"about_ca_topic_score_gemma":0.00013875919,"teacher_disagreement_score":0.23474877,"about_ca_system_score_codex":0.00006589169,"about_ca_system_score_gemma":0.000030380563,"threshold_uncertainty_score":0.38499036},"labels":[],"label_agreement":null},{"id":"W1993810555","doi":"10.1097/yic.0b013e32833e34d9","title":"Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder","year":2010,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"START Clinic","funders":"National Institutes of Health; National Institute of Mental Health; AstraZeneca","keywords":"Quetiapine; Quetiapine Fumarate; Placebo; Tolerability; Anxiety; Internal medicine; Atypical antipsychotic; Hamilton Anxiety Rating Scale; Medicine; Psychology; Somnolence; Psychiatry; Anesthesia; Adverse effect; Antipsychotic; Schizophrenia (object-oriented programming)","score_opus":0.05208654081187643,"score_gpt":0.4759349710285205,"score_spread":0.4238484302166441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993810555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86944056,0.0036853654,0.01489921,0.030395435,0.049649816,0.0038165238,0.00054080674,0.0005610175,0.027011279],"genre_scores_gemma":[0.89940655,0.039463308,0.0038492735,0.011275536,0.0058784056,0.0031196263,0.00035555678,0.00019091368,0.036460817],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994845,0.00046091742,0.0015620717,0.0018515761,0.00040476187,0.00087569497],"domain_scores_gemma":[0.99545354,0.0014411506,0.0008149893,0.0007357151,0.0010409041,0.0005136851],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00084755645,0.00071469496,0.00083931437,0.0004534789,0.0002342705,0.000077744095,0.00100388,0.0006759148,0.017837768],"category_scores_gemma":[0.00085878803,0.0006056882,0.0007670267,0.00048234867,0.00057257613,0.0002270402,0.000092650116,0.00082784216,0.0013419235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030498797,0.01233885,0.059840456,0.00002225909,0.0035303482,0.00007632036,0.00036682605,0.000020548407,0.0045682094,0.013869553,0.23329407,0.6415738],"study_design_scores_gemma":[0.03763277,0.0017908773,0.031243896,0.000015906024,0.00024634454,0.00007680056,0.00006072977,0.00043643446,0.00051456026,0.017271634,0.910082,0.00062808377],"about_ca_topic_score_codex":0.000266203,"about_ca_topic_score_gemma":0.00013641498,"teacher_disagreement_score":0.6767879,"about_ca_system_score_codex":0.00015327321,"about_ca_system_score_gemma":0.0001721096,"threshold_uncertainty_score":0.99963945},"labels":[],"label_agreement":null},{"id":"W1994418013","doi":"10.1097/00004850-200511000-00002","title":"Effect of valproate on plasma levels of interleukin-6 in healthy male humans","year":2005,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto; University of British Columbia","funders":"","keywords":"Valproic Acid; Evening; Blood sampling; Epilepsy; Medicine; Morning; Internal medicine; Endocrinology; Anticonvulsant; Cytokine; Plasma levels; Interleukin 6; Immune system; Interleukin; Immunology; Psychiatry","score_opus":0.08186881126748956,"score_gpt":0.5092163322183121,"score_spread":0.4273475209508225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994418013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97771776,0.00007664333,0.000013236183,0.008582029,0.0018371087,0.00057862216,0.000050395956,0.000020871983,0.011123329],"genre_scores_gemma":[0.99275637,0.00018645701,0.00014324003,0.005894721,0.0005149509,0.000045416808,0.000005919267,0.000013665472,0.00043924022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975052,0.00042905516,0.0011576762,0.00037641748,0.00028923017,0.00024244371],"domain_scores_gemma":[0.9965246,0.0027590774,0.00033444143,0.00013298915,0.00012052683,0.00012838702],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001418059,0.00018501925,0.00079490076,0.00024206594,0.000019525189,0.000002312704,0.00025488628,0.00017306131,0.0018926578],"category_scores_gemma":[0.000594444,0.00013837514,0.00028453663,0.00013932472,0.00030882514,0.000046692276,0.00008368423,0.0006106648,0.000089698624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18332246,0.0133017935,0.34454283,0.00063729775,0.0022763156,0.0003440158,0.00031189722,0.00075711234,0.10929934,0.0012123793,0.0253721,0.31862247],"study_design_scores_gemma":[0.1167658,0.07687057,0.6433271,0.00062876183,0.00048004312,0.000103415674,0.0000261051,0.0069818683,0.08788437,0.00034567213,0.06597664,0.00060964626],"about_ca_topic_score_codex":0.00001130414,"about_ca_topic_score_gemma":0.000014691718,"teacher_disagreement_score":0.31801283,"about_ca_system_score_codex":0.00009803935,"about_ca_system_score_gemma":0.000040397044,"threshold_uncertainty_score":0.99901974},"labels":[],"label_agreement":null},{"id":"W1995880596","doi":"10.1097/00004850-200207000-00007","title":"Do triglycerides modulate the effectiveness of clozapine?","year":2002,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Riverview Hospital","funders":"","keywords":"Clozapine; Triglyceride; Plasma levels; Internal medicine; Endocrinology; Blood lipids; Medicine; Pharmacology; Cholesterol; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.08566928400029161,"score_gpt":0.47022307356801757,"score_spread":0.38455378956772596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995880596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98244345,0.0007359709,0.00005441904,0.007047413,0.0021145055,0.0004918139,0.00001736691,0.00002611411,0.0070689153],"genre_scores_gemma":[0.99653465,0.0014132122,0.00025709372,0.0006828611,0.0005356863,0.00006848152,0.000008732566,0.000012140672,0.0004871552],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99829715,0.00047007715,0.00047753195,0.000273848,0.00031221323,0.00016916046],"domain_scores_gemma":[0.9968853,0.0024380977,0.000109175155,0.0002216676,0.00020968824,0.00013606153],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010587913,0.00010817389,0.0002973083,0.000088734676,0.000034067074,0.000008472519,0.00025213737,0.00008964042,0.0033298694],"category_scores_gemma":[0.0005597085,0.00006588053,0.00026533141,0.00012843598,0.00029021595,0.000036806236,0.000054499742,0.0003348736,0.00030221723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34895703,0.009764069,0.2677297,0.0001819634,0.007526294,0.00073062227,0.00008714588,0.00013242624,0.017749015,0.015859207,0.044611234,0.28667128],"study_design_scores_gemma":[0.056065906,0.0027852987,0.8956545,0.00011468762,0.00027867875,0.00019536166,0.000012311265,0.0037150965,0.0029943949,0.010658802,0.027347999,0.00017694783],"about_ca_topic_score_codex":0.000011032097,"about_ca_topic_score_gemma":0.0000018976343,"teacher_disagreement_score":0.6279248,"about_ca_system_score_codex":0.000047640093,"about_ca_system_score_gemma":0.000034102857,"threshold_uncertainty_score":0.99758124},"labels":[],"label_agreement":null},{"id":"W2000541904","doi":"10.1097/00004850-200015050-00003","title":"A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression","year":2000,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada East Spine Centre","funders":"","keywords":"Sertraline; Clomipramine; Tolerability; Clinical Global Impression; Psychology; Serotonin reuptake inhibitor; Internal medicine; Medicine; Anesthesia; Adverse effect; Antidepressant; Placebo","score_opus":0.048852164935280065,"score_gpt":0.4310610305031207,"score_spread":0.38220886556784067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000541904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962282,0.00009902369,0.0000011559015,0.0011556222,0.00031430373,0.0012214906,0.000012026245,0.0000084417015,0.00095969683],"genre_scores_gemma":[0.9987782,0.00016001686,0.0001324806,0.0002457541,0.00007310467,0.000025520163,0.000009113126,0.000011942331,0.0005638188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984256,0.00014351228,0.0007152841,0.00032737915,0.0002824131,0.00010582334],"domain_scores_gemma":[0.99901557,0.0004114593,0.00022223103,0.00018159408,0.00008848183,0.00008065351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025002376,0.00012718486,0.00036315896,0.00008598344,0.000022363869,0.0000031384254,0.00013814773,0.00010505057,0.00035293362],"category_scores_gemma":[0.00005210623,0.00007519845,0.000041624782,0.00011526732,0.00016795727,0.00005426898,0.00007506296,0.00027194535,0.0000020598923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16115624,0.0053226133,0.8134815,0.000018220915,0.0002565142,0.000019508443,0.00019584385,0.00004633644,0.00051687233,0.0000031359032,0.00011994249,0.018863242],"study_design_scores_gemma":[0.17168526,0.0018643219,0.82530224,0.00014530227,0.00015980547,0.000041243336,0.00003437859,0.00008908241,0.00019873025,0.000015364156,0.00040717644,0.000057089575],"about_ca_topic_score_codex":0.00008015185,"about_ca_topic_score_gemma":0.00007977052,"teacher_disagreement_score":0.018806154,"about_ca_system_score_codex":0.000020764272,"about_ca_system_score_gemma":0.000027504646,"threshold_uncertainty_score":0.38643757},"labels":[],"label_agreement":null},{"id":"W2003131209","doi":"10.1097/yic.0b013e32831daf6c","title":"Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study","year":2008,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Montreal Neurological Institute and Hospital; Hôpital Louis-H Lafontaine","funders":"","keywords":"Quetiapine; Voxel-based morphometry; Anterior cingulate cortex; Grey matter; Psychology; Clinical Global Impression; Prefrontal cortex; Positive and Negative Syndrome Scale; Orbitofrontal cortex; Schizophrenia (object-oriented programming); Cingulate cortex; Scale for the Assessment of Negative Symptoms; Internal medicine; Audiology; Psychiatry; Medicine; Psychosis; Brief Psychiatric Rating Scale; Magnetic resonance imaging; Cognition; White matter; Pathology; Central nervous system","score_opus":0.024532997260244938,"score_gpt":0.36655062608064015,"score_spread":0.3420176288203952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003131209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564195,0.00006211217,0.00001955018,0.0017263354,0.00034348224,0.0018242641,0.000059319464,0.000049244394,0.0002737279],"genre_scores_gemma":[0.9948503,0.000027115484,0.0013160734,0.0021886842,0.00027824193,0.0008593488,0.00010815433,0.00004871239,0.0003234087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702936,0.0003600171,0.0007468808,0.00074175757,0.00071313913,0.00040882925],"domain_scores_gemma":[0.9978816,0.0007327108,0.00019267568,0.00032249012,0.00048356582,0.00038699392],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018981742,0.0003831041,0.00069085247,0.00054358126,0.0000678754,0.000022200516,0.00017629893,0.00013138176,0.0017367436],"category_scores_gemma":[0.00008674688,0.00024644242,0.00015618066,0.00036005743,0.00045873466,0.00012010527,0.000044773828,0.00047774322,0.0003180554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23752153,0.010889162,0.7472382,0.000006390405,0.0011667231,0.0015602905,0.000107536456,0.000010909568,0.000006724779,0.000002100865,0.00037190178,0.0011184884],"study_design_scores_gemma":[0.12312011,0.012406925,0.86355513,0.00006121884,0.00019898142,0.00004965198,0.00004250602,0.0001524824,0.00006491721,0.000022728154,0.00011891996,0.00020641099],"about_ca_topic_score_codex":0.00034201916,"about_ca_topic_score_gemma":0.0006069935,"teacher_disagreement_score":0.116316915,"about_ca_system_score_codex":0.0004252592,"about_ca_system_score_gemma":0.00049571384,"threshold_uncertainty_score":0.9999988},"labels":[],"label_agreement":null},{"id":"W2006347666","doi":"10.1097/yic.0b013e3282f424d6","title":"Weight gain during olanzapine treatment for psychotic depression: effects of dose and age","year":2008,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Rehabilitation Institute; Toronto General Hospital; University Health Network","funders":"National Center for Advancing Translational Sciences; National Institute of Mental Health; Pfizer Canada; Forest Laboratories; Pfizer; Eli Lilly and Company; American Psychiatric Institute for Research and Education; U.S. Public Health Service; AstraZeneca","keywords":"Olanzapine; Weight gain; Medicine; Body mass index; Depression (economics); Confounding; Confidence interval; Placebo; Sertraline; Internal medicine; Schizophrenia (object-oriented programming); Psychology; Psychiatry; Body weight; Antidepressant","score_opus":0.06542924480534483,"score_gpt":0.4606878485556022,"score_spread":0.39525860375025734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006347666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939321,0.0009321521,0.0000754493,0.0021903026,0.0014734791,0.0008988352,0.000018985502,0.000028471914,0.00045017153],"genre_scores_gemma":[0.9912775,0.0037738215,0.0023899828,0.00041092685,0.0007762672,0.00023342324,0.00003514409,0.00001812166,0.0010847856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986387,0.0000853971,0.00048359443,0.00037851918,0.0002016754,0.0002121205],"domain_scores_gemma":[0.99829674,0.0010453513,0.000117816824,0.0001615123,0.00010830661,0.0002702837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012519737,0.00015291461,0.0004139848,0.00013487763,0.00006056868,0.0000037846944,0.00010394667,0.00011157294,0.0002043918],"category_scores_gemma":[0.00020110294,0.00011182042,0.00021420581,0.00006199141,0.0002088393,0.00003619219,0.00003237543,0.00015081037,0.000020883348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2999776,0.013536161,0.51879555,0.0004727636,0.005723329,0.005713802,0.0002863502,0.000009043781,0.061836876,0.00052517845,0.011983698,0.081139676],"study_design_scores_gemma":[0.09255612,0.0032477959,0.88949084,0.0000921469,0.00021066694,0.00039006508,0.0000033224374,0.00023999976,0.010018875,0.00077588484,0.0028501854,0.00012407172],"about_ca_topic_score_codex":0.000009231257,"about_ca_topic_score_gemma":0.0000063086723,"teacher_disagreement_score":0.37069535,"about_ca_system_score_codex":0.000068942274,"about_ca_system_score_gemma":0.00007463446,"threshold_uncertainty_score":0.45599043},"labels":[],"label_agreement":null},{"id":"W2007245256","doi":"10.1097/yic.0b013e3282eff7e0","title":"Which antidepressants have demonstrated superior efficacy? A review of the evidence","year":2007,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Ottawa","funders":"H. Lundbeck A/S","keywords":"Escitalopram; Venlafaxine; Mirtazapine; Duloxetine; Clomipramine; Milnacipran; Antidepressant; Major depressive disorder; Randomized controlled trial; MEDLINE; Psychiatry; Psychology; Medicine; Clinical psychology; Internal medicine; Alternative medicine; Anxiety; Mood","score_opus":0.256882085168053,"score_gpt":0.5804082420169554,"score_spread":0.3235261568489024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007245256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034514244,0.98431665,0.00000912171,0.0027210345,0.0061135287,0.0026329753,0.000082356906,0.00005387373,0.0037252954],"genre_scores_gemma":[0.0005939216,0.9939498,0.0001947154,0.002582834,0.00094067166,0.00010330247,0.00008103707,0.00006492634,0.0014888486],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937378,0.0009951375,0.0031126654,0.0009085883,0.00089753786,0.00034823443],"domain_scores_gemma":[0.9921523,0.004470164,0.0015220519,0.00084517227,0.00076103,0.00024928793],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019550875,0.00051536073,0.0027661119,0.00021696181,0.00005071797,0.000011432877,0.0012173017,0.0007362058,0.0020596131],"category_scores_gemma":[0.0048298137,0.00030736282,0.0016683437,0.00050559966,0.0004028035,0.00008378262,0.00032280805,0.0016499194,0.00023080385],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007542832,0.0017282869,0.005042733,0.031990122,0.0021329527,0.00013363117,0.000004428284,2.0091439e-7,0.000019318952,0.000014380238,0.04080731,0.91737235],"study_design_scores_gemma":[0.0022948429,0.00018523278,0.0050068153,0.23578101,0.0034601996,0.00033491378,7.7443804e-7,0.000004251411,0.000009711066,0.0000054080874,0.7527322,0.00018459499],"about_ca_topic_score_codex":0.000008629798,"about_ca_topic_score_gemma":0.0000076081656,"teacher_disagreement_score":0.91718775,"about_ca_system_score_codex":0.0001556819,"about_ca_system_score_gemma":0.0007621234,"threshold_uncertainty_score":0.99993783},"labels":[],"label_agreement":null},{"id":"W2009607401","doi":"10.1097/yic.0000000000000017","title":"Extended-release quetiapine fumarate (quetiapine XR) versus risperidone in the treatment of depressive symptoms in patients with schizoaffective disorder or schizophrenia","year":2013,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier; Les Laboratories Pierre Fabre; Eli Lilly and Company","keywords":"Quetiapine; Risperidone; Quetiapine Fumarate; Schizoaffective disorder; Population; Olanzapine; Atypical antipsychotic; Psychology; Psychiatry; Schizophrenia (object-oriented programming); Internal medicine; Medicine; Psychosis; Antipsychotic","score_opus":0.021367465840897257,"score_gpt":0.3842384638397511,"score_spread":0.3628709979988538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009607401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232966,0.00034412037,0.00001849561,0.003481423,0.0009969911,0.0022148618,0.0000253203,0.000029851915,0.0005592551],"genre_scores_gemma":[0.9975121,0.0005102902,0.00024132435,0.00046350213,0.00027173507,0.00063047453,0.00009822197,0.000033942273,0.00023840183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726343,0.0004404045,0.00089276157,0.0006100688,0.00047733105,0.00031599595],"domain_scores_gemma":[0.99760306,0.0012486526,0.00036465918,0.00036360775,0.00027215588,0.00014788406],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017742014,0.00033003837,0.0006278724,0.00029085053,0.000034886507,0.000015814485,0.0003148146,0.0001922528,0.0012797585],"category_scores_gemma":[0.000224886,0.00018155265,0.00016874564,0.00029234172,0.00030032668,0.00017454285,0.000047059308,0.0004063079,0.00011448203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.124443255,0.019025352,0.7960503,0.000015852136,0.00095424097,0.00014488123,0.00018162138,0.000085886575,0.0001450965,0.00005308846,0.0010205555,0.057879858],"study_design_scores_gemma":[0.11927633,0.010341996,0.86837775,0.000106506064,0.0001817456,0.0000067074575,0.000026219543,0.00034160068,0.0001108727,0.00009898772,0.00097455346,0.00015675646],"about_ca_topic_score_codex":0.0003586694,"about_ca_topic_score_gemma":0.00028157007,"teacher_disagreement_score":0.07232742,"about_ca_system_score_codex":0.00021876246,"about_ca_system_score_gemma":0.0000990381,"threshold_uncertainty_score":0.9996332},"labels":[],"label_agreement":null},{"id":"W2009666409","doi":"10.1097/yic.0b013e3283430a0e","title":"Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders","year":2011,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Louis-H Lafontaine; Université de Montréal","funders":"","keywords":"Quetiapine; Tolerability; Atypical antipsychotic; Placebo; Mania; Bipolar disorder; Psychiatry; Medicine; Quetiapine Fumarate; Antipsychotic; Schizophrenia (object-oriented programming); Generalized anxiety disorder; Psychology; Internal medicine; Anxiety; Adverse effect; Lithium (medication)","score_opus":0.1720207555705169,"score_gpt":0.5424592692725886,"score_spread":0.3704385137020717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009666409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02965216,0.9654272,0.000010737786,0.0006994308,0.0015541422,0.0012902142,0.00015661532,0.000028644283,0.0011808487],"genre_scores_gemma":[0.04405392,0.9549243,0.00023354695,0.00016497086,0.00022596154,0.00008856844,0.00006750027,0.000024296882,0.00021697785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99671847,0.00066643115,0.001492255,0.00072292495,0.00016594407,0.00023400593],"domain_scores_gemma":[0.9969363,0.0018337857,0.0005873872,0.0002694753,0.00012874603,0.00024430946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008257226,0.00039090955,0.002073522,0.00016141337,0.000050689363,0.000009872424,0.0002171091,0.00043326404,0.00035740397],"category_scores_gemma":[0.00018419775,0.0002996817,0.00039761016,0.00016127406,0.00074751856,0.00004225916,0.00014907331,0.0007245664,0.000036782803],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01006283,0.0039602686,0.015695382,0.0017499046,0.0026102113,0.0000057860566,0.0002116951,8.2967404e-8,0.0000017502367,0.0002291147,0.0008114641,0.96466154],"study_design_scores_gemma":[0.009085201,0.0017552474,0.12370037,0.00046043642,0.0014100481,0.000074075106,0.000012583808,0.0000051981633,2.640493e-7,0.00021467263,0.8630699,0.00021199987],"about_ca_topic_score_codex":0.00003762422,"about_ca_topic_score_gemma":0.00004681722,"teacher_disagreement_score":0.9644495,"about_ca_system_score_codex":0.000045688223,"about_ca_system_score_gemma":0.00016343925,"threshold_uncertainty_score":0.9999455},"labels":[],"label_agreement":null},{"id":"W2015979089","doi":"10.1097/00004850-200507000-00007","title":"Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo","year":2005,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Venlafaxine; Paroxetine; Fluoxetine; Placebo; Reuptake inhibitor; Venlafaxine Hydrochloride; Internal medicine; Psychology; Major depressive disorder; Hamilton Rating Scale for Depression; Anesthesia; Medicine; Psychiatry; Antidepressant; Serotonin; Mood; Anxiety","score_opus":0.08536644269240524,"score_gpt":0.5003743618899092,"score_spread":0.415007919197504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015979089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93825865,0.00016440937,0.00009574233,0.049891587,0.0024390172,0.00076080015,0.000033102955,0.00010839839,0.008248282],"genre_scores_gemma":[0.97412974,0.00013620028,0.0067490414,0.004050466,0.0017238194,0.00006154925,0.00009275154,0.000035170342,0.013021235],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972672,0.00019501349,0.0012643684,0.00054488797,0.0004214901,0.00030702678],"domain_scores_gemma":[0.9973223,0.0011994167,0.00034280698,0.00027713864,0.0004307141,0.00042758154],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00055845635,0.0002560952,0.00062507275,0.00022092705,0.000043246146,0.000011057871,0.00032916744,0.00022140742,0.008607529],"category_scores_gemma":[0.00074235065,0.00018705543,0.00020570829,0.0002161458,0.0001556345,0.00008456212,0.00011916474,0.00037944876,0.00030323866],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13178013,0.0072608474,0.29132557,0.000099961406,0.0011651876,0.00041065193,0.00009750788,0.00031783475,0.12794153,0.0002081295,0.40141484,0.037977822],"study_design_scores_gemma":[0.06278101,0.0029493433,0.36618355,0.00041397283,0.00047150423,0.00014113246,0.000077763456,0.0023431287,0.038202226,0.00021180899,0.5257198,0.0005047016],"about_ca_topic_score_codex":0.00001131996,"about_ca_topic_score_gemma":0.000008107809,"teacher_disagreement_score":0.124305,"about_ca_system_score_codex":0.00013079909,"about_ca_system_score_gemma":0.0001405618,"threshold_uncertainty_score":0.9922987},"labels":[],"label_agreement":null},{"id":"W2022871996","doi":"10.1097/00004850-200405000-00001","title":"A review of acute treatments for bipolar depression","year":2004,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Lamotrigine; Bipolar disorder; Mood stabilizer; Bupropion; Lithium (medication); Antidepressant; Carbamazepine; Olanzapine; Electroconvulsive therapy; Mania; Psychiatry; Quetiapine; Psychology; Divalproex; Medicine; Atypical antipsychotic; Antipsychotic; Epilepsy; Schizophrenia (object-oriented programming); Anxiety","score_opus":0.11384981653883985,"score_gpt":0.5568993853070621,"score_spread":0.4430495687682222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022871996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000018057,0.9918649,0.00008683451,0.0004944399,0.0030909134,0.0029018,0.00076198846,0.0000334475,0.00076387124],"genre_scores_gemma":[0.0000031454333,0.9941282,0.0010257682,0.0013609038,0.00050645554,0.0007597416,0.0014695458,0.000060067694,0.0006861437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997003,0.0001563009,0.0017638406,0.00061521336,0.00023771037,0.00022392583],"domain_scores_gemma":[0.9978404,0.0005260099,0.00084864727,0.0003348646,0.00025782033,0.00019228026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035459994,0.00038897095,0.0023840829,0.000187399,0.000028984123,0.000004012914,0.00033722076,0.0004657355,0.0007563936],"category_scores_gemma":[0.00012888925,0.00027360825,0.0018284508,0.00014355824,0.00011626722,0.000034686633,0.00007245738,0.0004309262,0.0001330461],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003973743,0.0020462468,0.00025721293,0.044255596,0.0120881265,0.000019102796,0.000002074245,1.5832695e-8,0.0000011868037,0.00003422962,0.0067944787,0.9341044],"study_design_scores_gemma":[0.006013644,0.0007896728,0.00011948028,0.07821068,0.02203718,0.00016066687,1.7948364e-7,7.9840123e-7,0.0000015060159,0.00010358498,0.89241135,0.00015125069],"about_ca_topic_score_codex":0.0000067883966,"about_ca_topic_score_gemma":8.705028e-7,"teacher_disagreement_score":0.9339531,"about_ca_system_score_codex":0.00020493752,"about_ca_system_score_gemma":0.0005065546,"threshold_uncertainty_score":0.9999716},"labels":[],"label_agreement":null},{"id":"W2026016551","doi":"10.1097/01.yic.0000166403.03732.72","title":"Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials","year":2005,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Risperidone; Placebo; Aggression; Psychology; Conduct disorder; Psychiatry; Randomized controlled trial; Crying; Intelligence quotient; Clinical psychology; Medicine; Internal medicine; Schizophrenia (object-oriented programming); Cognition","score_opus":0.04852347797344033,"score_gpt":0.45601085038314365,"score_spread":0.40748737240970334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026016551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858096,0.0009706781,0.0014653935,0.005367409,0.0028138054,0.0011849226,0.000069534224,0.000023063929,0.0022955772],"genre_scores_gemma":[0.9948082,0.0020324595,0.00041072475,0.0009979514,0.0005363169,0.00019027846,0.00006636872,0.000015491469,0.00094218604],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994661,0.0016797889,0.0023505446,0.00066568574,0.00036119024,0.00028179158],"domain_scores_gemma":[0.9950462,0.0034734558,0.0010191863,0.00013724485,0.00017264711,0.00015124766],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003946265,0.00027536863,0.0020461963,0.00058631407,0.00006364647,0.000023117149,0.00030791634,0.00017194066,0.00341394],"category_scores_gemma":[0.0005518711,0.00019230707,0.0006630874,0.00045544346,0.00043762085,0.0001050302,0.00006599228,0.0004431205,0.000033719734],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75560063,0.0059898803,0.15325566,0.000010384604,0.010659267,0.000044839533,0.002660787,0.0017481772,0.00014892242,0.003494516,0.0015205055,0.064866446],"study_design_scores_gemma":[0.73174584,0.00041281985,0.25394523,0.0003860933,0.0028144433,0.000014073759,0.00046977983,0.0060129743,0.00006369344,0.0016949687,0.0018152327,0.0006248667],"about_ca_topic_score_codex":0.00010771961,"about_ca_topic_score_gemma":0.00025054548,"teacher_disagreement_score":0.10068958,"about_ca_system_score_codex":0.00005245373,"about_ca_system_score_gemma":0.000050556224,"threshold_uncertainty_score":0.9974971},"labels":[],"label_agreement":null},{"id":"W2027478291","doi":"10.1097/01.yic.0000170263.46008.54","title":"Major depressive episode with psychotic features induced by pegylated interferon-α-2b and ribavirin treatment","year":2005,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Ribavirin; Pegylated interferon; Alpha interferon; Medicine; Psychosis; Depression (economics); Hepatitis C; Chronic hepatitis; Interferon; Psychiatry; Immunology; Virology; Pharmacology; Internal medicine; Gastroenterology; Virus","score_opus":0.05643365514573141,"score_gpt":0.4710022976697225,"score_spread":0.4145686425239911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027478291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96283436,0.00044553546,0.00008815682,0.026139984,0.0008789926,0.00074228237,0.00006572151,0.00008158934,0.008723355],"genre_scores_gemma":[0.9878883,0.0010308531,0.0006559232,0.0052422252,0.0008545231,0.00015617035,0.00008688818,0.000047057423,0.0040381006],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975177,0.00025610602,0.00069350586,0.0007217574,0.0004089049,0.0004020271],"domain_scores_gemma":[0.9982498,0.00059917185,0.00017461125,0.0002633236,0.00024981768,0.00046326313],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028596347,0.00028575747,0.00050372386,0.00019812965,0.0000730926,0.000039421753,0.0002707628,0.0002859662,0.0017814591],"category_scores_gemma":[0.00017655945,0.00021550687,0.00012746868,0.00013500192,0.00030487016,0.00013481673,0.00007211651,0.0007723079,0.0002968691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031669088,0.0055469763,0.2920256,0.000034490968,0.004049503,0.00048608653,0.00027083987,0.000015291784,0.048353124,0.0001377683,0.13910449,0.47830674],"study_design_scores_gemma":[0.09177957,0.015623821,0.4542286,0.0002343164,0.0007272009,0.0005772841,0.000049710066,0.0024462156,0.0117040165,0.00027845008,0.42139608,0.00095472974],"about_ca_topic_score_codex":0.00016212343,"about_ca_topic_score_gemma":0.00029920903,"teacher_disagreement_score":0.47735202,"about_ca_system_score_codex":0.00023756285,"about_ca_system_score_gemma":0.00010247057,"threshold_uncertainty_score":0.999131},"labels":[],"label_agreement":null},{"id":"W2028794531","doi":"10.1097/00004850-200309000-00007","title":"Increased use of antibiotics in clozapine-treated patients","year":2003,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut universitaire en santé mentale de Montréal","funders":"","keywords":"Clozapine; Schizoaffective disorder; Medicine; Antibiotics; Medical prescription; Schizophrenia (object-oriented programming); Retrospective cohort study; Psychosis; Pediatrics; Internal medicine; Psychiatry; Pharmacology","score_opus":0.08360990557208188,"score_gpt":0.4579341082284898,"score_spread":0.3743242026564079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028794531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964188,0.000038463477,0.000008409393,0.0006449921,0.0009139588,0.00037714915,0.00003687399,0.00001573986,0.0015456243],"genre_scores_gemma":[0.9963963,0.0004239059,0.0017436718,0.001042632,0.000083394174,0.0000028533098,0.00007952501,0.000012844568,0.00021485575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831736,0.00025057615,0.0006897722,0.000274097,0.00027553318,0.00019265772],"domain_scores_gemma":[0.99853784,0.0006869229,0.00013241093,0.00015231317,0.00029807742,0.00019240908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030237547,0.00011250966,0.00031668058,0.0002223427,0.000011673017,0.000005982646,0.000103665785,0.00012874688,0.0007509558],"category_scores_gemma":[0.0013467019,0.000094605886,0.0001402947,0.00018628985,0.00013546468,0.00005960613,0.000025415573,0.00028701095,0.000082697836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015521577,0.0037954892,0.973388,0.000007752617,0.00029087954,0.00011314506,0.0000045393163,0.0000038071912,0.0006059906,0.0007133648,0.0025669392,0.0029885028],"study_design_scores_gemma":[0.029533643,0.0007700087,0.95717824,0.000030275165,0.00005114048,0.000009033351,0.0000023307973,0.00016033195,0.0021679392,0.00026000116,0.009764777,0.00007230784],"about_ca_topic_score_codex":0.00007918433,"about_ca_topic_score_gemma":0.00003546272,"teacher_disagreement_score":0.016209804,"about_ca_system_score_codex":0.000077788056,"about_ca_system_score_gemma":0.00012201454,"threshold_uncertainty_score":0.8222439},"labels":[],"label_agreement":null},{"id":"W2029612948","doi":"10.1097/00004850-200211000-00002","title":"Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine","year":2002,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Venlafaxine; Hamilton Rating Scale for Depression; Psychology; Placebo; Reuptake inhibitor; Paroxetine; Major depressive disorder; Venlafaxine Hydrochloride; Fluoxetine; Mood; Psychiatry; Anxiety disorder; Anxiety; Internal medicine; Antidepressant; Serotonin; Medicine","score_opus":0.037448981268113225,"score_gpt":0.3871625853630552,"score_spread":0.34971360409494195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029612948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839384,0.0003138074,0.000027147444,0.0074970727,0.001989973,0.0029120622,0.000036262467,0.000088549095,0.0031967082],"genre_scores_gemma":[0.9966977,0.00012156744,0.00027358034,0.0008787897,0.0009548424,0.0004059416,0.000035383222,0.00005707571,0.0005751236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955757,0.0008623583,0.001460991,0.00073662924,0.0010369514,0.00032734426],"domain_scores_gemma":[0.9935669,0.0033446117,0.0016198851,0.0006062892,0.00066369906,0.00019866791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010386412,0.00040931348,0.000931502,0.00018768164,0.00018711378,0.000015255013,0.0005126326,0.00027929866,0.0003732273],"category_scores_gemma":[0.0007472023,0.00022005034,0.00031501605,0.00044865158,0.0006118602,0.000106663436,0.00014433268,0.0013148962,0.000022305425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01788347,0.0044601164,0.8819894,0.00007587427,0.0010900858,0.00004284121,0.0009175913,0.00047884378,0.04187172,0.000030946165,0.046167284,0.0049918327],"study_design_scores_gemma":[0.033694398,0.009248076,0.6972066,0.002184355,0.00065061124,0.00007161475,0.00049131666,0.0068625966,0.23787424,0.00006867987,0.011251613,0.000395863],"about_ca_topic_score_codex":0.000027307076,"about_ca_topic_score_gemma":0.000026323032,"teacher_disagreement_score":0.19600251,"about_ca_system_score_codex":0.00015729097,"about_ca_system_score_gemma":0.000048979742,"threshold_uncertainty_score":0.8973392},"labels":[],"label_agreement":null},{"id":"W2029648794","doi":"10.1097/yic.0b013e32801182e6","title":"Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin","year":2007,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Douglas Mental Health University Institute; McGill University","funders":"","keywords":"Internal medicine; Metformin; Endocrinology; Insulin resistance; Medicine; Olanzapine; Placebo; Insulin; Leptin; Glucagon; Schizophrenia (object-oriented programming); Obesity","score_opus":0.021051681698661773,"score_gpt":0.38129224064773604,"score_spread":0.36024055894907425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029648794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99330956,0.00068223855,0.000018645525,0.0009993416,0.0030051696,0.00065623986,0.000013171572,0.000022095981,0.0012935647],"genre_scores_gemma":[0.9978682,0.00014879894,0.00014143866,0.00043458922,0.0006661159,0.000019284695,0.0000067838682,0.00001336783,0.0007014128],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985407,0.00007364061,0.0006467569,0.00027129296,0.0002799866,0.00018760214],"domain_scores_gemma":[0.99883944,0.00042357706,0.00027911988,0.00015001545,0.00019146466,0.00011639037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004781623,0.000153097,0.0003881108,0.00008705761,0.000053928095,0.0000058913106,0.00015306329,0.00012684397,0.000071162525],"category_scores_gemma":[0.00045301937,0.00010562944,0.00016467345,0.00010203504,0.00034505047,0.000071506314,0.000098306744,0.00029929302,0.00000626873],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051860316,0.0011893251,0.46413296,0.00027822936,0.0013005495,0.00008481311,0.00032105393,3.475033e-7,0.5196387,0.00062894047,0.0008287545,0.0064102476],"study_design_scores_gemma":[0.0045315414,0.0002938861,0.8307437,0.00008110443,0.00013842735,0.00001576237,0.000034251374,0.000003971385,0.15790999,0.00013750835,0.006029419,0.000080480546],"about_ca_topic_score_codex":0.0000073769907,"about_ca_topic_score_gemma":0.0000075261496,"teacher_disagreement_score":0.36661068,"about_ca_system_score_codex":0.000033376342,"about_ca_system_score_gemma":0.000066517605,"threshold_uncertainty_score":0.43074438},"labels":[],"label_agreement":null},{"id":"W2029931114","doi":"10.1097/01.yic.0000063501.97247.38","title":"Clozapine, quetiapine and olanzapine among addicted schizophrenic patients","year":2003,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Louis-H Lafontaine","funders":"","keywords":"Olanzapine; Quetiapine; Clozapine; Medicine; Psychiatry; Psychology; Schizophrenia (object-oriented programming)","score_opus":0.07605975851459768,"score_gpt":0.4851785600373764,"score_spread":0.40911880152277874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029931114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031184815,0.98821676,0.000007724547,0.00060136255,0.0040235305,0.0020318113,0.00024582917,0.00010494953,0.0016495646],"genre_scores_gemma":[0.0003022637,0.9924477,0.00070992945,0.0009238389,0.0014500058,0.00037224777,0.0015735504,0.00010415291,0.0021163085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951046,0.0006454115,0.0019185664,0.0011644596,0.0006338558,0.00053310767],"domain_scores_gemma":[0.9966905,0.000918979,0.00065022864,0.00045393087,0.00043861815,0.00084771245],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056420226,0.0006624677,0.0023280666,0.0005752995,0.000080537895,0.00004376716,0.0004323345,0.0007949345,0.0031922155],"category_scores_gemma":[0.00072858314,0.00050779077,0.0009350919,0.00034846115,0.00050576427,0.00009266856,0.00020025099,0.001777006,0.0006517314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058917664,0.0017316736,0.0045358925,0.0009749941,0.0034082239,0.00025079568,0.000002511005,5.0052194e-8,1.3648902e-7,0.00024372865,0.030214641,0.9527456],"study_design_scores_gemma":[0.022167703,0.0010104665,0.012611384,0.0018275968,0.0016639846,0.00013808715,7.2038404e-7,0.000017381028,1.8227196e-7,0.00016866744,0.96004003,0.00035379],"about_ca_topic_score_codex":0.000014650452,"about_ca_topic_score_gemma":0.000017242766,"teacher_disagreement_score":0.9523918,"about_ca_system_score_codex":0.00023710141,"about_ca_system_score_gemma":0.0005751607,"threshold_uncertainty_score":0.9997374},"labels":[],"label_agreement":null},{"id":"W2032636178","doi":"10.1097/yic.0000000000000014","title":"Pharmacological treatment of antipsychotic-induced dyslipidemia and hypertension","year":2013,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Mental Health & Substance Use Services","funders":"Natural Sciences and Engineering Research Council of Canada; U.S. Food and Drug Administration; Rush University; Centre for Addiction and Mental Health; Provincial Health Services Authority; AstraZeneca","keywords":"Dyslipidemia; Antipsychotic; Medicine; Pharmacology; Schizophrenia (object-oriented programming); Psychiatry; Endocrinology; Diabetes mellitus","score_opus":0.29403028821381527,"score_gpt":0.5581999677391798,"score_spread":0.2641696795253645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032636178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026312916,0.9633165,0.0000049570717,0.0016042922,0.0051994603,0.0022735042,0.000031627365,0.00006452848,0.0011922005],"genre_scores_gemma":[0.0020105245,0.9927681,0.00035934238,0.0015065979,0.0020342804,0.00033341537,0.00005902684,0.00006267922,0.00086602115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959198,0.00051770604,0.002025819,0.00088417355,0.00028379902,0.00036869178],"domain_scores_gemma":[0.9957843,0.002369326,0.0008981935,0.00025615393,0.0004007991,0.0002912576],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037222996,0.0005855527,0.0036082047,0.00030871877,0.000048602855,0.000009896146,0.00028002594,0.00069991214,0.0012510542],"category_scores_gemma":[0.00022258835,0.0003893452,0.00096182886,0.00017477937,0.00039529963,0.00005015768,0.000083552484,0.00070261507,0.00021808204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010450314,0.0020162757,0.000432004,0.0006826957,0.0051853047,0.00012387798,0.0000129668,2.692689e-8,0.0012141895,0.00003162243,0.011000424,0.97825557],"study_design_scores_gemma":[0.00814225,0.0042669387,0.0007660696,0.00092153926,0.0042125047,0.00037300502,0.0000050911176,0.000017853105,0.000047415,0.00008527731,0.9808571,0.00030497342],"about_ca_topic_score_codex":0.000007745945,"about_ca_topic_score_gemma":8.445584e-7,"teacher_disagreement_score":0.97795063,"about_ca_system_score_codex":0.00018874538,"about_ca_system_score_gemma":0.00018266105,"threshold_uncertainty_score":0.9998558},"labels":[],"label_agreement":null},{"id":"W2032780198","doi":"10.1097/yic.0b013e32833948d8","title":"Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis","year":2010,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Escitalopram; Duloxetine; Tolerability; Venlafaxine; Major depressive disorder; Antidepressant; Internal medicine; Duloxetine Hydrochloride; Montgomery–Åsberg Depression Rating Scale; Medicine; Reuptake inhibitor; Psychology; Psychiatry; Adverse effect","score_opus":0.022148748943425202,"score_gpt":0.40104834020650554,"score_spread":0.3788995912630803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032780198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873707,0.00005962717,0.00015336479,0.0035449907,0.0049155843,0.0020371024,0.00036275105,0.00009898008,0.0014568479],"genre_scores_gemma":[0.99006635,0.000032735858,0.0036652235,0.0010288898,0.0009804019,0.0006866358,0.001176058,0.000055934277,0.0023077703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716365,0.000093633505,0.00093046314,0.00092080445,0.0005229846,0.00036847361],"domain_scores_gemma":[0.99676913,0.001327293,0.00050674356,0.00044121855,0.00055989646,0.00039573983],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00023723798,0.00038409198,0.0007504459,0.00036936178,0.00011406033,0.00003904076,0.0003227606,0.00033289634,0.003302653],"category_scores_gemma":[0.00042860967,0.0002771207,0.0006012562,0.00029577082,0.00020644143,0.00014074455,0.000074985466,0.00047856048,0.00011585805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072161846,0.009754241,0.86495376,0.000019210573,0.017718662,0.000104733896,0.000049454844,0.000030384037,0.0018756079,0.000078763405,0.0066146287,0.026638716],"study_design_scores_gemma":[0.20581171,0.014162931,0.639957,0.00004459149,0.011930225,0.00001915973,0.000029641982,0.001267605,0.0021061832,0.00014257955,0.123963274,0.00056507846],"about_ca_topic_score_codex":0.000058971997,"about_ca_topic_score_gemma":0.0009391171,"teacher_disagreement_score":0.22499673,"about_ca_system_score_codex":0.00015087663,"about_ca_system_score_gemma":0.00016113579,"threshold_uncertainty_score":0.9999681},"labels":[],"label_agreement":null},{"id":"W2036480935","doi":"10.1097/yic.0b013e32836508e6","title":"The social and economic burden of treatment-resistant schizophrenia","year":2013,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":389,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Mental Health; National Institutes of Health","keywords":"Schizophrenia (object-oriented programming); Medicine; Quality of life (healthcare); Psychiatry; Adverse effect; Suicidal ideation; Substance abuse; Incidence (geometry); Alcohol abuse; Antipsychotic; Indirect costs; Internal medicine; Poison control; Injury prevention; Environmental health","score_opus":0.13352015733015024,"score_gpt":0.5192197666543232,"score_spread":0.385699609324173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036480935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006602284,0.9850555,6.0990465e-7,0.002941469,0.0023609772,0.0013813302,0.0002058906,0.000024283501,0.0014276387],"genre_scores_gemma":[0.0011568106,0.9932985,0.00018504231,0.00005439243,0.002749082,0.000380257,0.000097412805,0.00003887291,0.0020396418],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738824,0.00033413724,0.0013002293,0.00050173537,0.00019107762,0.0002845538],"domain_scores_gemma":[0.99684495,0.0020103639,0.00055432663,0.00023972848,0.00011337226,0.00023728111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003712229,0.0003369037,0.0014843552,0.00015575577,0.00012869285,0.000039163377,0.0003539553,0.00034413594,0.0009110604],"category_scores_gemma":[0.00011476013,0.00019031105,0.00084424665,0.00005904888,0.0005841336,0.00003593497,0.000117435775,0.00048304218,0.00046155634],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065268795,0.00019646292,0.0000321798,0.00026324907,0.0039648083,0.000034452845,0.000009709262,6.7653296e-8,0.0000022798156,0.0010617889,0.0078043523,0.9801038],"study_design_scores_gemma":[0.008361352,0.0010594076,0.00026178,0.0003187029,0.00124118,0.00006511934,0.0000097236625,0.0000280169,7.227961e-7,0.00040911417,0.9881148,0.00013009676],"about_ca_topic_score_codex":0.00015068347,"about_ca_topic_score_gemma":0.000044698154,"teacher_disagreement_score":0.98031044,"about_ca_system_score_codex":0.00042026036,"about_ca_system_score_gemma":0.0009546133,"threshold_uncertainty_score":0.9975472},"labels":[],"label_agreement":null},{"id":"W2050562005","doi":"10.1097/00004850-200109000-00007","title":"A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics","year":2001,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Riverview Hospital","funders":"","keywords":"Clozapine; Antipsychotic; Schizophrenia (object-oriented programming); Medicine; Depot; Internal medicine; Anesthesia; Psychiatry; Pediatrics","score_opus":0.09978535542722063,"score_gpt":0.4838204559414711,"score_spread":0.3840351005142505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050562005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977415,0.000018745523,0.00008887287,0.0006508732,0.00061764865,0.00021997995,0.000019753112,0.000033938293,0.0006086814],"genre_scores_gemma":[0.998827,0.00007949221,0.00008540806,0.00048918714,0.00027534322,0.000010065739,0.00013896871,0.000017926348,0.000076636104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985572,0.00007288019,0.0006507607,0.000270835,0.00031191093,0.00013640706],"domain_scores_gemma":[0.9989719,0.00023778682,0.00028177162,0.0001072692,0.00027415864,0.00012715628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017935623,0.000121550074,0.0003652301,0.00012509782,0.00003033111,0.0000078598205,0.00010430799,0.00014866775,0.00020522946],"category_scores_gemma":[0.00007162622,0.00010217835,0.00006936986,0.00012008152,0.00017219654,0.00005191221,0.000029971545,0.00035387796,0.000001734301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016587147,0.00097046874,0.97655743,0.000004975297,0.00014856416,0.000018405251,0.000032348198,0.000002905915,0.00015976878,0.000008244653,0.00040085093,0.02003734],"study_design_scores_gemma":[0.008965662,0.0015322992,0.98723006,0.000033391883,0.00048810022,0.000015537447,0.000011752395,0.000080326034,0.00027747973,0.000012821649,0.0012664364,0.000086104206],"about_ca_topic_score_codex":0.000030641506,"about_ca_topic_score_gemma":0.000004539773,"teacher_disagreement_score":0.019951236,"about_ca_system_score_codex":0.00003075258,"about_ca_system_score_gemma":0.000022293601,"threshold_uncertainty_score":0.4166712},"labels":[],"label_agreement":null},{"id":"W2051467860","doi":"10.1097/yic.0b013e3283372977","title":"Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone","year":2010,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Humber River Regional Hospital","funders":"","keywords":"Risperidone; Medicine; Paliperidone; Randomized controlled trial; Positive and Negative Syndrome Scale; Clinical endpoint; Population; Somnolence; Schizophrenia (object-oriented programming); Adverse effect; Internal medicine; Patient satisfaction; Physical therapy; Psychiatry; Psychosis; Surgery","score_opus":0.04001636160128261,"score_gpt":0.4453616468816156,"score_spread":0.405345285280333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051467860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916616,0.000009493087,0.000020170537,0.004260061,0.0020916155,0.0017177119,0.000024448183,0.000026495112,0.00018836882],"genre_scores_gemma":[0.9971178,0.00005984229,0.0014967112,0.00060145266,0.0003277172,0.00028458066,0.000062444975,0.000021307707,0.000028139775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968104,0.0003830223,0.0012774327,0.0005722486,0.00069492304,0.00026201084],"domain_scores_gemma":[0.99794394,0.00064955617,0.0002782296,0.00030254596,0.0005189313,0.00030682317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010209815,0.0001813122,0.00046176426,0.00090758246,0.000028218234,0.000010827249,0.00020872473,0.00021344371,0.0006491368],"category_scores_gemma":[0.0022199114,0.0001710146,0.00010145799,0.0004763305,0.00010145532,0.00013177619,0.000076032964,0.000950949,0.00009627601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17692615,0.009058275,0.7755124,0.000007945005,0.00016961631,0.00010808435,0.0002023538,0.000022849037,0.0045046266,0.00009840598,0.0003680597,0.033021223],"study_design_scores_gemma":[0.06367657,0.0034824016,0.9316879,0.000031301915,0.00004611941,0.0000068952763,0.0000806217,0.00031303204,0.00024661826,0.00024612359,0.000073021874,0.00010940909],"about_ca_topic_score_codex":0.0002721589,"about_ca_topic_score_gemma":0.0033905504,"teacher_disagreement_score":0.15617548,"about_ca_system_score_codex":0.00017514532,"about_ca_system_score_gemma":0.0002813658,"threshold_uncertainty_score":0.7107592},"labels":[],"label_agreement":null},{"id":"W2053608340","doi":"10.1097/yic.0b013e3282f2d42c","title":"Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia","year":2008,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital","funders":"","keywords":"Quetiapine; Quetiapine Fumarate; Tolerability; Population; Adverse effect; Atypical antipsychotic; Medicine; Internal medicine; Positive and Negative Syndrome Scale; Schizophrenia (object-oriented programming); Psychiatry; Psychology; Anesthesia; Psychosis; Antipsychotic","score_opus":0.11977088058275479,"score_gpt":0.45676853519560195,"score_spread":0.33699765461284714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053608340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917093,0.00022867881,0.000052595515,0.005467394,0.00062768196,0.0014650314,0.00007806087,0.000015500165,0.00035575673],"genre_scores_gemma":[0.997574,0.00013670269,0.0012356482,0.00048636599,0.00022512274,0.00011932541,0.000051688818,0.00002139773,0.00014980554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995636,0.0008537863,0.0011948808,0.00056751707,0.0014750864,0.00027273994],"domain_scores_gemma":[0.99701005,0.00054100633,0.00044096872,0.00047590942,0.0012316898,0.00030038255],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017422481,0.00020340747,0.00054720487,0.0002223602,0.000047409703,0.0000047157655,0.0003567354,0.00012484113,0.0010671803],"category_scores_gemma":[0.0017638889,0.00013805111,0.0001931817,0.00038716523,0.00023180102,0.00009684338,0.00012447195,0.00054834795,0.000060434068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22531451,0.0069884034,0.7281428,0.000033494176,0.0010559645,0.00012000289,0.00021577923,0.00073552754,0.00958242,0.000093170376,0.0015705344,0.026147423],"study_design_scores_gemma":[0.048074592,0.001492685,0.9418395,0.0001646433,0.00024959195,0.000014567806,0.000016669148,0.0036190443,0.0026931837,0.0016419885,0.0000736912,0.00011981737],"about_ca_topic_score_codex":0.0008897501,"about_ca_topic_score_gemma":0.00059223856,"teacher_disagreement_score":0.21369675,"about_ca_system_score_codex":0.00031775932,"about_ca_system_score_gemma":0.0009884239,"threshold_uncertainty_score":0.999846},"labels":[],"label_agreement":null},{"id":"W2055658079","doi":"10.1097/yic.0b013e32835b0814","title":"Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine","year":2012,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Mental Health Research Topics","field":"Psychology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Servier; Sanofi; AstraZeneca","keywords":"Agomelatine; Medicine; Internal medicine; Oncology; Psychology; Antidepressant","score_opus":0.4378777859731027,"score_gpt":0.6243300459637704,"score_spread":0.18645225999066772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055658079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165004,0.000016501985,0.0010689527,0.0028971236,0.002313609,0.0011117826,0.00012643701,0.000010705597,0.00080485846],"genre_scores_gemma":[0.99216974,0.00001725992,0.0021634737,0.0040282835,0.0005594412,0.00013286532,0.000119456905,0.00002440067,0.0007850839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956891,0.0011653644,0.0019074135,0.00044136491,0.00044456974,0.00035218254],"domain_scores_gemma":[0.9970828,0.0013293679,0.0007636502,0.0002604459,0.00032486676,0.00023882565],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042545507,0.00015961859,0.0006777039,0.00038556426,0.000027984861,0.000009802772,0.00033508797,0.00013068534,0.004853414],"category_scores_gemma":[0.0005427665,0.00013955089,0.00009006116,0.00026826005,0.00009968466,0.000375659,0.0001263716,0.00029310628,0.00022902554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060543492,0.006370148,0.93289924,0.00006084966,0.0005235896,0.0000032145983,0.0031421706,0.000010455292,0.019207323,0.00020520174,0.0034309095,0.028092552],"study_design_scores_gemma":[0.0076549114,0.0011771178,0.9853813,0.00012257695,0.00004171378,0.0000010428283,0.00006072008,0.00004029624,0.000817696,0.000102269216,0.004467521,0.00013283709],"about_ca_topic_score_codex":0.00013041697,"about_ca_topic_score_gemma":0.000027682945,"teacher_disagreement_score":0.05248206,"about_ca_system_score_codex":0.00008252073,"about_ca_system_score_gemma":0.00004050452,"threshold_uncertainty_score":0.99605626},"labels":[],"label_agreement":null},{"id":"W2060249700","doi":"10.1097/00004850-200505000-00011","title":"Gabapentin in the treatment of antipsychotic-induced akathisia in schizophrenia","year":2005,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre; Hôpital Louis-H Lafontaine; McGill University","funders":"Pfizer; Eli Lilly and Company","keywords":"Akathisia; Antipsychotic; Gabapentin; Parkinsonism; Schizophrenia (object-oriented programming); Psychosis; Medicine; Anesthesia; Extrapyramidal symptoms; Psychology; Psychiatry; Internal medicine","score_opus":0.07039711655451125,"score_gpt":0.45572098112586645,"score_spread":0.3853238645713552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060249700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878017,0.000255342,0.000008338858,0.006012873,0.0013437698,0.0005057999,0.000014733106,0.000012835555,0.00404465],"genre_scores_gemma":[0.9956602,0.00093182485,0.0005333872,0.0020667384,0.00051650614,0.00008203647,0.000022375909,0.000012543351,0.00017440761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981989,0.00019596612,0.0007849454,0.000360441,0.00025420482,0.00020550977],"domain_scores_gemma":[0.9991409,0.00033892354,0.00016266682,0.00020767206,0.000057019308,0.000092803355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039735407,0.00015533925,0.00037094517,0.00022837882,0.000016207994,0.0000069952716,0.00022390574,0.00011966366,0.0008406635],"category_scores_gemma":[0.000053329506,0.00010830644,0.00022129946,0.0001852161,0.00006251676,0.000054738382,0.000012472901,0.00020941903,0.00017046224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02913985,0.051871132,0.6045214,0.000020656727,0.0008566176,0.001286586,0.00069614715,0.00003198938,0.011349983,0.0018080133,0.0026445542,0.29577306],"study_design_scores_gemma":[0.035412595,0.001517456,0.90508586,0.000040118277,0.00011136321,0.000043385302,0.000037897724,0.00072537025,0.0006934198,0.0006203777,0.05560425,0.00010788842],"about_ca_topic_score_codex":0.000033932065,"about_ca_topic_score_gemma":0.00009791825,"teacher_disagreement_score":0.30056447,"about_ca_system_score_codex":0.00011758252,"about_ca_system_score_gemma":0.00007117947,"threshold_uncertainty_score":0.92046756},"labels":[],"label_agreement":null},{"id":"W2060418293","doi":"10.1097/yic.0000000000000053","title":"Treatment of depressive symptoms in patients with schizophrenia","year":2014,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca; Eli Lilly and Company","keywords":"Quetiapine; Risperidone; Somnolence; Quetiapine Fumarate; Internal medicine; Schizophrenia (object-oriented programming); Population; Psychology; Positive and Negative Syndrome Scale; Psychiatry; Atypical antipsychotic; Medicine; Adverse effect; Psychosis; Antipsychotic","score_opus":0.02471278465266374,"score_gpt":0.40402510407600856,"score_spread":0.3793123194233448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060418293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543744,0.000045257766,0.00003492347,0.0014702831,0.0006518903,0.00047097018,0.000019126446,0.00001782831,0.0018522475],"genre_scores_gemma":[0.998221,0.00007740909,0.0008437522,0.00026792986,0.0002905344,0.000071954055,0.00006256867,0.000014736229,0.00015013693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851876,0.00013129544,0.00050814793,0.00033431995,0.00031135397,0.00019610654],"domain_scores_gemma":[0.99879956,0.00046279994,0.00014806335,0.00018929904,0.00021384862,0.00018642082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010715387,0.00014024398,0.00039026895,0.0001855968,0.000015168911,0.0000048908923,0.00013083471,0.00009424382,0.00043842115],"category_scores_gemma":[0.00012321415,0.0000941085,0.00012668066,0.0001100039,0.00016270099,0.000043086886,0.000023234501,0.00015361248,0.00006803788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.075124435,0.003950854,0.848856,0.0000043632263,0.0005526704,0.000032058004,0.000010298712,0.000008490471,0.00003177576,0.0003771188,0.000147422,0.07090455],"study_design_scores_gemma":[0.08408554,0.0061787143,0.90730655,0.000023883573,0.00007999928,0.000005895848,0.0000012050616,0.00023688289,0.00015475978,0.0003251618,0.0015313165,0.00007008454],"about_ca_topic_score_codex":0.000023310899,"about_ca_topic_score_gemma":0.000027558142,"teacher_disagreement_score":0.07083447,"about_ca_system_score_codex":0.000110680114,"about_ca_system_score_gemma":0.00009732044,"threshold_uncertainty_score":0.4800404},"labels":[],"label_agreement":null},{"id":"W2067569855","doi":"10.1097/00004850-200303000-00002","title":"Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients","year":2003,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Alliance for Research on Schizophrenia and Depression","keywords":"Lithium (medication); Bipolar disorder; Sodium; Creatine; Mood stabilizer; Internal medicine; Chemistry; Endocrinology; Valproic Acid; Psychology; Medicine; Epilepsy; Psychiatry","score_opus":0.039800843193126365,"score_gpt":0.38992151949332055,"score_spread":0.35012067630019417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067569855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907319,0.0012012498,0.000057566365,0.0019510204,0.001337895,0.0009406017,0.000095833384,0.000059238162,0.0036246816],"genre_scores_gemma":[0.9948151,0.0018440402,0.0003005724,0.0013057876,0.00030596976,0.00021957178,0.00019851036,0.000033225035,0.0009772154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747103,0.0003544784,0.00084632146,0.0006001922,0.00031271562,0.00041524507],"domain_scores_gemma":[0.9986065,0.00046257136,0.00017217657,0.0002290209,0.00020715593,0.00032255164],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024567835,0.000289666,0.00049304386,0.00014095716,0.00007801877,0.000021300128,0.00013883314,0.00018666347,0.0011513792],"category_scores_gemma":[0.00014166035,0.00022246676,0.0001637121,0.00016850882,0.0002905934,0.00009876944,0.000022166523,0.000438001,0.00027677903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029786425,0.006988376,0.98138404,0.000012697478,0.00079708785,0.000080600395,0.000056944493,0.000016082799,0.0019073179,0.0006624293,0.00033095927,0.0047848476],"study_design_scores_gemma":[0.04690113,0.008773145,0.8260322,0.000052548017,0.0004676723,0.00007820247,0.000030398947,0.0002583758,0.003044471,0.00010959447,0.113942966,0.00030926947],"about_ca_topic_score_codex":0.00021592464,"about_ca_topic_score_gemma":0.00053473364,"teacher_disagreement_score":0.15535179,"about_ca_system_score_codex":0.00046796622,"about_ca_system_score_gemma":0.00047487573,"threshold_uncertainty_score":0.9997617},"labels":[],"label_agreement":null},{"id":"W2069559197","doi":"10.1097/yic.0b013e32819f8400","title":"Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender–age interactions","year":2007,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Mental Health; National Alliance for Research on Schizophrenia and Depression; GlaxoSmithKline; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Bupropion; Serotonin reuptake inhibitor; Somatization; Hamilton Anxiety Rating Scale; Psychology; Antidepressant; Hamilton Rating Scale for Depression; Major depressive disorder; Reuptake inhibitor; Psychiatry; Anxiety; Fluoxetine; Internal medicine; Serotonin; Medicine; Mood","score_opus":0.09772833094981877,"score_gpt":0.498031774912075,"score_spread":0.40030344396225626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069559197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010633961,0.97172093,0.00014951984,0.0010209584,0.004390913,0.005350263,0.00009301008,0.00006653186,0.0065739146],"genre_scores_gemma":[0.030082911,0.96705794,0.0004581192,0.00028010536,0.0007605855,0.00043583018,0.00016558709,0.00007792599,0.00068100286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944477,0.0012133247,0.0025170695,0.0009862215,0.0004923747,0.0003433103],"domain_scores_gemma":[0.98980695,0.0078326985,0.0015221522,0.00040543615,0.00025881178,0.00017393821],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012028188,0.00053435145,0.002275771,0.0006514253,0.00008432669,0.000019456716,0.00043498707,0.0006388774,0.00019850895],"category_scores_gemma":[0.0015496769,0.0003405898,0.0008753929,0.00041680443,0.0008864232,0.00015356237,0.00029910918,0.0024149963,0.00003833371],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011321711,0.0034233767,0.014887696,0.0014139822,0.0046127243,0.0006137187,0.00036783225,0.0000060984853,0.000020973996,0.00061912247,0.0030457294,0.959667],"study_design_scores_gemma":[0.049297422,0.00057283445,0.039449006,0.00813487,0.0041113338,0.0004371822,0.00005084221,0.00007486665,0.000025543965,0.0008352306,0.89652663,0.00048421317],"about_ca_topic_score_codex":0.000083937986,"about_ca_topic_score_gemma":0.000052329506,"teacher_disagreement_score":0.9591828,"about_ca_system_score_codex":0.00023700358,"about_ca_system_score_gemma":0.00021500577,"threshold_uncertainty_score":0.99990463},"labels":[],"label_agreement":null},{"id":"W2069919941","doi":"10.1097/yic.0b013e32833a5ff9","title":"Phosphodiesterase 4B genetic variants are not associated with antipsychotic-induced tardive dyskinesia","year":2010,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Tardive dyskinesia; Antipsychotic; Schizophrenia (object-oriented programming); Dyskinesia; Medicine; Pharmacology; Internal medicine; Psychiatry","score_opus":0.026781812637581073,"score_gpt":0.3637141882568271,"score_spread":0.33693237561924605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069919941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839397,0.000021445992,0.00068640424,0.0021177935,0.011622636,0.00029480667,0.000063081185,0.000047129775,0.0012069911],"genre_scores_gemma":[0.98919195,0.00008129944,0.00056686916,0.007181898,0.0015308035,0.00004678121,0.00019361143,0.000040979143,0.0011658333],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978576,0.00018878836,0.0006422684,0.00071986835,0.00028356732,0.00030792248],"domain_scores_gemma":[0.9983955,0.00015515146,0.00044110595,0.00034595066,0.00044784765,0.00021443664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004335464,0.00027168673,0.00031129565,0.00008450068,0.00011438486,0.000046289915,0.00041361657,0.00043899068,0.0006131371],"category_scores_gemma":[0.0004220255,0.00023426104,0.00018852929,0.00012153657,0.00022076246,0.00001519008,0.00008559294,0.0005133844,0.00009682697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008155398,0.0018406701,0.31381777,0.000008399784,0.0012997166,0.00015415068,0.000041480234,0.0001174159,0.6328437,0.00009052065,0.036116783,0.0055140513],"study_design_scores_gemma":[0.0075103785,0.0006176931,0.9449056,0.000021186592,0.00009342486,0.000080849764,0.000014948435,0.00039621786,0.016749283,0.00010113173,0.029115876,0.00039345023],"about_ca_topic_score_codex":0.0000111458685,"about_ca_topic_score_gemma":0.000118114716,"teacher_disagreement_score":0.6310878,"about_ca_system_score_codex":0.000020474108,"about_ca_system_score_gemma":0.00008955873,"threshold_uncertainty_score":0.9552888},"labels":[],"label_agreement":null},{"id":"W2072716458","doi":"10.1097/yic.0b013e32834e3bea","title":"Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder","year":2011,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Riverview Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Pfizer; Servier; GlaxoSmithKline; H. Lundbeck A/S; Eli Lilly and Company","keywords":"Quetiapine; Risperidone; Mood stabilizer; Mood; Atypical antipsychotic; Bipolar disorder; Psychiatry; Psychology; Neuropsychology; Verbal memory; Neuropsychological test; Antipsychotic; Schizophrenia (object-oriented programming); Clinical psychology; Verbal learning; Population; Bipolar I disorder; Randomized controlled trial; Medicine; Internal medicine; Cognition; Mania","score_opus":0.05650657488474105,"score_gpt":0.4350242997825321,"score_spread":0.37851772489779106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072716458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583745,0.0009392404,0.00013899857,0.00023802623,0.0010499434,0.00064261886,0.000019953595,0.00001783212,0.0011159598],"genre_scores_gemma":[0.9986229,0.00028643484,0.00051850564,0.0003525386,0.0000603402,0.000040057494,0.0000370713,0.000019359411,0.00006280621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981043,0.00020531737,0.0008772385,0.00037723582,0.00025779667,0.00017814871],"domain_scores_gemma":[0.99870974,0.00044034419,0.0003290349,0.00018281196,0.00022978894,0.00010827256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015118154,0.00017743692,0.0006439737,0.00018078486,0.000012286299,0.0000013245822,0.0001952829,0.00015852004,0.00085810566],"category_scores_gemma":[0.0001868798,0.000115910516,0.00012004314,0.00021138506,0.0003372842,0.000047030706,0.000050233888,0.00040170585,0.000019922694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027483165,0.016616723,0.94455075,0.00004754373,0.00047217341,0.00002294826,0.0001707295,0.000001819794,0.00037018524,0.000063088526,0.00017474519,0.010026125],"study_design_scores_gemma":[0.023410086,0.008114157,0.96567506,0.000063841515,0.00017193775,0.0000043903856,0.0000147762385,0.000049980204,0.0004828462,0.00007344521,0.0018408578,0.000098620534],"about_ca_topic_score_codex":0.00008765481,"about_ca_topic_score_gemma":0.00009455326,"teacher_disagreement_score":0.021124309,"about_ca_system_score_codex":0.000026457317,"about_ca_system_score_gemma":0.000044261295,"threshold_uncertainty_score":0.93956554},"labels":[],"label_agreement":null},{"id":"W2074253019","doi":"10.1097/yic.0b013e328337910b","title":"Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching","year":2010,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Brand names; Equivalence (formal languages); Medicine; Bioequivalence; Generic drug; Key (lock); Risk analysis (engineering); Business; Advertising; Intensive care medicine; Computer science; Drug; Psychiatry; Pharmacology; Computer security; Mathematics","score_opus":0.11950303845872741,"score_gpt":0.5020726205829491,"score_spread":0.3825695821242217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074253019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95392907,0.00023637658,0.0012353398,0.04122355,0.002658662,0.00040264268,0.000099820245,0.000018722378,0.00019585043],"genre_scores_gemma":[0.9845034,0.0002783555,0.008055912,0.006231346,0.00082598324,0.000035089448,0.000009431844,0.00001642628,0.00004405262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733084,0.00032530326,0.001462628,0.00041989822,0.00028268548,0.00017863035],"domain_scores_gemma":[0.98689616,0.0119512,0.0004080565,0.00020497179,0.0002433183,0.00029629748],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016783918,0.00016081263,0.0005531073,0.00011658728,0.00008444085,0.000019726811,0.00013674158,0.0001973034,0.0016198035],"category_scores_gemma":[0.0065984163,0.000111122645,0.00021051323,0.00007565064,0.00022035731,0.0001764347,0.00019158659,0.0007778712,0.000018044282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04528422,0.00128603,0.8569692,0.00002904467,0.0009643776,0.00017468647,0.0005910018,0.0000079061365,0.06012786,0.0003594307,0.0022885778,0.03191767],"study_design_scores_gemma":[0.0078198975,0.00083691993,0.9436935,0.000093456394,0.00041576457,0.000106732674,0.000048474565,0.0015965111,0.0003189408,0.009228112,0.035659496,0.00018219317],"about_ca_topic_score_codex":0.000090007685,"about_ca_topic_score_gemma":0.00039542175,"teacher_disagreement_score":0.08672431,"about_ca_system_score_codex":0.000015779748,"about_ca_system_score_gemma":0.00009286423,"threshold_uncertainty_score":0.99929285},"labels":[],"label_agreement":null},{"id":"W2076012649","doi":"10.1097/yic.0b013e32835b09cd","title":"Safety and tolerability of duloxetine in elderly patients with major depressive disorder","year":2012,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Duloxetine; Duloxetine Hydrochloride; Placebo; Tolerability; Adverse effect; Medicine; Internal medicine; Discontinuation; Nausea; Anesthesia","score_opus":0.020558531167731448,"score_gpt":0.39723884824329436,"score_spread":0.37668031707556293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076012649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943162,0.00024190109,0.000072964125,0.002160913,0.00089809817,0.00046811698,0.000029404193,0.00001589708,0.0017965141],"genre_scores_gemma":[0.9983175,0.00010173244,0.0006447927,0.00053084764,0.0001764061,0.000024911797,0.000045713925,0.000013259892,0.00014483945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849117,0.00013717667,0.0006704472,0.00027619334,0.00023955172,0.00018546646],"domain_scores_gemma":[0.998768,0.0005502125,0.00022003485,0.00014616024,0.00015498104,0.000160658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003207919,0.00012673746,0.0003686756,0.00009209308,0.000017962237,0.0000025744805,0.00009633163,0.00012297384,0.0006934251],"category_scores_gemma":[0.0002545488,0.0000917084,0.000061992556,0.000073194664,0.00019179872,0.00011601438,0.00006325802,0.00027129747,0.0000124462795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011328758,0.003689803,0.96360177,0.000019140012,0.00016489731,0.000006126572,0.000041246323,0.0000034480947,0.00010945246,0.000036232886,0.00028952883,0.020709602],"study_design_scores_gemma":[0.026766546,0.0007650572,0.9683943,0.00004702328,0.00008849984,0.000006239885,0.000007659555,0.00003090745,0.0000724142,0.00006109687,0.0036833945,0.000076870434],"about_ca_topic_score_codex":0.000028858743,"about_ca_topic_score_gemma":0.000017360595,"teacher_disagreement_score":0.020632733,"about_ca_system_score_codex":0.00004061676,"about_ca_system_score_gemma":0.000024218698,"threshold_uncertainty_score":0.7592519},"labels":[],"label_agreement":null},{"id":"W2079218917","doi":"10.1097/yic.0b013e3282f2b4c5","title":"Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients","year":2008,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Hôtel-Dieu Grace Healthcare","funders":"","keywords":"Risperidone; Bipolar disorder; Medicine; Psychiatry; Concomitant; Treatment of bipolar disorder; Antipsychotic; Mood stabilizer; Pharmacotherapy; Schizophrenia (object-oriented programming); Pediatrics; Atypical antipsychotic; Antipsychotic Agent; Mood; Extrapyramidal symptoms; Refractory (planetary science); Internal medicine; Mania","score_opus":0.04698393468892187,"score_gpt":0.41285942839306433,"score_spread":0.36587549370414246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079218917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948887,0.00052542,0.000012111925,0.0004887211,0.00075546623,0.0009831476,0.000019348452,0.000008213923,0.0023188617],"genre_scores_gemma":[0.99816746,0.0011455703,0.00012904305,0.00023526134,0.000054869073,0.000080287915,0.000028615572,0.000010955952,0.00014791927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980664,0.0002069543,0.0008891501,0.00026460987,0.00043822714,0.00013464884],"domain_scores_gemma":[0.99914664,0.00019560498,0.00022735349,0.00022492152,0.00015508379,0.00005039724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029244905,0.00012094381,0.00032810622,0.00012809639,0.000026984668,0.0000015602823,0.00026851677,0.0000722428,0.0004577318],"category_scores_gemma":[0.00004056309,0.00008495967,0.00012823094,0.00017826335,0.00013892373,0.000029196732,0.00007256085,0.00023626312,0.000036554113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027499446,0.029846923,0.95599526,0.00002210751,0.0006601239,0.00003193046,0.0006806584,0.000008192314,0.000012270259,0.00004607278,0.0006828448,0.009263672],"study_design_scores_gemma":[0.022321096,0.003955529,0.9618957,0.000018509598,0.00015698058,0.0000045054767,0.00038321217,0.000030462117,0.000010495576,0.00003637576,0.011126474,0.00006064971],"about_ca_topic_score_codex":0.00010556303,"about_ca_topic_score_gemma":0.000068596746,"teacher_disagreement_score":0.025891395,"about_ca_system_score_codex":0.000029754287,"about_ca_system_score_gemma":0.00001768522,"threshold_uncertainty_score":0.5011842},"labels":[],"label_agreement":null},{"id":"W2079449062","doi":"10.1097/yic.0b013e32831d7980","title":"Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial","year":2009,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; Hamilton Health Sciences","funders":"GlaxoSmithKline; Pfizer","keywords":"Pregabalin; Placebo; Hamilton Anxiety Rating Scale; Medicine; Generalized anxiety disorder; Anxiety; Anxiolytic; Internal medicine; Clinical endpoint; Adverse effect; Venlafaxine; Randomized controlled trial; Gastroenterology; Anesthesia; Psychiatry; Antidepressant","score_opus":0.0923804960608773,"score_gpt":0.4760551853894529,"score_spread":0.3836746893285756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079449062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716501,0.0021589443,0.00019884511,0.0024463406,0.007326049,0.0026298235,0.00013913999,0.00005223878,0.013398484],"genre_scores_gemma":[0.9867966,0.009564411,0.00047894573,0.0006912121,0.0010983313,0.00031707645,0.000094922165,0.000031917676,0.00092658546],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99440247,0.00082104205,0.002823478,0.0010674781,0.00046176632,0.00042375622],"domain_scores_gemma":[0.9943313,0.0031559307,0.0014342616,0.00038716148,0.00049218896,0.00019915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019027969,0.00038796008,0.0012368164,0.000788623,0.000044482436,0.000019598578,0.00067060895,0.00049864565,0.00090859074],"category_scores_gemma":[0.0016655576,0.00034621506,0.00045293017,0.0006993858,0.00040071463,0.00014892088,0.00009373919,0.00061725505,0.000039960396],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88308245,0.011576649,0.015266449,0.000011161039,0.0008686649,0.000015820335,0.00035518658,0.000032850432,0.00025476655,0.000719429,0.005596007,0.08222054],"study_design_scores_gemma":[0.92047507,0.0032832832,0.05248986,0.000051467752,0.00022441352,0.000012479777,0.00007264656,0.0001378998,0.00014219013,0.0020956283,0.020719765,0.00029527798],"about_ca_topic_score_codex":0.000118434444,"about_ca_topic_score_gemma":0.000032029333,"teacher_disagreement_score":0.08192526,"about_ca_system_score_codex":0.000050637238,"about_ca_system_score_gemma":0.000101288686,"threshold_uncertainty_score":0.99989897},"labels":[],"label_agreement":null},{"id":"W2083196423","doi":"10.1097/01.yic.0000195658.91524.61","title":"Sleep disturbances and depression: a challenge for antidepressants","year":2006,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Sleep and related disorders","field":"Psychology","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Depression (economics); Insomnia; Agomelatine; Sedative; Antidepressant; Sleep (system call); Sleep disorder; Medicine; Psychiatry; Sedation; Adverse effect; Psychology; Anesthesia; Internal medicine; Anxiety","score_opus":0.10450793233081816,"score_gpt":0.5136065227362556,"score_spread":0.40909859040543745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083196423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004554449,0.9266866,0.0002176428,0.0004523874,0.03474543,0.0013215285,0.00026937053,0.000102307495,0.036159184],"genre_scores_gemma":[0.00030883704,0.9895307,0.00012383741,0.00052363006,0.0052022873,0.0010100286,0.00030042333,0.00009660807,0.0029036717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99574494,0.0004714506,0.001751227,0.0013319701,0.00021934172,0.0004810949],"domain_scores_gemma":[0.9955049,0.002929923,0.00086780434,0.00036004547,0.00014483032,0.0001924563],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005868539,0.0005442724,0.0016624618,0.00027553175,0.00011125149,0.000038395305,0.00084973953,0.0014014803,0.0013526946],"category_scores_gemma":[0.00018471545,0.0004305341,0.0009299589,0.00013711589,0.0004016567,0.00007202412,0.00015434086,0.001053562,0.00030064257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034054698,0.0007447895,0.00028879134,0.00047784878,0.0031921084,0.00005642104,0.000023087989,5.776217e-7,3.3268446e-8,0.0006127117,0.10319317,0.8910699],"study_design_scores_gemma":[0.005096924,0.00015362434,0.00019499585,0.0005689361,0.0017240618,0.000051866245,0.000014040978,0.000026485093,2.1485071e-8,0.0009183799,0.99081385,0.00043681083],"about_ca_topic_score_codex":0.000020421163,"about_ca_topic_score_gemma":0.000009453972,"teacher_disagreement_score":0.8906331,"about_ca_system_score_codex":0.0000351204,"about_ca_system_score_gemma":0.00004238101,"threshold_uncertainty_score":0.9998949},"labels":[],"label_agreement":null},{"id":"W2083219020","doi":"10.1097/00004850-200403000-00008","title":"Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania","year":2004,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Risperidone; Mania; Lithium (medication); Medicine; Psychiatry; Bipolar disorder; Pharmacology; Psychology; Schizophrenia (object-oriented programming)","score_opus":0.05787318869760582,"score_gpt":0.4440735273378229,"score_spread":0.3862003386402171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083219020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98505807,0.0015487394,0.00015930286,0.006396965,0.002798566,0.0006537086,0.00004832571,0.000032291922,0.0033040554],"genre_scores_gemma":[0.9920462,0.005739768,0.000827627,0.00034228005,0.00032862852,0.000083399216,0.00008278378,0.000020083116,0.00052928197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983101,0.0000779499,0.0007584921,0.0004277651,0.0002173971,0.00020833474],"domain_scores_gemma":[0.99914885,0.000222658,0.00019466772,0.00016145453,0.00012547089,0.00014689022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001894847,0.00019800784,0.00053904735,0.0001634028,0.000026622538,0.000008995419,0.000099847515,0.0001813674,0.00028680288],"category_scores_gemma":[0.00004896974,0.00016946165,0.00014841424,0.00011404274,0.00020959022,0.00007186854,0.0000363111,0.0001999847,0.000061534054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23855107,0.024199806,0.5139224,0.00013248278,0.016330976,0.0012424227,0.003974933,0.0006075838,0.03213645,0.0047889114,0.0015061392,0.16260684],"study_design_scores_gemma":[0.2546949,0.009722375,0.7108628,0.00008151823,0.0013144464,0.00014110113,0.00011643305,0.0010622337,0.0031039908,0.0011077045,0.017457662,0.00033479428],"about_ca_topic_score_codex":0.00023820625,"about_ca_topic_score_gemma":0.00025481347,"teacher_disagreement_score":0.19694045,"about_ca_system_score_codex":0.00042265517,"about_ca_system_score_gemma":0.00015789362,"threshold_uncertainty_score":0.69104457},"labels":[],"label_agreement":null},{"id":"W2088919847","doi":"10.1097/00004850-200015040-00005","title":"Divalproex sodium increases plasma GABA levels in healthy volunteers","year":2000,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Anticonvulsant; Derivatization; Pharmacology; Medicine; Mood; High-performance liquid chromatography; Internal medicine; Chemistry; Psychology; Endocrinology; Psychiatry; Epilepsy; Chromatography","score_opus":0.08271650141297898,"score_gpt":0.484277862468787,"score_spread":0.40156136105580803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088919847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.953666,0.00014224245,0.0000055603596,0.020334471,0.0012666036,0.00052177766,0.00007789751,0.000058133293,0.023927325],"genre_scores_gemma":[0.98328686,0.0011325558,0.00033505863,0.0094161825,0.0009497761,0.00011103176,0.00006590725,0.000022637014,0.004679989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974947,0.00025673935,0.00085605605,0.0005279374,0.00041696132,0.00044760967],"domain_scores_gemma":[0.998346,0.00078640867,0.00007463189,0.0001987359,0.00012962583,0.00046462606],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00062746514,0.00018001987,0.00042102288,0.00021210812,0.000043577176,0.000014689139,0.00026592266,0.00017555234,0.020646865],"category_scores_gemma":[0.00032500114,0.00015675256,0.00021761794,0.00016909553,0.00023661324,0.0000883058,0.000046298926,0.00067814783,0.0021006542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037095968,0.006762,0.8190336,0.000028125121,0.0006321404,0.001173686,0.000047046393,0.000023451621,0.00028803275,0.00017274407,0.039819717,0.09492345],"study_design_scores_gemma":[0.030277519,0.0027448859,0.853195,0.00005418989,0.000055065288,0.00014659675,0.000020217527,0.0014866514,0.000079822654,0.0005029253,0.11126275,0.00017435467],"about_ca_topic_score_codex":0.0002579053,"about_ca_topic_score_gemma":0.00016481483,"teacher_disagreement_score":0.0947491,"about_ca_system_score_codex":0.00019671593,"about_ca_system_score_gemma":0.00023585951,"threshold_uncertainty_score":0.9986763},"labels":[],"label_agreement":null},{"id":"W2094664948","doi":"10.1097/yic.0b013e328362db99","title":"Absence of evidence that the pro re nata regimen confers benefit","year":2013,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Dainippon Sumitomo Pharma","keywords":"Pro re nata; Medicine; Risperidone; Olanzapine; Quetiapine; Psychiatry; Lorazepam; Population; Schizophrenia (object-oriented programming); Internal medicine","score_opus":0.28183136811909804,"score_gpt":0.5199563019582739,"score_spread":0.23812493383917588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094664948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86893046,0.00044724232,0.000041029274,0.1233587,0.0016653363,0.0009918136,0.000013710643,0.000029319754,0.00452241],"genre_scores_gemma":[0.99093664,0.0012390864,0.000625947,0.003734094,0.00041944245,0.00017480527,0.000010673939,0.000011186753,0.0028481153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832857,0.000120378776,0.00050026964,0.00033465825,0.00050004566,0.00021608302],"domain_scores_gemma":[0.99685633,0.0019322289,0.0002530794,0.00031872015,0.0004453089,0.0001943275],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058657175,0.00011834309,0.0002674084,0.00007322933,0.00004105425,0.000017712022,0.00049389334,0.0001030497,0.005685387],"category_scores_gemma":[0.0008922026,0.00006488283,0.00017823931,0.00009860082,0.0004204189,0.00012611589,0.00011378368,0.00042721492,0.00055212463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03770993,0.0023274769,0.5229195,0.00008146102,0.0028257798,0.0002278581,0.00018918297,0.000013296507,0.0059129577,0.0058418186,0.25975522,0.16219552],"study_design_scores_gemma":[0.012275325,0.0014984217,0.9533132,0.00024060735,0.000132678,0.0000909352,0.00013461712,0.0010376851,0.0019567837,0.009830312,0.01932258,0.00016689661],"about_ca_topic_score_codex":0.00012508115,"about_ca_topic_score_gemma":0.000023227869,"teacher_disagreement_score":0.43039367,"about_ca_system_score_codex":0.00005810936,"about_ca_system_score_gemma":0.00016164395,"threshold_uncertainty_score":0.9952235},"labels":[],"label_agreement":null},{"id":"W2094885305","doi":"10.1097/yic.0b013e328080ca57","title":"A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania","year":2007,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Divalproex; Quetiapine; Mania; Lithium (medication); Placebo; Bipolar disorder; Young Mania Rating Scale; Tolerability; Psychology; Medicine; Psychiatry; Internal medicine; Adverse effect; Schizophrenia (object-oriented programming)","score_opus":0.10092405127406186,"score_gpt":0.4979474015834935,"score_spread":0.39702335030943164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094885305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96564025,0.001857619,0.0007617495,0.008397275,0.00435197,0.016951434,0.000046174464,0.000032789932,0.001960711],"genre_scores_gemma":[0.98609275,0.004375295,0.00051754055,0.0019114368,0.0017340687,0.0020802238,0.000046297064,0.000034939316,0.003207462],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99733305,0.000238903,0.0014250302,0.0004043908,0.0003579126,0.00024072627],"domain_scores_gemma":[0.9934824,0.0052512446,0.0004219839,0.000311792,0.00033614977,0.00019642065],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020027496,0.00024156348,0.001191332,0.00020574193,0.000048972997,0.000008060763,0.00026330978,0.00018841,0.00092652004],"category_scores_gemma":[0.0003035231,0.00012341203,0.0007486621,0.00012089804,0.00021079606,0.000031770232,0.000015751057,0.00015932134,0.00003067526],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9364643,0.014357783,0.00044712776,0.0000073513115,0.0041660345,0.000008055695,0.0002523731,0.000007974697,0.0005225093,0.0007088512,0.0005143141,0.042543318],"study_design_scores_gemma":[0.8984691,0.033806294,0.0004936457,0.000014605444,0.0006992946,0.000009104811,0.000029641405,0.00012928764,0.0021832497,0.00029455472,0.06377862,0.000092642615],"about_ca_topic_score_codex":0.00014556883,"about_ca_topic_score_gemma":0.00015848788,"teacher_disagreement_score":0.063264295,"about_ca_system_score_codex":0.00006940072,"about_ca_system_score_gemma":0.00014407169,"threshold_uncertainty_score":0.99998677},"labels":[],"label_agreement":null},{"id":"W2165348295","doi":"10.1097/00004850-200201000-00007","title":"Relationship between neuroleptic dosage and subjective cognitive dysfunction in schizophrenic patients treated with either conventional or atypical neuroleptic medication","year":2002,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Riverview Hospital","funders":"","keywords":"Clozapine; Olanzapine; Risperidone; Neurocognitive; Schizophrenia (object-oriented programming); Psychology; Psychopathology; Cognition; Psychosis; Psychiatry; Medicine; Clinical psychology","score_opus":0.07810214116235702,"score_gpt":0.4065204257726802,"score_spread":0.3284182846103232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165348295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931,0.00005861243,0.000087580156,0.004752839,0.0003803234,0.00084847014,0.00004496327,0.000049963113,0.0006772625],"genre_scores_gemma":[0.99753183,0.000086741675,0.00014969625,0.00092314574,0.00038292474,0.00016127522,0.0002281139,0.00002832344,0.00050796807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754757,0.0004152776,0.00066345936,0.00060446083,0.0004991452,0.000270108],"domain_scores_gemma":[0.99633175,0.002778108,0.00019362585,0.00012309886,0.0002596912,0.00031369622],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030206522,0.00021166686,0.00035096193,0.00033858753,0.0000744712,0.000021217844,0.00010875728,0.00019999107,0.0016289724],"category_scores_gemma":[0.0011063111,0.00015660774,0.00009665837,0.00030071498,0.0003565414,0.0001534615,0.000041146675,0.0007846746,0.00025295795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05866344,0.0014492021,0.9309161,0.000010902021,0.00028318906,0.00013862974,0.0000222068,0.000001176293,0.000007359527,0.00012803503,0.0003248161,0.008054945],"study_design_scores_gemma":[0.04331994,0.0032122831,0.95153344,0.000063625994,0.00024369919,0.000052461975,0.000010764323,0.0009164293,0.000008321446,0.00038136047,0.00013157638,0.00012611086],"about_ca_topic_score_codex":0.000015508294,"about_ca_topic_score_gemma":0.000075700904,"teacher_disagreement_score":0.020617327,"about_ca_system_score_codex":0.00011310134,"about_ca_system_score_gemma":0.00007999757,"threshold_uncertainty_score":0.9992837},"labels":[],"label_agreement":null},{"id":"W2306562730","doi":"10.1097/yic.0000000000000121","title":"An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder","year":2016,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); York University","funders":"Pfizer Canada; Pfizer","keywords":"Major depressive disorder; Antidepressant; Placebo; Internal medicine; Reuptake inhibitor; Serotonin reuptake inhibitor; Medicine; Population; Psychiatry; Psychology","score_opus":0.06735467632118762,"score_gpt":0.5010312144244039,"score_spread":0.43367653810321627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306562730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10848493,0.88603675,0.00006399255,0.0009936031,0.0011482367,0.002233131,0.0006977797,0.000010749838,0.00033082624],"genre_scores_gemma":[0.0760848,0.9232139,0.000085964624,0.000081246646,0.00012969902,0.00009665771,0.00016508352,0.00002039917,0.00012223356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99610627,0.0010542319,0.0019072484,0.00045043806,0.00034244137,0.00013935621],"domain_scores_gemma":[0.9940254,0.003794118,0.0013610374,0.00055629015,0.00019420854,0.00006894717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005048942,0.00029423705,0.0021005964,0.0004350058,0.000020490392,0.000003172191,0.00056098326,0.00031708129,0.00045878434],"category_scores_gemma":[0.000299463,0.00012077726,0.0009409279,0.0005590561,0.00047889797,0.000032688364,0.000052697527,0.00027862797,0.0000028214843],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00288032,0.007061093,0.03794577,0.00033904554,0.010099393,0.00001857395,0.000100776524,0.000007831826,0.000039837945,0.000054899818,0.00013568916,0.9413168],"study_design_scores_gemma":[0.028503388,0.003238957,0.25080287,0.005264746,0.031214131,0.000032691605,0.0000308113,0.00009686182,0.000035073175,0.00006876835,0.6804697,0.00024201977],"about_ca_topic_score_codex":0.00006116829,"about_ca_topic_score_gemma":0.00005429413,"teacher_disagreement_score":0.9410747,"about_ca_system_score_codex":0.00009213243,"about_ca_system_score_gemma":0.00014661947,"threshold_uncertainty_score":0.5023367},"labels":[],"label_agreement":null},{"id":"W2312753591","doi":"10.1097/yic.0b013e328363aa5a","title":"Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics","year":2013,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Depot; Schizophrenia (object-oriented programming); Psychiatry; Medicine; Political science","score_opus":0.08944316725605528,"score_gpt":0.4812767298087197,"score_spread":0.39183356255266444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312753591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96262,0.000039417027,0.00007652075,0.016244685,0.0029444932,0.00043985186,0.000029081555,0.0000300887,0.017575867],"genre_scores_gemma":[0.98847187,0.0002381338,0.0014321163,0.008531008,0.00038879403,0.000035383127,0.000021122634,0.00001738148,0.0008642023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825007,0.000097472126,0.00069150305,0.00031829966,0.0004440389,0.00019862514],"domain_scores_gemma":[0.99803543,0.0009380748,0.00030633688,0.00014642441,0.00037622728,0.00019750973],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025035703,0.0001558863,0.0004059195,0.000090355636,0.00003983481,0.0000120357045,0.00020936767,0.00010934197,0.0047319387],"category_scores_gemma":[0.0002956991,0.00010698652,0.00018509106,0.00009598541,0.00027030127,0.00010067263,0.000052004052,0.0004651327,0.00072435575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013376751,0.0025367637,0.94546175,0.000019723966,0.0017877737,0.000022406264,0.000012641562,0.0000066152193,0.0002844439,0.0011931707,0.026292358,0.009005579],"study_design_scores_gemma":[0.014845493,0.0014290253,0.9526491,0.00003727315,0.00017711063,0.000011998138,0.000021617576,0.00018799577,0.00012592188,0.00058482337,0.029806705,0.0001228913],"about_ca_topic_score_codex":0.000012173806,"about_ca_topic_score_gemma":0.0000020240348,"teacher_disagreement_score":0.025851866,"about_ca_system_score_codex":0.000026549782,"about_ca_system_score_gemma":0.000041219515,"threshold_uncertainty_score":0.99617785},"labels":[],"label_agreement":null},{"id":"W2313477739","doi":"10.1097/yic.0000000000000105","title":"A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan","year":2015,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"Eli Lilly Japan; Meiji Seika Pharma; Shionogi; Pfizer Japan; Abbott Japan; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; AbbVie; Novartis Pharma; Otsuka Pharmaceutical; Eisai; Astellas Pharma; GlaxoSmithKline Japan; Kyowa Hakko Kirin; Pfizer; Dainippon Sumitomo Pharma; Boehringer Ingelheim Japan; Astellas Foundation for Research on Metabolic Disorders; GlaxoSmithKline; FP Pharmaceutical Corporation; Bristol-Myers Squibb; Eli Lilly and Company; MSD K.K.; Asahi Kasei Pharma Corporation","keywords":"Venlafaxine; Placebo; Major depressive disorder; Medicine; Term (time); Randomized controlled trial; Immediate release; Anesthesia; Venlafaxine Hydrochloride; Internal medicine; Psychiatry; Pharmacology; Antidepressant; Anxiety; Physics; Alternative medicine; Mood","score_opus":0.05728496281993833,"score_gpt":0.4471914282007698,"score_spread":0.38990646538083146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313477739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97666484,0.00022333092,0.00008775489,0.0018656846,0.0006829361,0.020397548,0.000013326712,0.00001939702,0.00004519654],"genre_scores_gemma":[0.9975825,0.00004434031,0.00012652125,0.0003874834,0.0001421608,0.001553529,0.000021701642,0.000029817103,0.00011193919],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965251,0.000848385,0.0011801396,0.0006690862,0.00056523946,0.00021206375],"domain_scores_gemma":[0.99492663,0.003546882,0.00035804696,0.00029574754,0.00061072933,0.00026194516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024670665,0.00026421147,0.0011667223,0.00022217905,0.00005754163,0.000017183793,0.00019503101,0.00008586301,0.000039239912],"category_scores_gemma":[0.0018388127,0.0001459392,0.00011836186,0.0001220253,0.00020865168,0.0000768796,0.00016640198,0.00029346903,0.0000039729925],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55776715,0.012223008,0.42498952,0.000007579597,0.0009184379,0.000023489367,0.00042432718,0.000029393683,0.000014223582,0.0000034480438,0.00006921281,0.0035302364],"study_design_scores_gemma":[0.51998585,0.004941624,0.47371665,0.00005273637,0.0008539876,0.0000052571286,0.0001120005,0.00021814804,0.0000024267722,0.000030627773,0.00000739468,0.00007329985],"about_ca_topic_score_codex":0.00004496237,"about_ca_topic_score_gemma":0.000117746684,"teacher_disagreement_score":0.04872714,"about_ca_system_score_codex":0.00005415051,"about_ca_system_score_gemma":0.00007899739,"threshold_uncertainty_score":0.59512275},"labels":[],"label_agreement":null},{"id":"W2314697748","doi":"10.1097/01.yic.0000423366.01355.8a","title":"Recovery is such a huge word","year":2012,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Word (group theory); Computer science; Natural language processing; Psychology; Philosophy; Linguistics","score_opus":0.06557486367087356,"score_gpt":0.4726603440295946,"score_spread":0.40708548035872105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314697748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.794242,0.00047682688,0.000100296915,0.032975122,0.012962755,0.0002785674,0.000014738027,0.000086078144,0.15886359],"genre_scores_gemma":[0.9076542,0.0008910154,0.00061329594,0.060562007,0.0049686157,0.00003399916,0.00002620493,0.000025602772,0.025225013],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981275,0.00017390543,0.0006990369,0.00030138687,0.00034118438,0.00035697658],"domain_scores_gemma":[0.99739885,0.0017375896,0.00012687735,0.00019603885,0.00013001099,0.00041060027],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000975309,0.00015742928,0.00058803364,0.00011692684,0.000032924745,0.000012416852,0.00018252224,0.00023909497,0.009741572],"category_scores_gemma":[0.00044466386,0.00013131638,0.00080642005,0.00011828521,0.00013790157,0.00012653688,0.000049911392,0.00046440275,0.0019838416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004987407,0.0015366152,0.7473809,0.000012949029,0.0013009988,0.00017137952,0.00009336617,7.3959956e-7,0.00047762308,0.0024165101,0.19035694,0.05126456],"study_design_scores_gemma":[0.0030647155,0.00011924208,0.3166658,0.000008088071,0.00011961402,0.00015758327,0.000010234021,0.0000138970245,0.00005799384,0.00011500225,0.6795655,0.000102304795],"about_ca_topic_score_codex":0.000007316211,"about_ca_topic_score_gemma":5.488415e-7,"teacher_disagreement_score":0.48920858,"about_ca_system_score_codex":0.00006384144,"about_ca_system_score_gemma":0.00005264064,"threshold_uncertainty_score":0.99879324},"labels":[],"label_agreement":null},{"id":"W2315927007","doi":"10.1097/yic.0000000000000031","title":"Predictors of functional improvement in employed adults with major depressive disorder treated with desvenlafaxine","year":2014,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); University of British Columbia","funders":"Pfizer","keywords":"Major depressive disorder; Hamilton Rating Scale for Depression; Rating scale; Placebo; Depression (economics); Post-hoc analysis; Internal medicine; Psychology; Psychiatry; Medicine; Physical therapy; Cognition","score_opus":0.01820573840165302,"score_gpt":0.35671394959965935,"score_spread":0.33850821119800634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315927007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99428034,0.000049649814,0.00085448445,0.0016991587,0.0007319942,0.00074470154,0.0000273416,0.000055525095,0.0015568337],"genre_scores_gemma":[0.99736893,0.000049260354,0.0005137626,0.00072547415,0.00037845658,0.00019174899,0.00014471314,0.000034879533,0.0005927671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785453,0.00012979818,0.00075804716,0.00054552924,0.0004814561,0.00023062935],"domain_scores_gemma":[0.9984106,0.0005319063,0.00035084173,0.00022927283,0.00030506443,0.00017235559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024956255,0.00022890382,0.0004679299,0.00022159558,0.000026897422,0.0000055365203,0.00016960809,0.00015795424,0.0007680612],"category_scores_gemma":[0.00014233415,0.00014984526,0.000106388994,0.00016847161,0.00023747078,0.000089156456,0.00004855647,0.0003516481,0.000021740734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040803075,0.002931476,0.94308937,0.000029656283,0.0008158312,0.000061284176,0.000027123993,0.00021829977,0.0023413084,0.000025845373,0.0012578793,0.008398844],"study_design_scores_gemma":[0.062039293,0.006057406,0.9271481,0.00022792847,0.00027840375,0.000040248826,0.000019210289,0.0007776588,0.0013944583,0.00004445561,0.0018220854,0.00015077471],"about_ca_topic_score_codex":0.00008901673,"about_ca_topic_score_gemma":0.00013459797,"teacher_disagreement_score":0.021236219,"about_ca_system_score_codex":0.00008134887,"about_ca_system_score_gemma":0.00007551211,"threshold_uncertainty_score":0.84097314},"labels":[],"label_agreement":null},{"id":"W2318292225","doi":"10.1097/yic.0000000000000099","title":"Management of aripiprazole-induced tardive Pisa syndrome","year":2015,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Parkinson's Disease and Spinal Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Aripiprazole; Dystonia; Medicine; Trunk; Side effect (computer science); Anesthesia; Physical medicine and rehabilitation; Pediatrics; Psychology; Schizophrenia (object-oriented programming); Psychiatry; Computer science","score_opus":0.10954743023457313,"score_gpt":0.47933243507801576,"score_spread":0.3697850048434426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318292225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93161535,0.00018508677,0.00014510812,0.0046344404,0.003868184,0.00030918044,0.000019390005,0.000041234012,0.05918201],"genre_scores_gemma":[0.9938125,0.00035220681,0.0005287417,0.0038372746,0.00024901252,0.000035927114,0.000033624652,0.00001556182,0.0011351301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821943,0.00008883117,0.0007352292,0.00034248212,0.00042049456,0.00019353272],"domain_scores_gemma":[0.99889296,0.00009038439,0.00020610234,0.00019427843,0.00025809646,0.00035816085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048522928,0.00013670973,0.00036857236,0.00013047179,0.000015923302,0.000005438374,0.00027718762,0.00012676786,0.0007935693],"category_scores_gemma":[0.000094305906,0.0001273467,0.00025672966,0.00011388781,0.00012595071,0.00006405801,0.00008816575,0.0002704531,0.00046771724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04217071,0.014488127,0.5943418,0.00036231455,0.014529489,0.010326749,0.00025671843,0.000119340875,0.0035637927,0.010119599,0.26354605,0.046175316],"study_design_scores_gemma":[0.018417336,0.0015755232,0.8376526,0.00010138136,0.00050193415,0.00016651797,0.00019407213,0.0003974078,0.00012872134,0.0028568918,0.1377864,0.00022121325],"about_ca_topic_score_codex":0.000015344092,"about_ca_topic_score_gemma":8.2149126e-7,"teacher_disagreement_score":0.2433108,"about_ca_system_score_codex":0.00006299355,"about_ca_system_score_gemma":0.00009835177,"threshold_uncertainty_score":0.86890274},"labels":[],"label_agreement":null},{"id":"W2319063634","doi":"10.1097/yic.0b013e328343ba60","title":"Long-term efficacy of risperidone long-acting injectable in bipolar disorder with psychotic features","year":2011,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hôtel-Dieu Grace Healthcare; Western University","funders":"Canadian Institutes of Health Research; AstraZeneca","keywords":"Risperidone; Bipolar disorder; Term (time); Medicine; Psychology; Psychiatry; Schizophrenia (object-oriented programming); Lithium (medication); Physics","score_opus":0.050307854249508566,"score_gpt":0.41442800989747497,"score_spread":0.3641201556479664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319063634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857801,0.0036086515,0.00023724824,0.00068780687,0.0015390271,0.0005398698,0.000011004271,0.000042725806,0.0075535667],"genre_scores_gemma":[0.99689305,0.0010881879,0.00069496443,0.00052714907,0.00023407821,0.00003983152,0.00003795916,0.000035590874,0.00044921142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805564,0.00012641538,0.00076428754,0.00048864575,0.0002684141,0.00029661003],"domain_scores_gemma":[0.99885345,0.00032464767,0.00025591408,0.00025788043,0.00014776309,0.0001603233],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003009827,0.0002238511,0.0005053178,0.00024977888,0.00003147262,0.000007312995,0.0002568576,0.00019321896,0.001923916],"category_scores_gemma":[0.000101994534,0.00017583313,0.00016595797,0.00025014937,0.0002487407,0.00009737329,0.000049852624,0.0006049946,0.0000628337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00933015,0.0056477226,0.94885254,0.00003776336,0.0007600203,0.00010330345,0.00022197905,0.0000050962244,0.0003962492,0.00011153754,0.00016659455,0.034367036],"study_design_scores_gemma":[0.018133406,0.0014909647,0.978021,0.00009768188,0.00020551552,0.000106944455,0.00002148127,0.000014997075,0.00037957262,0.000071949544,0.0013013834,0.000155064],"about_ca_topic_score_codex":0.00021485158,"about_ca_topic_score_gemma":0.000735937,"teacher_disagreement_score":0.03421197,"about_ca_system_score_codex":0.000053308548,"about_ca_system_score_gemma":0.00008401112,"threshold_uncertainty_score":0.99898845},"labels":[],"label_agreement":null},{"id":"W2319238862","doi":"10.1097/yic.0000000000000100","title":"Use of benzodiazepines in obsessive–compulsive disorder","year":2015,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Richmond Hospital","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Anxiety; Obsessive compulsive; Benzodiazepine; Psychology; Anxiety disorder; Clonazepam; Psychiatry; Clinical psychology; Medicine; Internal medicine","score_opus":0.11439863408449251,"score_gpt":0.4689470046037267,"score_spread":0.35454837051923416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319238862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95871466,0.00047743466,0.0004099033,0.005313892,0.019410394,0.0004903202,0.00008802734,0.00006464505,0.0150307035],"genre_scores_gemma":[0.99372005,0.00012376567,0.0007831993,0.003053845,0.00067074975,0.00008989551,0.00006551138,0.00004565375,0.0014473181],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610186,0.00073848997,0.0015551029,0.0007605082,0.0003860001,0.00045805733],"domain_scores_gemma":[0.9964272,0.0017810516,0.00065166596,0.00038227942,0.0004904536,0.00026739112],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005985426,0.00029212618,0.0006609021,0.00046239173,0.000024060215,0.000022946371,0.0008313829,0.00031899833,0.0037624252],"category_scores_gemma":[0.0011116011,0.0002924914,0.00028362806,0.00044019925,0.00053425605,0.00028388476,0.00018996651,0.00067611225,0.0007624343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035241349,0.0032155158,0.8985939,0.000007595315,0.0005677273,0.00019258012,0.0007334628,0.0008036216,0.00015095575,0.007515606,0.060393352,0.024301544],"study_design_scores_gemma":[0.016795605,0.0006770924,0.8534582,0.000037345744,0.00006431483,0.000028388366,0.0007078293,0.0008591522,0.000032463828,0.007186428,0.11967927,0.00047385588],"about_ca_topic_score_codex":0.00053695677,"about_ca_topic_score_gemma":0.00022289479,"teacher_disagreement_score":0.059285916,"about_ca_system_score_codex":0.000096867385,"about_ca_system_score_gemma":0.00012616316,"threshold_uncertainty_score":0.99995273},"labels":[],"label_agreement":null},{"id":"W2329067297","doi":"10.1097/yic.0b013e328356acad","title":"Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia","year":2012,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risperidone; Paliperidone; Neurocognitive; Positive and Negative Syndrome Scale; Schizophrenia (object-oriented programming); Psychology; Randomized controlled trial; Psychiatry; Medicine; Internal medicine; Clinical psychology; Cognition; Psychosis","score_opus":0.056762757058961,"score_gpt":0.43032528274506926,"score_spread":0.37356252568610826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329067297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898789,0.000072231,0.0001620007,0.0025126801,0.00520101,0.0011038316,0.0000633506,0.000037055583,0.00096893555],"genre_scores_gemma":[0.99467236,0.000053472344,0.0015037521,0.0013824868,0.0016038901,0.00033936626,0.00023460014,0.00002971268,0.00018037393],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99832416,0.000108526205,0.00046312087,0.0003640758,0.00033975657,0.00040036094],"domain_scores_gemma":[0.9983425,0.00074770104,0.00011508846,0.00013316947,0.0003348119,0.0003267194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033120322,0.00017435905,0.00030550768,0.00018979117,0.000042279127,0.000011321466,0.000111495494,0.00012576338,0.0008226543],"category_scores_gemma":[0.00034321885,0.00013531315,0.0001449277,0.00014899446,0.00013279174,0.0001628387,0.00003793983,0.00039360378,0.00019974382],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5006647,0.0030307933,0.47018272,0.0000073166784,0.0005745996,0.000010118173,0.000012522644,0.0000015742186,0.00004579414,0.00024947303,0.002459831,0.022760568],"study_design_scores_gemma":[0.12347843,0.0037733961,0.86397564,0.000017796428,0.00015483654,0.0000034364427,0.000009843402,0.00006239842,0.000045725912,0.0001094745,0.00825247,0.000116553485],"about_ca_topic_score_codex":0.000007083529,"about_ca_topic_score_gemma":0.000019548457,"teacher_disagreement_score":0.3937929,"about_ca_system_score_codex":0.00011612132,"about_ca_system_score_gemma":0.00009093432,"threshold_uncertainty_score":0.9007488},"labels":[],"label_agreement":null},{"id":"W2332743496","doi":"10.1097/yic.0b013e32834c2488","title":"Assessing the relationship between functional impairment/recovery and depression severity","year":2011,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Depression (economics); Functional impairment; Psychology; Medicine; Clinical psychology; Economics","score_opus":0.22410403835261347,"score_gpt":0.49022974845831996,"score_spread":0.2661257101057065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332743496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983462,0.000133899,0.00071057124,0.0027868035,0.0035306495,0.00031645418,0.000010920955,0.000074149175,0.008974567],"genre_scores_gemma":[0.99429137,0.00005304047,0.0012314132,0.0021712133,0.0013206308,0.0000380516,0.00004933856,0.000017594637,0.0008273764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829274,0.00026348006,0.0005662802,0.0004051219,0.00030003084,0.00017234981],"domain_scores_gemma":[0.9969057,0.0023916068,0.00021864186,0.00019329038,0.0001213326,0.00016943614],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007387963,0.00014805906,0.00022881066,0.00009851024,0.00015238585,0.000030011397,0.00015258069,0.00020239709,0.0011348261],"category_scores_gemma":[0.00069556426,0.00010009354,0.00015264412,0.00008146163,0.00021723627,0.00029619483,0.0001226878,0.00057688414,0.00011135915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009597092,0.00046036017,0.9767905,0.00000682799,0.00021951576,0.000025553058,0.000031457927,6.5225356e-7,0.000099402154,0.000072130075,0.008304765,0.013029113],"study_design_scores_gemma":[0.004334452,0.00020200701,0.9892019,0.00004178073,0.00020234688,0.000076685064,0.000027463831,0.000060542097,0.000075505006,0.0032912507,0.0023952806,0.000090793146],"about_ca_topic_score_codex":0.000015451315,"about_ca_topic_score_gemma":0.000001545266,"teacher_disagreement_score":0.012938321,"about_ca_system_score_codex":0.00005641507,"about_ca_system_score_gemma":0.00006326398,"threshold_uncertainty_score":0.9997783},"labels":[],"label_agreement":null},{"id":"W2333163906","doi":"10.1097/01.yic.0000423254.26080.9f","title":"Lithium use for bipolar disorder - does the LiTMUS trial change anything?","year":2012,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Litmus; Bipolar disorder; Lithium (medication); Psychology; Medicine; Psychiatry; Chemistry","score_opus":0.1290522916230237,"score_gpt":0.47193055650982085,"score_spread":0.3428782648867972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333163906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88168794,0.010176425,0.0005883385,0.060720492,0.041422974,0.0040005585,0.00023470854,0.00013567679,0.0010328604],"genre_scores_gemma":[0.96957016,0.0024576955,0.00054902886,0.013516771,0.010432185,0.0009218065,0.00011074607,0.00003979159,0.002401791],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982912,0.00018236648,0.0006045568,0.00031465755,0.0002396715,0.00036753254],"domain_scores_gemma":[0.997745,0.0014556913,0.00016825886,0.0002456633,0.00016590739,0.00021949061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082843186,0.0001834238,0.0003095532,0.0000798529,0.00011185981,0.000028550283,0.00023520296,0.00021350278,0.0007882831],"category_scores_gemma":[0.0004794182,0.0001018959,0.00034534643,0.00008441503,0.00018448914,0.00023324626,0.00006831071,0.00042008606,0.00012692828],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06655362,0.006880784,0.7763947,0.00002740036,0.0017426262,0.000005149115,0.00053760636,2.7168514e-7,0.00018973112,0.0021371138,0.020621259,0.124909684],"study_design_scores_gemma":[0.044152454,0.0007453983,0.19605006,0.000007927188,0.00027743552,0.000016160095,0.000020030891,0.00006382292,0.000018848352,0.00031375675,0.75823677,0.00009735501],"about_ca_topic_score_codex":0.00008185871,"about_ca_topic_score_gemma":0.00004812861,"teacher_disagreement_score":0.73761547,"about_ca_system_score_codex":0.00004912894,"about_ca_system_score_gemma":0.00004137878,"threshold_uncertainty_score":0.8631148},"labels":[],"label_agreement":null},{"id":"W2333649059","doi":"10.1097/yic.0b013e3283528d22","title":"Efficacy and safety of ziprasidone in the treatment of first-episode psychosis","year":2012,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer Pharmaceuticals","keywords":"Ziprasidone; Positive and Negative Syndrome Scale; Schizoaffective disorder; Clinical Global Impression; Schizophrenia (object-oriented programming); Internal medicine; Adverse effect; Schizophreniform disorder; Medicine; Population; Global Assessment of Functioning; Depression (economics); Psychiatry; Psychology; Psychosis; Antipsychotic; Placebo","score_opus":0.08186127582196423,"score_gpt":0.48189086329520814,"score_spread":0.4000295874732439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333649059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496723,0.0010730448,0.000013157243,0.0111825,0.00075311365,0.00054322754,0.000022383238,0.000005816198,0.0014395372],"genre_scores_gemma":[0.99269056,0.005767748,0.0005831084,0.0003918162,0.00040157558,0.00007275637,0.000015613412,0.0000073309657,0.00006949375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862,0.00016601973,0.00061252253,0.0001754972,0.0002389063,0.00018706487],"domain_scores_gemma":[0.9977466,0.0017443432,0.00013615163,0.00016798479,0.00007460227,0.00013032636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005038801,0.00010397783,0.0003296855,0.00011741904,0.00001860217,0.000002316956,0.00013072592,0.000083845516,0.0004304195],"category_scores_gemma":[0.00015548384,0.00006388766,0.00013602636,0.000118514254,0.00022113662,0.000038628794,0.000016878466,0.00014241207,0.000018244158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039949242,0.009636585,0.9133992,0.000013385652,0.0005426707,0.000014120001,0.00020599879,0.00000157099,0.00010760148,0.0005458276,0.001396425,0.03418733],"study_design_scores_gemma":[0.028081652,0.0022022233,0.945639,0.000024956353,0.000111014204,0.000028421986,0.000027868597,0.000045352223,0.00025167875,0.00018132258,0.023361683,0.00004483899],"about_ca_topic_score_codex":0.000106966974,"about_ca_topic_score_gemma":0.00012333266,"teacher_disagreement_score":0.034142494,"about_ca_system_score_codex":0.000052260544,"about_ca_system_score_gemma":0.00001617952,"threshold_uncertainty_score":0.47127914},"labels":[],"label_agreement":null},{"id":"W2333723698","doi":"10.1097/yic.0000000000000125","title":"Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy","year":2016,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Janssen Scientific Affairs","keywords":"Risperidone; Antipsychotic; Medicine; Schizophrenia (object-oriented programming); Relapse prevention; Internal medicine; Schizoaffective disorder; Proportional hazards model; Psychiatry; Post-hoc analysis; Psychosis","score_opus":0.14859341014902064,"score_gpt":0.4625397788618425,"score_spread":0.3139463687128219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333723698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911096,0.00008744338,0.00017065805,0.0056219343,0.0014920029,0.0006988242,0.000023330611,0.00007743025,0.0007187572],"genre_scores_gemma":[0.99665916,0.00024639055,0.00039487355,0.0013793467,0.00028577444,0.00010213275,0.000020590143,0.000035900845,0.0008758298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746126,0.00025307495,0.00069013576,0.00064978824,0.00046921129,0.0004765314],"domain_scores_gemma":[0.9971612,0.0017001492,0.00018821984,0.00024450663,0.00026585706,0.00044005283],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006306886,0.00024966596,0.0004729214,0.00034249178,0.000054761564,0.000024907727,0.0003175409,0.0001778102,0.001636627],"category_scores_gemma":[0.0011799693,0.00014443388,0.00015513142,0.00041903133,0.00015461938,0.00015016683,0.000053483127,0.0004855617,0.00022469187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06531961,0.0016229274,0.8631847,0.0000030523277,0.0006828172,0.00025288202,0.000041754134,0.000004030629,0.0035246997,0.00007623399,0.0010975101,0.064189814],"study_design_scores_gemma":[0.040645048,0.0037741116,0.9529572,0.0002633233,0.00003161628,0.000011627519,0.000011916286,0.00002418065,0.0011475845,0.00045344894,0.0004896257,0.00019030736],"about_ca_topic_score_codex":0.00003271723,"about_ca_topic_score_gemma":0.00032304472,"teacher_disagreement_score":0.089772545,"about_ca_system_score_codex":0.00026418958,"about_ca_system_score_gemma":0.00025651316,"threshold_uncertainty_score":0.99927604},"labels":[],"label_agreement":null},{"id":"W2335391602","doi":"10.1097/01.yic.0000425948.30166.26","title":"Advancing bipolar disorders research via collaborative knowledge translation","year":2012,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Psychopharmacology; Psychology; Medicine; Psychiatry","score_opus":0.12493642474446953,"score_gpt":0.5433096485007194,"score_spread":0.41837322375624986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335391602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6699913,0.09766814,0.005835399,0.042544875,0.025167283,0.0032501381,0.0001080201,0.0003211642,0.15511367],"genre_scores_gemma":[0.99079674,0.004844903,0.0013820246,0.00056895387,0.0015489312,0.00010335655,0.000069242764,0.00002916378,0.0006566737],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997784,0.00049874047,0.00056135387,0.00033964135,0.000343288,0.00047292816],"domain_scores_gemma":[0.9976987,0.0013127305,0.000087627224,0.00016311344,0.00039035577,0.00034747468],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015879779,0.00015422047,0.00027973205,0.00025598335,0.00012020022,0.000010604455,0.00016421017,0.00020380993,0.0014330441],"category_scores_gemma":[0.00024375018,0.00013737072,0.00014758864,0.00039562478,0.00025545745,0.00019689283,0.00004396405,0.000700872,0.00081275543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002200218,0.005567659,0.5138237,0.000024362575,0.00079204486,0.0000040779546,0.00085526204,0.0000029933422,0.003936064,0.00061202614,0.010775652,0.46140593],"study_design_scores_gemma":[0.0062885135,0.000661738,0.19949189,0.000017194594,0.00011208722,0.000017819617,0.00010697111,0.000332605,0.00022755605,0.00086401874,0.7917481,0.00013149664],"about_ca_topic_score_codex":0.000020914467,"about_ca_topic_score_gemma":0.00014383138,"teacher_disagreement_score":0.7809725,"about_ca_system_score_codex":0.00014458633,"about_ca_system_score_gemma":0.00012991388,"threshold_uncertainty_score":0.99996525},"labels":[],"label_agreement":null},{"id":"W2413247405","doi":"10.1097/yic.0000000000000094","title":"Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder","year":2015,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Placebo; Major depressive disorder; Confidence interval; Odds ratio; Internal medicine; Post-hoc analysis; Psychology; Psychiatry; Sexual function; Medicine; Antidepressant; Cognition","score_opus":0.05018944234956795,"score_gpt":0.41088989903616147,"score_spread":0.3607004566865935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413247405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005795,0.00013702111,0.0002599716,0.0007842926,0.006028847,0.00049184123,0.000006812944,0.00002939646,0.0022038866],"genre_scores_gemma":[0.99667805,0.000027694268,0.00007795063,0.0019536295,0.0003625476,0.000060381375,0.000031428528,0.000015712736,0.0007926131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986097,0.00012524588,0.0004423627,0.00035014388,0.00033410586,0.00013844056],"domain_scores_gemma":[0.9981705,0.0010926886,0.00017130005,0.00009330127,0.00031460755,0.00015762268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023343,0.00014620036,0.00032271387,0.0001890005,0.000025725958,0.0000050840968,0.000060024286,0.00012003063,0.00016526373],"category_scores_gemma":[0.0006269751,0.000111480156,0.000038524457,0.00012471371,0.00016216506,0.00006774745,0.000043148528,0.00030336357,0.00005215545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1852221,0.0020088728,0.7940921,0.000027156564,0.00054594537,0.000012374303,0.00005905734,0.00003533667,0.00007231071,0.00008071091,0.011270137,0.006573899],"study_design_scores_gemma":[0.10761821,0.010259455,0.8686303,0.000028962315,0.0001767647,0.000002573266,0.0000920583,0.00007972731,0.00003241144,0.00003529081,0.0129377125,0.00010654215],"about_ca_topic_score_codex":0.000032936176,"about_ca_topic_score_gemma":0.000020917456,"teacher_disagreement_score":0.07760389,"about_ca_system_score_codex":0.000056739584,"about_ca_system_score_gemma":0.000046408197,"threshold_uncertainty_score":0.4546029},"labels":[],"label_agreement":null},{"id":"W2415583435","doi":"10.1097/yic.0000000000000148","title":"Adverse events in children and adolescents treated with quetiapine","year":2016,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"H. Lundbeck A/S; Novo Nordisk; Pfizer; Bristol-Myers Squibb","keywords":"Quetiapine; Medicine; Pediatrics; Adverse effect; Psychiatry; Danish; Quetiapine Fumarate; Psychosis; Atypical antipsychotic; Population; Antipsychotic; Schizophrenia (object-oriented programming); Internal medicine","score_opus":0.04784931414317471,"score_gpt":0.4643678070081879,"score_spread":0.4165184928650132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415583435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981721,0.00011421934,0.000026715777,0.016138334,0.0003441636,0.00031964062,0.000011712793,0.000024996,0.0012992466],"genre_scores_gemma":[0.9921957,0.0021204983,0.000082354745,0.004733506,0.00034152396,0.000019017883,0.0000060626376,0.000011342038,0.00048999104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988057,0.000116390795,0.00038969316,0.0003337585,0.00016824093,0.00018623716],"domain_scores_gemma":[0.9992712,0.00028629194,0.00011035208,0.00007833018,0.00007579758,0.00017804024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029673122,0.00012005629,0.00024519325,0.00007344631,0.000021418939,0.00000138723,0.00010280143,0.00008586629,0.00058048556],"category_scores_gemma":[0.00016353864,0.00006914368,0.00005388738,0.000079289,0.00016232593,0.000096566175,0.000059167378,0.00024981226,0.000096563344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007591802,0.0006448155,0.9724331,0.000004472877,0.00032716384,0.000038666843,0.0000042078505,2.68941e-7,0.0005066275,0.000025172667,0.0010116608,0.017412078],"study_design_scores_gemma":[0.020385647,0.00041876087,0.9679324,0.00011635032,0.00009003407,0.00008516345,0.0000025140914,0.000022195749,0.000057107958,0.00008217916,0.010717502,0.00009011393],"about_ca_topic_score_codex":0.000031568954,"about_ca_topic_score_gemma":0.00001337751,"teacher_disagreement_score":0.017321963,"about_ca_system_score_codex":0.000044521377,"about_ca_system_score_gemma":0.000020970443,"threshold_uncertainty_score":0.635591},"labels":[],"label_agreement":null},{"id":"W2485425172","doi":"10.1097/yic.0000000000000143","title":"Psychological dependence on antidepressants in patients with panic disorder","year":2016,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Astellas Pharma","keywords":"Panic disorder; Panic; Psychiatry; Psychology; Clinical psychology; Internal medicine; Medicine; Anxiety","score_opus":0.05361500174004916,"score_gpt":0.4554414760138532,"score_spread":0.401826474273804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485425172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9571873,0.00020827122,0.0010219332,0.0022056524,0.012006237,0.0006776982,0.0001293394,0.00012804553,0.026435502],"genre_scores_gemma":[0.9907283,0.0024230685,0.0001896086,0.0038031137,0.00075660704,0.00026655511,0.000027864082,0.00006108199,0.0017438118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99532753,0.0006195427,0.0010819659,0.0016403098,0.00065593584,0.0006747121],"domain_scores_gemma":[0.9959505,0.002365221,0.0004715086,0.00051960733,0.00042544288,0.00026771103],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00063256774,0.0004378522,0.00051603303,0.0005535391,0.00007649504,0.000029067332,0.0010562062,0.00044003667,0.013808569],"category_scores_gemma":[0.00083492795,0.0002727539,0.00018224979,0.000568676,0.0004888094,0.0002606153,0.00013229091,0.0006708854,0.0029103337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008494493,0.0066585913,0.73881286,0.0000020075877,0.00025666654,0.000050398918,0.000028169841,0.0000017094882,0.000015784164,0.00045504145,0.011092564,0.23413172],"study_design_scores_gemma":[0.024654064,0.0018537284,0.9286921,0.00006966807,0.0000366006,0.0000075861694,0.00002154565,0.0000027258538,0.0000128934425,0.0019295488,0.04235189,0.0003676656],"about_ca_topic_score_codex":0.000020015876,"about_ca_topic_score_gemma":0.000023390496,"teacher_disagreement_score":0.23376405,"about_ca_system_score_codex":0.00010791749,"about_ca_system_score_gemma":0.0000291954,"threshold_uncertainty_score":0.99997246},"labels":[],"label_agreement":null},{"id":"W2549416108","doi":"10.1097/yic.0000000000000157","title":"Effects of levomilnacipran extended-release on major depressive disorder patients with cognitive impairments","year":2016,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Allergan; School of Medicine, Duke University; Genentech; H. Lundbeck A/S; Daiichi-Sankyo; FORUM Pharmaceuticals; Cerecor; Forest Research Institute; Sunovion; F. Hoffmann-La Roche; Indivior; Sanofi; National Institute of Mental Health; Pfizer; Brain and Behavior Research Foundation; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Population; Psychosocial; Psychology; Post-hoc analysis; Major depressive disorder; Cognition; Rating scale; Depression (economics); Placebo; Psychiatry; Clinical psychology; Medicine; Internal medicine; Developmental psychology","score_opus":0.013062396005296491,"score_gpt":0.3870389944269966,"score_spread":0.37397659842170006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549416108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934618,0.000068591864,0.00037759964,0.0017246818,0.0016991182,0.0011011345,0.000100933146,0.000049540606,0.0014166158],"genre_scores_gemma":[0.99661225,0.00010791207,0.000137559,0.0018133001,0.00026113857,0.00014153146,0.000043995464,0.00003639368,0.0008459437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787337,0.00020653574,0.00059503014,0.0005521808,0.0005271786,0.00024569905],"domain_scores_gemma":[0.9965144,0.002283127,0.0003833632,0.00017794497,0.00039725812,0.00024393895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012239136,0.00023873807,0.00042875446,0.00016258974,0.000037830832,0.000004341416,0.00019155836,0.00016366247,0.00083642534],"category_scores_gemma":[0.0006489687,0.00013537692,0.00019408818,0.00007527814,0.0002860336,0.0001063056,0.00006855763,0.00023905806,0.00021695065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04591992,0.012023598,0.85100526,0.00004294899,0.0015500076,0.00022948998,0.000023181494,8.9861135e-7,0.0027370637,0.000035666122,0.0030872435,0.083344705],"study_design_scores_gemma":[0.089840524,0.0049136565,0.8991585,0.00051606906,0.0004444223,0.000007967155,0.0000042199945,0.000007343469,0.0039293584,0.00015538342,0.0008788254,0.00014376243],"about_ca_topic_score_codex":0.000006982683,"about_ca_topic_score_gemma":0.0000020867465,"teacher_disagreement_score":0.08320094,"about_ca_system_score_codex":0.000075170334,"about_ca_system_score_gemma":0.00005976192,"threshold_uncertainty_score":0.9158271},"labels":[],"label_agreement":null},{"id":"W2605044346","doi":"10.1097/yic.0000000000000174","title":"Antidepressant effect in older depressed patients","year":2017,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Mental Health Research Topics","field":"Psychology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute for Health and Care Research","keywords":"Agomelatine; Placebo; Antidepressant; Placebo response; Depression (economics); Medicine; Clinical trial; Internal medicine; Psychiatry; Clinical psychology; Psychology; Intensive care medicine; Alternative medicine","score_opus":0.09843570535062048,"score_gpt":0.5848377536607898,"score_spread":0.48640204831016937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605044346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8927633,0.000063743035,0.000023951723,0.003284926,0.02117816,0.00076423585,0.000031761425,0.000034106946,0.08185579],"genre_scores_gemma":[0.99281114,0.00009579555,0.000064663276,0.0030724523,0.00094853464,0.00021522173,0.000025835609,0.000026859892,0.0027394877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666274,0.0007933448,0.00092822127,0.00068662496,0.00039466858,0.0005343926],"domain_scores_gemma":[0.997279,0.0012449106,0.0004015739,0.00068076624,0.00013080203,0.00026297168],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016010645,0.00018643322,0.00037930356,0.0001773331,0.0001623438,0.000061918676,0.0015298619,0.00028519766,0.008543814],"category_scores_gemma":[0.00096987543,0.00017181624,0.00015560618,0.000048050286,0.00034013102,0.00018023473,0.00031699982,0.0008970986,0.0016065233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020814282,0.0013566384,0.9024863,0.000013912796,0.000104884224,0.00014743257,0.000047201218,0.0000010821827,0.000030666135,0.0004061186,0.03750546,0.055818826],"study_design_scores_gemma":[0.015448621,0.0003833844,0.9594382,0.000026992575,0.000010310668,0.0000025994252,0.0000045715606,0.0001047614,0.000040355488,0.00055224064,0.023849513,0.00013842004],"about_ca_topic_score_codex":0.00022550378,"about_ca_topic_score_gemma":0.00006371938,"teacher_disagreement_score":0.10004783,"about_ca_system_score_codex":0.000090251284,"about_ca_system_score_gemma":0.00003528509,"threshold_uncertainty_score":0.99917084},"labels":[],"label_agreement":null},{"id":"W2613043758","doi":"10.1097/yic.0000000000000179","title":"Advanced glycation end products among patients maintained on antipsychotics","year":2017,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research","funders":"Qatar National Research Fund; International Business Machines Corporation","keywords":"Medicine; Statistical significance; Schizophrenia (object-oriented programming); Internal medicine; Prospective cohort study; Significant difference; Glycation; Psychiatry; Pediatrics","score_opus":0.03850985625461896,"score_gpt":0.45071914001930474,"score_spread":0.4122092837646858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613043758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744392,0.000025841771,0.00052548357,0.0067926836,0.0077668917,0.0005312079,0.000048306883,0.000024264362,0.009846088],"genre_scores_gemma":[0.9902986,0.0004474133,0.0010603697,0.0016889195,0.0018434691,0.000055972007,0.00032597838,0.00003403366,0.00424523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785566,0.00015897013,0.00053332996,0.00082140294,0.0003362253,0.00029440055],"domain_scores_gemma":[0.99773085,0.00008786377,0.00045778457,0.000859423,0.00071809895,0.00014595526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005380566,0.00018700813,0.00018026476,0.00008210503,0.00024138625,0.00005762975,0.0010185337,0.0001897943,0.00024044732],"category_scores_gemma":[0.003104724,0.00018508227,0.00009987866,0.0000503693,0.00044319528,0.000029741492,0.00019336703,0.0003465245,0.0001781965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025612254,0.004791151,0.49081948,0.00004470066,0.0008739858,0.00003024324,0.000049885784,0.0010240487,0.14014113,0.0022862894,0.110896334,0.22343048],"study_design_scores_gemma":[0.0068458975,0.000989088,0.69266194,0.000015715103,0.000016068889,0.0000027368012,0.000006807873,0.000117201635,0.017077051,0.0008979929,0.28106573,0.0003037402],"about_ca_topic_score_codex":0.0000029638668,"about_ca_topic_score_gemma":0.000006057738,"teacher_disagreement_score":0.22312675,"about_ca_system_score_codex":0.0000379679,"about_ca_system_score_gemma":0.000075421216,"threshold_uncertainty_score":0.7547436},"labels":[],"label_agreement":null},{"id":"W2623679632","doi":"10.1097/yic.0000000000000183","title":"Long-term function and psychosocial outcomes with venlafaxine extended release 75–225 mg/day versus placebo in the PREVENT study","year":2017,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Venlafaxine; Psychosocial; Placebo; Quality of life (healthcare); Medicine; Post-hoc analysis; Venlafaxine Hydrochloride; Internal medicine; Psychology; Psychiatry; Antidepressant; Anxiety","score_opus":0.07418117069487426,"score_gpt":0.4903316870584873,"score_spread":0.416150516363613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623679632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97572684,0.00007383073,0.000036314337,0.015219217,0.0053937063,0.0014336973,0.00000866933,0.00003569273,0.0020720446],"genre_scores_gemma":[0.9965829,0.0001183558,0.000051734612,0.001236038,0.0009001997,0.00021087796,0.000021730446,0.00002223649,0.0008558847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776274,0.00040168868,0.00056924304,0.0005565008,0.0004926974,0.00021710608],"domain_scores_gemma":[0.99795574,0.00096649444,0.00037198944,0.00047548412,0.00009668503,0.00013362682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095877395,0.0002203649,0.00039215919,0.00010631977,0.00017452189,0.00005820318,0.0004236547,0.00014691992,0.0003430083],"category_scores_gemma":[0.00047813897,0.00013713789,0.00012292717,0.000044311368,0.00025266848,0.00018305377,0.00009837736,0.0005840885,0.000052432475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046448473,0.0067065936,0.9244501,0.000008972935,0.0008035716,0.00051426666,0.00014548942,0.0000015350679,0.000089228786,0.000049334554,0.0019641733,0.01881828],"study_design_scores_gemma":[0.068597145,0.0033169787,0.9265093,0.000045500474,0.00040011454,0.000028234295,0.0000710857,0.000026396958,0.000004836605,0.00016445524,0.0007182722,0.00011765837],"about_ca_topic_score_codex":0.00002993615,"about_ca_topic_score_gemma":0.00018629001,"teacher_disagreement_score":0.022148672,"about_ca_system_score_codex":0.00007965985,"about_ca_system_score_gemma":0.00005280935,"threshold_uncertainty_score":0.55923206},"labels":[],"label_agreement":null},{"id":"W2626036701","doi":"10.1097/yic.0000000000000185","title":"Placebo response in trichotillomania","year":2017,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"H. Lundbeck A/S; University of Oxford; National Institute on Drug Abuse; TLC Foundation for Body-Focused Repetitive Behaviors; National Institute on Alcohol Abuse and Alcoholism; BrainsWay; American Psychiatric Publishing; International OCD Foundation; National Center for Responsible Gaming; Wellcome Trust","keywords":"Placebo; Placebo response; Internal medicine; Medicine; Clinical trial; Psychiatry; Psychology","score_opus":0.0527838860741489,"score_gpt":0.48714668406830475,"score_spread":0.43436279799415584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626036701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8287466,0.00009227473,0.00008369225,0.017804164,0.024820315,0.00038014943,0.00002352702,0.000066125765,0.12798311],"genre_scores_gemma":[0.98750395,0.000067357294,0.00017513859,0.0034995289,0.0009410617,0.000119697565,0.000007763521,0.000039714887,0.007645806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964001,0.0009649398,0.0010346489,0.00084039185,0.0002705261,0.00048935285],"domain_scores_gemma":[0.9962524,0.0020151923,0.000640347,0.0007853458,0.000119819924,0.0001868496],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001913247,0.0002448331,0.00043561237,0.00034879285,0.00017047646,0.00008366161,0.0019687682,0.00033589566,0.014964121],"category_scores_gemma":[0.0018113134,0.00025501766,0.0002544298,0.000096758136,0.00055642903,0.00020602714,0.00022126107,0.00089387904,0.0044335746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.120294,0.0031532864,0.73051584,0.000004919981,0.00074395095,0.0016042021,0.00046557188,0.00003111363,0.0010677739,0.008992418,0.089866236,0.04326068],"study_design_scores_gemma":[0.018232008,0.00035004417,0.87225795,0.000010441998,0.000019647863,0.00002543701,0.00007880285,0.00013399895,0.000012596017,0.0028814417,0.105766095,0.00023154129],"about_ca_topic_score_codex":0.000119919976,"about_ca_topic_score_gemma":0.00011112576,"teacher_disagreement_score":0.15875728,"about_ca_system_score_codex":0.00011556314,"about_ca_system_score_gemma":0.00007363968,"threshold_uncertainty_score":0.9999902},"labels":[],"label_agreement":null},{"id":"W2742484016","doi":"10.1097/yic.0000000000000191","title":"Risk of hair loss with different antidepressants","year":2017,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"University of British Columbia","keywords":"Bupropion; Sertraline; Venlafaxine; Citalopram; Escitalopram; Paroxetine; Fluoxetine; Fluvoxamine; Medicine; Mirtazapine; Internal medicine; Duloxetine; Population; Pharmacology; Psychology; Antidepressant; Serotonin; Smoking cessation","score_opus":0.040435980559892476,"score_gpt":0.4519172755265202,"score_spread":0.4114812949666278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742484016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686952,0.000047741847,0.00034766836,0.004273723,0.0022853937,0.00020558445,0.000038153674,0.000024841253,0.024081696],"genre_scores_gemma":[0.99684906,0.0005219297,0.00019207693,0.0012449009,0.0004792874,0.000013441131,0.000011326124,0.000014347331,0.0006736017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986938,0.00007409857,0.00050145434,0.00030239,0.00025918678,0.00016904355],"domain_scores_gemma":[0.9984999,0.0002997785,0.00045211136,0.0003648347,0.00019918923,0.00018418842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025965847,0.00012375263,0.00036796098,0.00006945138,0.00008116682,0.000013097267,0.0003977297,0.000117935466,0.0008285932],"category_scores_gemma":[0.0005727278,0.000086500215,0.00017620403,0.000021032885,0.00055534637,0.000075030424,0.00007685874,0.00035788756,0.000050219307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005560906,0.0008762725,0.979649,0.000014611396,0.00057835906,0.00008261075,0.000016027061,0.000004110877,0.00026769887,0.00019399375,0.0043550744,0.008401349],"study_design_scores_gemma":[0.012529071,0.00057552854,0.9781815,0.000037566973,0.0001607063,0.000024904337,0.000010385508,0.00025312364,0.0004255178,0.0006190334,0.007093909,0.00008875638],"about_ca_topic_score_codex":0.00004677024,"about_ca_topic_score_gemma":0.000032206517,"teacher_disagreement_score":0.02815389,"about_ca_system_score_codex":0.000012634911,"about_ca_system_score_gemma":0.00005061881,"threshold_uncertainty_score":0.9072515},"labels":[],"label_agreement":null},{"id":"W2742530754","doi":"10.1097/yic.0000000000000192","title":"The impact of fatigue and energy on work functioning and impairment in patients with major depressive disorder treated with desvenlafaxine","year":2017,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Major depressive disorder; Rating scale; Depression (economics); Psychology; Placebo; Psychiatry; Clinical psychology; Medicine; Physical therapy; Cognition; Developmental psychology","score_opus":0.026386629143611774,"score_gpt":0.40071972993538574,"score_spread":0.37433310079177395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742530754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975894,0.00010080282,0.000031625998,0.0011135715,0.00020233399,0.0002503975,0.00000951293,0.000009800867,0.0006925303],"genre_scores_gemma":[0.9992157,0.00014764728,0.0000831159,0.0001137966,0.000073341056,0.00005007546,0.000019355875,0.000015293359,0.0002816279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989521,0.00008245497,0.00032391702,0.00029675607,0.00020055113,0.00014421919],"domain_scores_gemma":[0.9987301,0.00049102976,0.0003357448,0.00021427331,0.00012486626,0.0001039463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014033394,0.00014953862,0.00025572215,0.000074972464,0.00013265102,0.00002567053,0.000119592245,0.0000789179,0.000058653113],"category_scores_gemma":[0.000108432476,0.000074373886,0.00004984302,0.00004014089,0.00032040547,0.0000759445,0.0000553484,0.00019108318,0.0000010443733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03136129,0.0011012855,0.94093037,0.0000030689705,0.0005579619,0.00002133854,0.000013834241,0.00005968185,0.00002001687,0.000016790274,0.00034416962,0.025570199],"study_design_scores_gemma":[0.028553085,0.004246217,0.96654385,0.00014749885,0.00008992384,0.0000056430345,0.00000506816,0.00011966943,0.000032378724,0.000039750586,0.00014607006,0.000070852024],"about_ca_topic_score_codex":0.00019427354,"about_ca_topic_score_gemma":0.000057189085,"teacher_disagreement_score":0.02561348,"about_ca_system_score_codex":0.00005382788,"about_ca_system_score_gemma":0.000029673978,"threshold_uncertainty_score":0.30328792},"labels":[],"label_agreement":null},{"id":"W2756185629","doi":"10.1097/yic.0000000000000196","title":"Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression","year":2017,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Concordia University; Université de Montréal; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Treatment-resistant depression; Depression (economics); Antidepressant; Hamilton Rating Scale for Depression; Psychology; Antipsychotic; Rating scale; Internal medicine; Psychiatry; Montgomery–Åsberg Depression Rating Scale; Comorbidity; Major depressive disorder; Personality disorders; Medicine; Personality; Schizophrenia (object-oriented programming); Anxiety; Mood","score_opus":0.13592372994369623,"score_gpt":0.48674824274596123,"score_spread":0.350824512802265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756185629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97497267,0.00035703878,0.000109414395,0.002531227,0.0119132865,0.0011062749,0.000058603604,0.00010014362,0.008851363],"genre_scores_gemma":[0.99466026,0.0012322362,0.00053864403,0.0004447157,0.0009987176,0.00012714833,0.00039935767,0.00005336298,0.0015455509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638295,0.0003472517,0.0012388701,0.0010288467,0.00058501353,0.00041707404],"domain_scores_gemma":[0.9973604,0.00046022073,0.00083726645,0.000835935,0.00024061014,0.00026556427],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006133025,0.0003912737,0.0006785857,0.00039003204,0.0003418105,0.00014856437,0.00053947285,0.00038141065,0.0014237419],"category_scores_gemma":[0.0004742068,0.0003477232,0.00029146214,0.0000983955,0.0002646455,0.0006788708,0.0001328346,0.00045176773,0.00021982862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03394151,0.0045337793,0.8023244,0.00003476139,0.00083423033,0.0006462405,0.000097473,0.00009416942,0.1138467,0.00019178416,0.0058173635,0.03763755],"study_design_scores_gemma":[0.07897653,0.0012887251,0.8984331,0.00013858688,0.00024579445,0.000030398574,0.000021610138,0.0058180667,0.008944942,0.00016404202,0.005651337,0.00028689505],"about_ca_topic_score_codex":0.00013273604,"about_ca_topic_score_gemma":0.00036288227,"teacher_disagreement_score":0.10490175,"about_ca_system_score_codex":0.00052649644,"about_ca_system_score_gemma":0.00016209694,"threshold_uncertainty_score":0.9998975},"labels":[],"label_agreement":null},{"id":"W2799604498","doi":"10.1097/yic.0000000000000221","title":"Antipsychotic drug exposure and risk of fracture","year":2018,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; McMaster University","funders":"","keywords":"Medicine; Confounding; Observational study; Confidence interval; Odds ratio; Relative risk; Hip fracture; Pharmacoepidemiology; Population; Internal medicine; Environmental health; Pharmacology; Osteoporosis","score_opus":0.09991378660356631,"score_gpt":0.5483406798708127,"score_spread":0.4484268932672464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799604498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035203688,0.98730206,0.000011079178,0.0012451832,0.0049791485,0.0010640211,0.00012492182,0.00002917305,0.0017240108],"genre_scores_gemma":[0.00087990926,0.99253696,0.00028566457,0.0017526328,0.00266214,0.000060108596,0.00011545599,0.00005142119,0.0016557174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995759,0.00073659536,0.0019874487,0.00072491274,0.00045822572,0.00033377873],"domain_scores_gemma":[0.9955032,0.00216965,0.0010280114,0.00038307867,0.00043918777,0.00047689173],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016959421,0.00033042076,0.0020510987,0.0003382382,0.000052216903,0.000012297389,0.00039372785,0.0007491079,0.0018463661],"category_scores_gemma":[0.0008848614,0.00024397575,0.00071210903,0.00020149675,0.00059111346,0.0000427948,0.000113244154,0.0020256261,0.00027613572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015555912,0.00079948385,0.009367343,0.0066194404,0.0018160247,0.00005763651,0.000023784574,6.317901e-8,6.980845e-7,0.000014372578,0.16380176,0.8159438],"study_design_scores_gemma":[0.0034075072,0.00069145096,0.006005673,0.0025430042,0.0012669486,0.00013085348,0.0000044166804,0.000010504932,6.1696016e-7,0.00010400932,0.9856763,0.00015874134],"about_ca_topic_score_codex":0.000026574742,"about_ca_topic_score_gemma":0.0000087986755,"teacher_disagreement_score":0.8218745,"about_ca_system_score_codex":0.00005166194,"about_ca_system_score_gemma":0.00047623203,"threshold_uncertainty_score":0.99906605},"labels":[],"label_agreement":null},{"id":"W2799973089","doi":"10.1097/yic.0000000000000223","title":"A pilot, open-label, 8-week study evaluating desvenlafaxine for treatment of major depression in methadone-maintained individuals with opioid use disorder","year":2018,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Health Canada; Pfizer Canada; Pfizer","keywords":"Tolerability; Methadone; Depression (economics); Methadone maintenance; Medicine; Major depressive disorder; Internal medicine; Randomized controlled trial; Psychiatry; Clinical trial; Opioid use disorder; Opioid; Psychology; Adverse effect; Mood","score_opus":0.23979035206828764,"score_gpt":0.5491802309517423,"score_spread":0.30938987888345465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799973089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99084336,0.0001242186,0.0007233694,0.0013368565,0.0013221035,0.005249949,0.000078214114,0.000040622588,0.0002812897],"genre_scores_gemma":[0.9725057,0.000066871864,0.024161171,0.0006265452,0.00047435894,0.001241657,0.0001032626,0.000053715037,0.0007667022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655676,0.00050703035,0.0012731638,0.0008323401,0.0004979347,0.0003327828],"domain_scores_gemma":[0.99580395,0.0025469994,0.0005561208,0.00039215886,0.00051505654,0.00018572317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012428423,0.00031185683,0.0008543009,0.00031519737,0.0000801655,0.000034816258,0.0004513306,0.00012042775,0.0004994596],"category_scores_gemma":[0.00084560073,0.00021755691,0.000099264864,0.00023600602,0.00024005257,0.0002427172,0.00019580823,0.00017008005,0.000021891054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05033245,0.046798497,0.8667155,0.00001648694,0.0013232767,0.00005672522,0.00027570582,0.00001075277,0.006232099,0.000021746851,0.00077901053,0.027437756],"study_design_scores_gemma":[0.20301016,0.1063978,0.68313956,0.00022268757,0.00083394686,0.000030241452,0.00013532455,0.0012818376,0.0013510796,0.00036795792,0.0029823799,0.0002470193],"about_ca_topic_score_codex":0.00029979332,"about_ca_topic_score_gemma":0.0003485507,"teacher_disagreement_score":0.18357593,"about_ca_system_score_codex":0.00019378982,"about_ca_system_score_gemma":0.0001925535,"threshold_uncertainty_score":0.8871713},"labels":[],"label_agreement":null},{"id":"W2909821273","doi":"10.1097/yic.0000000000000251","title":"Hyoscine for clozapine-induced hypersalivation","year":2019,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"King's College London; National Institute for Health and Care Research; South London and Maudsley NHS Foundation Trust","keywords":"Hypersalivation; Clozapine; Placebo; Schizophrenia (object-oriented programming); Psychology; Medicine; Atypical antipsychotic; Anesthesia; Antipsychotic; Psychiatry","score_opus":0.09722528395156863,"score_gpt":0.507904316988038,"score_spread":0.41067903303646935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909821273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96236795,0.0000573032,0.00015307202,0.026823644,0.005551078,0.0010405695,0.00002221462,0.000056975055,0.0039271773],"genre_scores_gemma":[0.98696613,0.00014698476,0.002725034,0.00526162,0.0015861656,0.000133399,0.00012397033,0.000020880036,0.00303583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860513,0.000056249635,0.00047485306,0.00038833474,0.0002585872,0.00021685468],"domain_scores_gemma":[0.9985523,0.0006683104,0.00010403605,0.00017827345,0.00030164205,0.00019543292],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00042330843,0.0001164488,0.0002787903,0.00013355706,0.000026874237,0.0000108901295,0.00016268172,0.00013069273,0.002378444],"category_scores_gemma":[0.00034806287,0.000095903175,0.00023821364,0.00008928342,0.000042188036,0.00006147264,0.00003442021,0.0002485136,0.0009810353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24778333,0.0053030592,0.31992,0.00011028523,0.0034744244,0.00015195293,0.000048385777,0.00001631913,0.1014753,0.013747777,0.11592254,0.19204661],"study_design_scores_gemma":[0.13640513,0.007911472,0.54035646,0.00007346832,0.0003019216,0.00014430104,0.000037800393,0.0065386817,0.0044127554,0.0062504355,0.2971791,0.0003884655],"about_ca_topic_score_codex":0.0000079865085,"about_ca_topic_score_gemma":0.000004565946,"teacher_disagreement_score":0.22043645,"about_ca_system_score_codex":0.0000897887,"about_ca_system_score_gemma":0.00013810952,"threshold_uncertainty_score":0.9997968},"labels":[],"label_agreement":null},{"id":"W2936650608","doi":"10.1097/yic.0000000000000264","title":"Concomitant use of alcohol and benzodiazepine hypnotics in psychiatric outpatients","year":2019,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Sleep and related disorders","field":"Psychology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Concomitant; Odds ratio; Medicine; Benzodiazepine; Psychiatry; Logistic regression; Confidence interval; Depression (economics); Insomnia; Schizophrenia (object-oriented programming); Internal medicine","score_opus":0.05777006794037953,"score_gpt":0.42966230938811906,"score_spread":0.3718922414477395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936650608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649036,0.00037650001,0.000028439796,0.0017844042,0.017687153,0.0004390858,0.000038535207,0.00002265308,0.014719664],"genre_scores_gemma":[0.9951444,0.00051748723,0.00036583433,0.0026118925,0.00021826637,0.00001803913,0.00002115317,0.0000216549,0.0010812695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976952,0.00025153297,0.0011354833,0.0004771354,0.00018630363,0.0002543548],"domain_scores_gemma":[0.99808407,0.001127358,0.00034523846,0.00021835875,0.00011395874,0.000111043286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039112798,0.00016224764,0.0003812303,0.00032027194,0.000014211595,0.000009672568,0.00029540816,0.00035465733,0.0029811836],"category_scores_gemma":[0.00015822495,0.0001520949,0.0001404009,0.00021327507,0.00019333209,0.00009965517,0.00007527348,0.0005466481,0.00046061634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023868512,0.0018296598,0.9710071,0.000008424653,0.0007231163,0.000021842769,0.00020074435,0.00007901413,0.00018145471,0.002502565,0.009617051,0.0114421705],"study_design_scores_gemma":[0.04441371,0.0011073087,0.8907563,0.000033057528,0.00016643037,0.000020682399,0.00017039909,0.0011246997,0.000014745872,0.0020117317,0.059820276,0.0003606568],"about_ca_topic_score_codex":0.000082147075,"about_ca_topic_score_gemma":0.000017166703,"teacher_disagreement_score":0.0802508,"about_ca_system_score_codex":0.000024895899,"about_ca_system_score_gemma":0.000026574711,"threshold_uncertainty_score":0.9979302},"labels":[],"label_agreement":null},{"id":"W2946354012","doi":"10.1097/yic.0000000000000269","title":"Addressing clozapine under-prescribing and barriers to initiation","year":2019,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dr. Georges-L.-Dumont University Hospital Centre; Vitalité Health Network","funders":"","keywords":"Clozapine; Schizophrenia (object-oriented programming); Medicine; Psychiatry; Perception; Antipsychotic; Family medicine; Psychology; Clinical psychology","score_opus":0.14308838852583175,"score_gpt":0.5006738307647532,"score_spread":0.3575854422389215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946354012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667433,0.00013008389,0.00011293784,0.02634535,0.0022379588,0.00046530156,0.00001281987,0.000041464275,0.0039107734],"genre_scores_gemma":[0.9839923,0.00023696704,0.001582261,0.013058556,0.00046945605,0.00003195103,0.000029207817,0.00001527525,0.0005840511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998665,0.000100996054,0.0003848118,0.00037467075,0.00027092017,0.00020364192],"domain_scores_gemma":[0.99863034,0.00041922968,0.0000671936,0.00013388296,0.00014872092,0.0006006399],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038022676,0.000108015636,0.00022703651,0.00016628696,0.000044537264,0.000025923417,0.00011419228,0.00010100878,0.0035546732],"category_scores_gemma":[0.00051382557,0.000094882584,0.00008520928,0.000095473566,0.00007046681,0.00008545797,0.00008684141,0.000314227,0.00053252163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.086246125,0.0009668455,0.69718003,0.000076078366,0.0018564671,0.00033063427,0.0002046275,0.00013215691,0.030192686,0.010081405,0.031633787,0.14109913],"study_design_scores_gemma":[0.04601543,0.0024779418,0.9089611,0.00016557373,0.0001741015,0.00016967267,0.00016798078,0.002773815,0.001077761,0.00695004,0.030735787,0.00033080377],"about_ca_topic_score_codex":0.000009883684,"about_ca_topic_score_gemma":0.000009221555,"teacher_disagreement_score":0.21178104,"about_ca_system_score_codex":0.0000829274,"about_ca_system_score_gemma":0.00015789685,"threshold_uncertainty_score":0.99735624},"labels":[],"label_agreement":null},{"id":"W2957405451","doi":"10.1097/yic.0000000000000276","title":"Effectiveness and safety of long-term benzodiazepine use in anxiety disorders","year":2019,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Discontinuation; Anxiety; Placebo; Randomized controlled trial; Medicine; Meta-analysis; Panic; Adverse effect; Hamilton Anxiety Rating Scale; Psychiatry; Anxiety disorder; Internal medicine","score_opus":0.12152631462371016,"score_gpt":0.5192403396675317,"score_spread":0.39771402504382153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957405451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0067008715,0.96444887,0.00033242904,0.000083633335,0.021621393,0.0025967748,0.0006571959,0.00005891736,0.0034999314],"genre_scores_gemma":[0.0143463705,0.98297143,0.00009002002,0.00021755252,0.0007186574,0.00050791213,0.00037724755,0.00012358738,0.00064724096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99260074,0.0021331413,0.0024847845,0.0018370652,0.000395472,0.00054878485],"domain_scores_gemma":[0.9882476,0.009120292,0.0015004112,0.000567918,0.00033623676,0.00022755013],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015982001,0.00078466337,0.002749831,0.001172417,0.000046729452,0.00003770127,0.0010035302,0.0012068126,0.0030013518],"category_scores_gemma":[0.0010241503,0.0006986721,0.0008811291,0.00088512833,0.0005824349,0.00025721436,0.00035594736,0.0014817367,0.0004094247],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016934816,0.0018574938,0.22707853,0.002415892,0.0017344272,0.000025466788,0.000030247164,7.954145e-7,5.4601645e-7,0.00012982286,0.0011206482,0.7639127],"study_design_scores_gemma":[0.007393942,0.0003491458,0.3154944,0.0027356255,0.00079345563,0.000044509314,0.0000073020597,0.0000017369163,4.9258216e-7,0.00022609184,0.6724477,0.00050565985],"about_ca_topic_score_codex":0.00006651633,"about_ca_topic_score_gemma":0.00004548627,"teacher_disagreement_score":0.763407,"about_ca_system_score_codex":0.00018889512,"about_ca_system_score_gemma":0.00017107753,"threshold_uncertainty_score":0.99954647},"labels":[],"label_agreement":null},{"id":"W2988235388","doi":"10.1097/yic.0000000000000295","title":"Ophthalmic adverse effects of lithium","year":2019,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Ottawa","funders":"","keywords":"Medicine; Photophobia; Adverse effect; Lithium (medication); Exophthalmos; Intensive care medicine; Ophthalmology; Surgery; Psychiatry; Internal medicine","score_opus":0.09847464799369035,"score_gpt":0.5218891884449253,"score_spread":0.42341454045123494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988235388","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012941635,0.9675366,0.00000918104,0.00017810619,0.013331442,0.0014373168,0.00006451367,0.000032731426,0.017280685],"genre_scores_gemma":[0.0006318202,0.99299043,0.00013885659,0.0003670116,0.00088541716,0.000119499244,0.00021158227,0.00005426463,0.0046011345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724436,0.0002780775,0.0013980393,0.00057474215,0.0002896956,0.00021508221],"domain_scores_gemma":[0.9970392,0.0016311314,0.0006390279,0.00036731214,0.00015348481,0.00016983504],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00026737532,0.00034972545,0.0021621075,0.0002503398,0.000013319135,0.0000032428052,0.00037547637,0.0006189489,0.0012355039],"category_scores_gemma":[0.00020921613,0.00026791307,0.0013306554,0.00014021793,0.00015791733,0.000032661286,0.000109178785,0.0008538049,0.0014934901],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048280437,0.0026303723,0.0021541594,0.016045958,0.0056809494,0.00015570859,0.00000931605,1.4206529e-7,0.000005552229,0.00013232937,0.006474123,0.9662286],"study_design_scores_gemma":[0.0051054945,0.00090162415,0.0013560775,0.0035252774,0.0043994277,0.00020445828,9.210298e-7,0.0000031506854,0.0000023448815,0.000046500565,0.9842825,0.00017224895],"about_ca_topic_score_codex":0.0000064901974,"about_ca_topic_score_gemma":6.6636784e-7,"teacher_disagreement_score":0.97780836,"about_ca_system_score_codex":0.00010378765,"about_ca_system_score_gemma":0.00031755527,"threshold_uncertainty_score":0.9999773},"labels":[],"label_agreement":null},{"id":"W3005602333","doi":"10.1097/yic.0000000000000307","title":"Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial","year":2020,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Akathisia; Placebo; Tolerability; Bipolar I disorder; Internal medicine; Extrapyramidal symptoms; Adverse effect; Nausea; Medicine; Psychology; Bipolar disorder; Psychiatry; Antipsychotic; Mania; Schizophrenia (object-oriented programming)","score_opus":0.14853191189811432,"score_gpt":0.5037474588684917,"score_spread":0.3552155469703774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005602333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731864,0.009769057,0.000044669338,0.009113544,0.00089514395,0.00512815,0.000023810417,0.00000824647,0.0018309912],"genre_scores_gemma":[0.9949502,0.0031219423,0.00006946924,0.0005290604,0.00050646445,0.0007462239,0.0000402182,0.000008560081,0.00002790024],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969545,0.0009136188,0.0011493621,0.0002975287,0.00057685317,0.000108112705],"domain_scores_gemma":[0.9978052,0.0013053688,0.00036889198,0.00013377606,0.00029125714,0.00009555041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024683871,0.00014864911,0.0009333286,0.000107069965,0.000028228993,0.0000045974316,0.00012782753,0.00012882771,0.00046829422],"category_scores_gemma":[0.00045973298,0.000086314125,0.00032649428,0.00011761071,0.0002069857,0.000038474936,0.000022886346,0.00017098666,0.0000044040994],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94152945,0.008157846,0.0030783063,0.00000834518,0.0017853497,0.0000067107517,0.00060991297,0.000016210242,0.00032988194,0.000080486454,0.00016840265,0.044229105],"study_design_scores_gemma":[0.98034537,0.0062708016,0.00064513844,0.000012958778,0.0028802596,0.000010602586,0.000036115438,0.0046933554,0.00018291708,0.00021169463,0.0046538073,0.000056956374],"about_ca_topic_score_codex":0.00005309835,"about_ca_topic_score_gemma":0.000034389,"teacher_disagreement_score":0.04417215,"about_ca_system_score_codex":0.000042380474,"about_ca_system_score_gemma":0.00014909034,"threshold_uncertainty_score":0.5127493},"labels":[],"label_agreement":null},{"id":"W3015341766","doi":"10.1097/yic.0000000000000310","title":"Impact of early use of long-acting injectable antipsychotics on psychotic relapses and hospitalizations in first-episode psychosis","year":2020,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire en santé mentale de Montréal; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Antipsychotic; Psychosis; Medicine; Medical prescription; Early psychosis; Psychiatry; Intervention (counseling); Schizophrenia (object-oriented programming); Prospective cohort study; Pediatrics; Internal medicine; Pharmacology","score_opus":0.11024883096650032,"score_gpt":0.4710722058285814,"score_spread":0.36082337486208105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015341766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300724,0.00009818253,0.00017254887,0.0051798266,0.00063672796,0.0004844881,0.00006007936,0.000020887941,0.0003400406],"genre_scores_gemma":[0.99658877,0.0011554655,0.0012902707,0.00067945715,0.00017506797,0.00002360685,0.000023914394,0.000024191326,0.000039272833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979837,0.0001239669,0.00091606716,0.00043049874,0.00031561396,0.00023017125],"domain_scores_gemma":[0.99783427,0.0011552948,0.00029354737,0.00018784298,0.00023502055,0.00029404348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020739433,0.00017576545,0.00050599605,0.00025636127,0.000026454853,0.0000151602535,0.00016851058,0.00014723348,0.00040678502],"category_scores_gemma":[0.00093096204,0.00014942772,0.00025390298,0.00038982678,0.00020635816,0.00013267211,0.000040582254,0.00042443263,0.000020585114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037932925,0.0020507781,0.95234185,0.0000375136,0.0006875874,0.000055196248,0.00009711116,0.00023456427,0.00018155212,0.00016989335,0.0028522576,0.0033587464],"study_design_scores_gemma":[0.011361954,0.005228182,0.98111486,0.00013650088,0.00008217139,0.000011866318,0.000008201324,0.0014272467,0.00012370799,0.00025675117,0.00014686909,0.00010165543],"about_ca_topic_score_codex":0.00022763091,"about_ca_topic_score_gemma":0.0001046639,"teacher_disagreement_score":0.02877302,"about_ca_system_score_codex":0.000059963222,"about_ca_system_score_gemma":0.000059987575,"threshold_uncertainty_score":0.60934854},"labels":[],"label_agreement":null},{"id":"W3027044460","doi":"10.1097/yic.0000000000000314","title":"Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders","year":2020,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"National Institute of Child Health and Human Development; National Institute of Mental Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Research for Patient Benefit Programme; Servier; The Wellcome Trust DBT India Alliance; Universität Zürich; Purdue University; Wellcome Trust; University of Sydney; Allergan; Teva Pharmaceutical Industries; Department of Health and Social Care; Indian Council of Medical Research; Department of Biotechnology, Ministry of Science and Technology, India; Pfizer; LivaNova; Purdue Pharma; Eli Lilly and Company; U.S. Department of Defense; Western Sydney Local Health District; National Institute for Health and Care Research; BrainsWay; H. Lundbeck A/S; Western Sydney University; European College of Neuropsychopharmacology; Neurocrine Biosciences","keywords":"Position statement; Obsessive compulsive; Neurostimulation; Psychotherapist; Intervention (counseling); Psychology; Position paper; Psychological intervention; Evidence-based practice; Clinical psychology; Psychiatry; Medicine; Alternative medicine; Family medicine; Neuroscience","score_opus":0.03484097919763624,"score_gpt":0.46002517481125993,"score_spread":0.4251841956136237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027044460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091005384,0.91207117,0.0007823584,0.020340193,0.044706263,0.0046364954,0.0065523824,0.00015426823,0.009846819],"genre_scores_gemma":[0.0055473633,0.98504037,0.00025081422,0.0027944248,0.0023692918,0.0010515003,0.001841751,0.00024835672,0.00085612957],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98176724,0.00436557,0.008181825,0.003065799,0.0013893069,0.0012302514],"domain_scores_gemma":[0.9830389,0.008755516,0.006294185,0.001038509,0.00037411155,0.0004987804],"candidate_categories":["metaepi_narrow","open_science","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.001973005,0.0015907349,0.0048031034,0.0008333979,0.0002054319,0.00007997959,0.0055402787,0.0012781739,0.006119551],"category_scores_gemma":[0.0009817634,0.0013196181,0.0028827982,0.0013184947,0.002008155,0.00051211845,0.0010187655,0.004336255,0.0010698072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030477298,0.006342547,0.010234121,0.0006558962,0.0056295856,0.0004634794,0.00033246347,0.00005526324,0.0000015686556,0.0068392963,0.09162384,0.8747742],"study_design_scores_gemma":[0.010989117,0.0011157723,0.002541641,0.0013741399,0.0009073523,0.000082796825,0.000632598,0.00019803137,6.600854e-7,0.0047507435,0.9762752,0.0011319483],"about_ca_topic_score_codex":0.00016881805,"about_ca_topic_score_gemma":0.00041061646,"teacher_disagreement_score":0.88465136,"about_ca_system_score_codex":0.00078675314,"about_ca_system_score_gemma":0.0008185314,"threshold_uncertainty_score":0.9998402},"labels":[],"label_agreement":null},{"id":"W3031969505","doi":"10.1097/yic.0000000000000316","title":"Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology","year":2020,"lang":"en","type":"review","venue":"International Clinical Psychopharmacology","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Waypoint Centre for Mental Health Care; Centre for Addiction and Mental Health","funders":"","keywords":"Antidepressant; Benzodiazepine; Anxiety; Monoaminergic; Neuropharmacology; Psychology; Psychiatry; Depression (economics); Medicine; Internal medicine; Serotonin","score_opus":0.3680515959617024,"score_gpt":0.5357258199768008,"score_spread":0.1676742240150984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031969505","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005457993,0.91501933,0.00013093826,0.006199219,0.06281129,0.008009047,0.000275716,0.00024334344,0.0018531072],"genre_scores_gemma":[0.03969017,0.9514176,0.0000029194325,0.0068324376,0.0013735245,0.00038032606,0.0000029046876,0.00009221341,0.00020789707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9895087,0.004980739,0.0020771374,0.0018616711,0.00079057517,0.0007811861],"domain_scores_gemma":[0.9563102,0.041819952,0.0010287577,0.00047061694,0.000058777987,0.00031169064],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00077686884,0.00064002303,0.0019351109,0.0007313266,0.00016600064,0.00006585467,0.0030888524,0.00049654307,0.00044981137],"category_scores_gemma":[0.007262335,0.00044923835,0.00085737015,0.0012928472,0.0013825864,0.00021972133,0.00079252705,0.004049511,0.00035282376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039703464,0.0048958627,0.00038367158,0.0043916637,0.00047953436,0.016483312,0.00007273465,0.00006882347,0.048387963,0.0024762356,0.034980852,0.883409],"study_design_scores_gemma":[0.0052934675,0.002128529,0.00007093234,0.0014016604,0.00036435097,0.00022552045,0.0000017489886,0.00040667763,0.0032651392,0.0004181403,0.9859482,0.00047560866],"about_ca_topic_score_codex":0.0000043189416,"about_ca_topic_score_gemma":0.0000045059846,"teacher_disagreement_score":0.9509674,"about_ca_system_score_codex":0.0003945824,"about_ca_system_score_gemma":0.0005908898,"threshold_uncertainty_score":0.9997959},"labels":[],"label_agreement":null},{"id":"W3109615028","doi":"10.1097/yic.0000000000000344","title":"Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies","year":2020,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Placebo; Post-hoc analysis; Depression (economics); Bipolar disorder; Internal medicine; Bipolar I disorder; Medicine; Randomized controlled trial; Rating scale; Psychology; Psychiatry; Mania","score_opus":0.03949122080845649,"score_gpt":0.44339924525587093,"score_spread":0.40390802444741447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109615028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98534596,0.008355535,0.000055536588,0.0038748072,0.0008400426,0.0011684234,0.00018554504,0.000017652537,0.00015650166],"genre_scores_gemma":[0.9947325,0.0031679417,0.00013378794,0.0015466688,0.00014430056,0.00010592654,0.00013346512,0.000013676523,0.000021716583],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966362,0.00047333507,0.0019726593,0.0004061335,0.00032664888,0.0001849946],"domain_scores_gemma":[0.99570113,0.0027396898,0.0007520041,0.00016057893,0.0004982594,0.0001483245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073901966,0.00019529436,0.0023111508,0.0002559911,0.000020753887,0.0000043088,0.0001772999,0.0001477819,0.0003314526],"category_scores_gemma":[0.0025428878,0.00014242923,0.0008178773,0.00037359202,0.00029276797,0.0000391224,0.00010813147,0.0003162994,0.000012614099],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7334332,0.002472697,0.20780344,0.00004105526,0.025111768,0.000032959073,0.0011315369,0.0000510544,0.002809191,0.00002054996,0.00009596298,0.026996618],"study_design_scores_gemma":[0.68933374,0.0014357119,0.29743823,0.000057499517,0.006909301,0.0000033774033,0.00013661149,0.0035140677,0.0002634079,0.000019793963,0.00076463324,0.00012364086],"about_ca_topic_score_codex":0.000044273926,"about_ca_topic_score_gemma":0.000043737633,"teacher_disagreement_score":0.08963479,"about_ca_system_score_codex":0.00004605356,"about_ca_system_score_gemma":0.00006206343,"threshold_uncertainty_score":0.58080953},"labels":[],"label_agreement":null},{"id":"W3110396742","doi":"10.1097/yic.0000000000000342","title":"Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology","year":2020,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"European College of Neuropsychopharmacology; National Institute for Health and Care Research","keywords":"Body dysmorphic disorder; Obsessive compulsive; Psychiatry; Psychology; Medicine","score_opus":0.022743495237674615,"score_gpt":0.3339445960319447,"score_spread":0.3112011007942701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110396742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8945194,0.0012521464,0.000013036884,0.089924626,0.0050570383,0.0013230559,0.0015450359,0.00001618008,0.0063494914],"genre_scores_gemma":[0.9948503,0.0028201237,0.000040329578,0.0017782424,0.00022213421,0.00006492801,0.0000067050946,0.00003808219,0.00017917583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99479103,0.0023311106,0.0015596612,0.00067787844,0.00034780568,0.00029249187],"domain_scores_gemma":[0.99073887,0.0069175297,0.0016831441,0.00033507767,0.00021686399,0.0001084984],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0006269839,0.0003749982,0.0009547019,0.000086469954,0.00018197054,0.000006076147,0.00087113486,0.00015587207,0.00028420213],"category_scores_gemma":[0.00071171665,0.00022701889,0.00040153117,0.00036927173,0.004712636,0.000040100338,0.0005428419,0.0005525441,0.000004139792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051883537,0.006528224,0.775307,0.00018525575,0.019269915,0.00017263879,0.0067422776,0.0010864142,0.0030623989,0.06995842,0.045560047,0.02024389],"study_design_scores_gemma":[0.033540033,0.0018960228,0.9416208,0.00014066209,0.0012497541,0.0000820597,0.0016405578,0.0016921493,0.00020146398,0.009330684,0.008234704,0.00037106103],"about_ca_topic_score_codex":0.00014014043,"about_ca_topic_score_gemma":0.00010240691,"teacher_disagreement_score":0.16631387,"about_ca_system_score_codex":0.000029549114,"about_ca_system_score_gemma":0.000076910605,"threshold_uncertainty_score":0.997996},"labels":[],"label_agreement":null},{"id":"W3158641115","doi":"10.1097/yic.0000000000000363","title":"Adjunctive music improves the tolerability of intravenous ketamine for bipolar depression","year":2021,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"","keywords":"Ketamine; Tolerability; Dissociative; Bipolar disorder; Distress; Anxiety; Psychology; Dissociation (chemistry); Anesthesia; Music therapy; Psychiatry; Clinical psychology; Psychotherapist; Medicine; Cognition; Adverse effect; Internal medicine","score_opus":0.08303040136712138,"score_gpt":0.4649321585020709,"score_spread":0.38190175713494956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158641115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9402635,0.004957332,0.0020262368,0.008795088,0.02788259,0.00063373946,0.00023097477,0.000040750063,0.015169793],"genre_scores_gemma":[0.9920965,0.00033655006,0.00034001668,0.004235569,0.0015098754,0.0002170726,0.000039314506,0.000020471558,0.0012046731],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975996,0.00036451122,0.0009772974,0.0005970955,0.0001922123,0.00026927266],"domain_scores_gemma":[0.9954654,0.002898701,0.00048673456,0.00038112054,0.00068801036,0.00008005342],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010133286,0.00017214078,0.00042165458,0.00005650907,0.000102236634,0.000011666675,0.00049432856,0.00019511954,0.0020034597],"category_scores_gemma":[0.0008445416,0.00012494155,0.0003672146,0.00014707638,0.0003993181,0.000042432162,0.00015380523,0.0003791042,0.0000397618],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009185112,0.0077956347,0.073378704,0.000059199083,0.0045784903,0.000048897506,0.0022558765,0.000027230291,0.029836062,0.014596824,0.17743891,0.68079907],"study_design_scores_gemma":[0.008362958,0.000607087,0.57180357,0.000019720987,0.00020491812,0.000032147545,0.0005458129,0.0003218894,0.0013487567,0.011096479,0.40539446,0.00026221885],"about_ca_topic_score_codex":0.000039993327,"about_ca_topic_score_gemma":0.000056570894,"teacher_disagreement_score":0.6805368,"about_ca_system_score_codex":0.000030042524,"about_ca_system_score_gemma":0.00007300398,"threshold_uncertainty_score":0.9989088},"labels":[],"label_agreement":null},{"id":"W3165315636","doi":"10.1097/yic.0000000000000360","title":"Case report: asenapine and anticholinergic toxicity","year":2021,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Electroconvulsive Therapy Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto; University Health Network","funders":"","keywords":"Asenapine; Anticholinergic; Medicine; Olanzapine; Pharmacology; Anticholinergic agents; Anesthesia; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.06594291347588983,"score_gpt":0.4834465997257009,"score_spread":0.4175036862498111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165315636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96158653,0.0008711298,0.0001436433,0.029422855,0.0025549429,0.00016025241,0.000010933358,0.000052263826,0.0051974524],"genre_scores_gemma":[0.97512895,0.001652683,0.00096925406,0.017007718,0.0014433695,0.00001651158,0.000029244527,0.000016875154,0.0037353972],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9983209,0.0001391071,0.0006960848,0.00047773554,0.00017042892,0.00019579378],"domain_scores_gemma":[0.9984283,0.0005380591,0.00016367494,0.00018234251,0.0005104193,0.00017721696],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045710054,0.00013578299,0.00038338453,0.00006887021,0.00005840154,0.000011657834,0.00006658752,0.00011683021,0.0010817517],"category_scores_gemma":[0.00088316895,0.00012288496,0.00013786081,0.0001175517,0.00022449213,0.000046835266,0.00008737299,0.00043916857,0.000041940148],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025754042,0.0017301444,0.079007566,0.00003384946,0.0021011208,0.7713509,0.000073598385,0.000002268879,0.08744257,0.0005449682,0.04258005,0.012557554],"study_design_scores_gemma":[0.018463543,0.0009787886,0.06668871,0.000044395238,0.00041550933,0.7865303,0.000075061595,0.00050467456,0.009328277,0.0015951608,0.11502062,0.00035496376],"about_ca_topic_score_codex":0.0000065159197,"about_ca_topic_score_gemma":0.000017609409,"teacher_disagreement_score":0.07811429,"about_ca_system_score_codex":0.000034567853,"about_ca_system_score_gemma":0.00008998658,"threshold_uncertainty_score":0.9998314},"labels":[],"label_agreement":null},{"id":"W3183401491","doi":"10.1097/yic.0000000000000376","title":"Vortioxetine improves cognition in mild cognitive impairment","year":2021,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vortioxetine; Digit symbol substitution test; Montreal Cognitive Assessment; Cognition; Clinical Dementia Rating; Adverse effect; Medicine; Dementia; Effects of sleep deprivation on cognitive performance; Cognitive impairment; Internal medicine; Psychology; Audiology; Psychiatry; Major depressive disorder; Disease","score_opus":0.05414265949380021,"score_gpt":0.4880621425768187,"score_spread":0.4339194830830185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183401491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563794,0.00019102363,0.00014826168,0.011246507,0.0021859612,0.00057177513,0.000044697365,0.000041288407,0.029191054],"genre_scores_gemma":[0.981828,0.000762487,0.00024311832,0.012223068,0.0007659008,0.00016098961,0.0003552856,0.000018919978,0.0036422354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975268,0.0002901611,0.00082882494,0.00056758686,0.00044210049,0.0003445221],"domain_scores_gemma":[0.99795246,0.00060872256,0.00012761459,0.00010439833,0.000973148,0.0002336366],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076769234,0.00015810307,0.0003330954,0.00021199687,0.000035812245,0.000024753015,0.000118491625,0.00015023291,0.0069431886],"category_scores_gemma":[0.000715757,0.00015435832,0.00020400225,0.0003030027,0.0001906841,0.00010151985,0.00011241134,0.0006157797,0.0004922377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014064061,0.011165595,0.8497469,0.00007396864,0.001231414,0.0028789896,0.00007713157,9.0547354e-7,0.033648923,0.00015338056,0.014764912,0.07219386],"study_design_scores_gemma":[0.024392148,0.0009709119,0.95616645,0.00013748527,0.00016872058,0.00012500914,0.00018763584,0.00026093566,0.0056198156,0.00074444665,0.01106476,0.0001616708],"about_ca_topic_score_codex":0.000008642455,"about_ca_topic_score_gemma":0.00001926947,"teacher_disagreement_score":0.1064196,"about_ca_system_score_codex":0.00008171911,"about_ca_system_score_gemma":0.00028217016,"threshold_uncertainty_score":0.9939646},"labels":[],"label_agreement":null},{"id":"W4200088445","doi":"10.1097/yic.0000000000000385","title":"Personality profile and therapeutic response to lithium carbonate and sodium valproate in mania with psychotic features","year":2021,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lithium carbonate; Mania; Lithium (medication); Bipolar disorder; Mood stabilizer; Mood; Psychology; Novelty seeking; Harm avoidance; Psychiatry; Internal medicine; Personality; Medicine; Temperament; Chemistry","score_opus":0.035229706057921556,"score_gpt":0.41421944037646946,"score_spread":0.3789897343185479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200088445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.950559,0.0021757765,0.000009901716,0.042223096,0.0006421615,0.00040382656,0.000021364478,0.000023186365,0.0039416943],"genre_scores_gemma":[0.9891987,0.00037431446,0.00067029544,0.006833496,0.00014428722,0.00006958762,0.000013990185,0.000017960852,0.002677389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984591,0.00029996477,0.00032902166,0.0005258893,0.00019090531,0.00019512483],"domain_scores_gemma":[0.9990799,0.00039261967,0.00005591439,0.00013859969,0.00013395508,0.00019900645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004937979,0.0001545642,0.000294457,0.000100642705,0.000032324173,0.000020975878,0.00007275093,0.000121572,0.0002980797],"category_scores_gemma":[0.0000846607,0.00012154691,0.000048713664,0.00012879963,0.00014391018,0.000028368453,0.0000486091,0.00039140214,0.00001881314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05151187,0.0019397048,0.9204643,0.000055852543,0.00087388855,0.0004902932,0.00064472813,0.0000024782232,0.009119786,0.00035069886,0.0010635989,0.013482849],"study_design_scores_gemma":[0.009638763,0.00091991713,0.9756369,0.0000410895,0.0001158674,0.00035025188,0.000062183244,0.00008773639,0.00019249528,0.0004941417,0.012339759,0.00012089207],"about_ca_topic_score_codex":0.00003941089,"about_ca_topic_score_gemma":0.00021054226,"teacher_disagreement_score":0.05517265,"about_ca_system_score_codex":0.000045829565,"about_ca_system_score_gemma":0.00011343201,"threshold_uncertainty_score":0.4956539},"labels":[],"label_agreement":null},{"id":"W4210390943","doi":"10.1097/yic.0000000000000394","title":"Oxcarbazepine versus sodium valproate in treatment of acute mania: a double-blind randomized clinical trial","year":2022,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Oxcarbazepine; Adverse effect; Randomized controlled trial; Mania; Clinical Global Impression; Young Mania Rating Scale; Clinical trial; Anticonvulsant","score_opus":0.16460491679814862,"score_gpt":0.5188471833791097,"score_spread":0.35424226658096114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210390943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96084,0.00081747567,0.000031456806,0.008758796,0.01794679,0.003461178,0.000093883165,0.000044019842,0.0080064],"genre_scores_gemma":[0.99198705,0.002865311,0.00028438077,0.0006312407,0.0011808592,0.0013171623,0.0002607306,0.000031147865,0.0014421274],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9951367,0.0011112024,0.0023428574,0.0006522541,0.00046573218,0.0002913001],"domain_scores_gemma":[0.9967847,0.0020667661,0.0005279575,0.0002968558,0.00012970781,0.00019405464],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021684584,0.00025632355,0.0014962401,0.00028331045,0.00005571754,0.000007828922,0.00029257548,0.00019410063,0.0032132377],"category_scores_gemma":[0.00013851214,0.00021129429,0.00103305,0.00021714723,0.00033569423,0.000044528228,0.00013475373,0.0005930677,0.00006395784],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9584831,0.0154489335,0.010164565,0.0000055428436,0.0060356576,0.0001725275,0.00007543305,0.000011263186,0.000048838065,0.00038832775,0.00084029615,0.008325497],"study_design_scores_gemma":[0.954555,0.0121361185,0.004471961,0.000005816916,0.0016745001,0.0000361576,0.000020872778,0.00043057202,0.000039837872,0.0003278167,0.026159829,0.0001415275],"about_ca_topic_score_codex":0.00010512281,"about_ca_topic_score_gemma":0.000044874338,"teacher_disagreement_score":0.031147042,"about_ca_system_score_codex":0.0002627574,"about_ca_system_score_gemma":0.00026843173,"threshold_uncertainty_score":0.99769795},"labels":[],"label_agreement":null},{"id":"W4252967237","doi":"10.1097/01.yic.0000080801.87368.93","title":"Increased use of antibiotics in clozapine-treated patients","year":2003,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut universitaire en santé mentale de Montréal","funders":"","keywords":"Clozapine; Schizoaffective disorder; Medicine; Antibiotics; Medical prescription; Schizophrenia (object-oriented programming); Retrospective cohort study; Pediatrics; Psychosis; Internal medicine; Psychiatry; Pharmacology","score_opus":0.08360990557208188,"score_gpt":0.4579341082284898,"score_spread":0.3743242026564079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252967237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964188,0.000038463477,0.000008409393,0.0006449921,0.0009139588,0.00037714915,0.00003687399,0.00001573986,0.0015456243],"genre_scores_gemma":[0.9963963,0.0004239059,0.0017436718,0.001042632,0.000083394174,0.0000028533098,0.00007952501,0.000012844568,0.00021485575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831736,0.00025057615,0.0006897722,0.000274097,0.00027553318,0.00019265772],"domain_scores_gemma":[0.99853784,0.0006869229,0.00013241093,0.00015231317,0.00029807742,0.00019240908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030237547,0.00011250966,0.00031668058,0.0002223427,0.000011673017,0.000005982646,0.000103665785,0.00012874688,0.0007509558],"category_scores_gemma":[0.0013467019,0.000094605886,0.0001402947,0.00018628985,0.00013546468,0.00005960613,0.000025415573,0.00028701095,0.000082697836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015521577,0.0037954892,0.973388,0.000007752617,0.00029087954,0.00011314506,0.0000045393163,0.0000038071912,0.0006059906,0.0007133648,0.0025669392,0.0029885028],"study_design_scores_gemma":[0.029533643,0.0007700087,0.95717824,0.000030275165,0.00005114048,0.000009033351,0.0000023307973,0.00016033195,0.0021679392,0.00026000116,0.009764777,0.00007230784],"about_ca_topic_score_codex":0.00007918433,"about_ca_topic_score_gemma":0.00003546272,"teacher_disagreement_score":0.016209804,"about_ca_system_score_codex":0.000077788056,"about_ca_system_score_gemma":0.00012201454,"threshold_uncertainty_score":0.8222439},"labels":[],"label_agreement":null},{"id":"W4282549478","doi":"10.1097/yic.0000000000000409","title":"Repeated subcutaneous racemic ketamine in treatment-resistant depression: case series","year":2022,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Université de Montréal; BC Mental Health & Substance Use Services; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Ketamine; Treatment-resistant depression; Dosing; Medicine; Depression (economics); Anesthesia; Major depressive disorder; Electroconvulsive therapy; Clinical endpoint; Clinical trial; Internal medicine","score_opus":0.04585327333616393,"score_gpt":0.43261320368525813,"score_spread":0.38675993034909417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282549478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833369,0.00061523775,0.0000045967226,0.006351361,0.0040134885,0.0006518528,0.00010129868,0.0001291171,0.004796127],"genre_scores_gemma":[0.98714024,0.00038156,0.00032019455,0.0014784774,0.0004432494,0.00032184922,0.00017982179,0.000038323356,0.009696302],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971755,0.00044876724,0.0009869739,0.0007037506,0.00038367632,0.0003013053],"domain_scores_gemma":[0.9984708,0.00063498766,0.00025789003,0.00034155295,0.0000884134,0.00020637843],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039487958,0.00024540894,0.0005022599,0.00028059873,0.00013976976,0.000012155316,0.00021923335,0.00013537733,0.0069665685],"category_scores_gemma":[0.00017439117,0.00021117627,0.00024420675,0.00021763524,0.00012859798,0.000087537315,0.00018377625,0.00057617784,0.00008073698],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10306101,0.010004345,0.4219709,0.00002216379,0.0011217406,0.3664434,0.00022416397,0.00033929144,0.0293518,0.00006217989,0.018918877,0.048480146],"study_design_scores_gemma":[0.11468238,0.018979518,0.11877781,0.000119688746,0.0009460401,0.28364086,0.00059472275,0.0024759704,0.0024125543,0.00068070233,0.45572153,0.00096822315],"about_ca_topic_score_codex":0.00011232231,"about_ca_topic_score_gemma":0.00008777577,"teacher_disagreement_score":0.43680266,"about_ca_system_score_codex":0.00056350103,"about_ca_system_score_gemma":0.00012424518,"threshold_uncertainty_score":0.9939412},"labels":[],"label_agreement":null},{"id":"W4375955590","doi":"10.1097/yic.0000000000000462","title":"Ketamine for depression: a potential role in requests for Medical Aid in Dying?","year":2023,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Treatment of Major Depression","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Université de Montréal; McGill University","funders":"","keywords":"Depression (economics); Psychiatry; Ketamine; Intervention (counseling); Mood; Medicine; Major depressive disorder; Psychotherapist; Psychology","score_opus":0.04771850948401163,"score_gpt":0.49477960000518734,"score_spread":0.4470610905211757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4375955590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9612523,0.00017885544,0.0006666703,0.029499542,0.0057535125,0.0014685001,0.00004892697,0.00012565956,0.0010060486],"genre_scores_gemma":[0.9900962,0.00032355165,0.0014735706,0.0038524377,0.0016129955,0.0009097538,0.0002639813,0.00003794877,0.0014295197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747264,0.00012358793,0.0010227186,0.00059187046,0.0004300046,0.00035919127],"domain_scores_gemma":[0.99761444,0.0017212409,0.00015075099,0.0001670199,0.00012736066,0.00021916718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013682275,0.0001643281,0.0004454276,0.00040174273,0.00002810477,0.000008958481,0.0003060284,0.00039063263,0.0006224189],"category_scores_gemma":[0.0017353799,0.00014348952,0.00022731816,0.00020473749,0.00009213507,0.000079467805,0.000103048915,0.00041989554,0.00008941844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039230924,0.005005216,0.6739682,0.00012636665,0.00044525202,0.0014044816,0.00010566489,0.00022320428,0.009794418,0.0002172836,0.10208111,0.16739786],"study_design_scores_gemma":[0.120057814,0.0016217513,0.6783188,0.00050627167,0.00014974379,0.00014567876,0.000046579138,0.078154616,0.00082001457,0.007911366,0.111906774,0.00036058485],"about_ca_topic_score_codex":0.000015778518,"about_ca_topic_score_gemma":0.000046311918,"teacher_disagreement_score":0.16703728,"about_ca_system_score_codex":0.000104135186,"about_ca_system_score_gemma":0.00013887964,"threshold_uncertainty_score":0.681505},"labels":[],"label_agreement":null},{"id":"W4385664517","doi":"10.1097/yic.0000000000000500","title":"Efficacy of cariprazine in patients with bipolar depression and higher or lower levels of baseline anxiety: a pooled post hoc analysis","year":2023,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto","funders":"H. Lundbeck A/S; Purdue Pharma; Supernus Pharmaceuticals; Allergan; Shionogi; Sage Therapeutics; Canadian Network for Mood and Anxiety Treatments; Canadian Institutes of Health Research; Sunovion; Purdue University; Neos Therapeutics; Teva Pharmaceutical Industries; Sanofi; GlaxoSmithKline; Dainippon Sumitomo Pharma; Pfizer; Shire; AstraZeneca; Eli Lilly and Company","keywords":"Placebo; Post-hoc analysis; Psychology; Anxiety; Internal medicine; Young Mania Rating Scale; Tolerability; Mania; Bipolar I disorder; Bipolar disorder; Psychiatry; Medicine; Adverse effect; Mood","score_opus":0.030664042088499443,"score_gpt":0.40256207978707587,"score_spread":0.37189803769857643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385664517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970145,0.00046591772,0.000023766786,0.0013078698,0.00047863193,0.0003203074,0.0001995995,0.000019378434,0.00017002664],"genre_scores_gemma":[0.9984397,0.00037196054,0.0002107096,0.0004297415,0.00007161018,0.000013131898,0.00018077456,0.000014578609,0.0002677904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998424,0.00012435052,0.00068409584,0.0003406987,0.00028437653,0.00014251105],"domain_scores_gemma":[0.9986998,0.0005277419,0.00021160286,0.00016297307,0.00029299632,0.000104878745],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003513485,0.00013186301,0.00050174625,0.00042657735,0.0000131719935,0.000002734232,0.00010679785,0.00012725715,0.0011307108],"category_scores_gemma":[0.00015142892,0.000088105655,0.00013253464,0.0006555683,0.0001261456,0.00004333052,0.00006171558,0.00019922097,0.000011530681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026637517,0.002615512,0.9331717,0.000019359308,0.0024109099,0.000015628275,0.000026946838,0.00002169994,0.0006598233,0.000006921692,0.0002326429,0.03418136],"study_design_scores_gemma":[0.026892025,0.0017109755,0.9673874,0.00003650438,0.0010864866,0.0000015119656,0.0000039049332,0.00022945536,0.00007536214,0.00001177844,0.0024889887,0.00007563903],"about_ca_topic_score_codex":0.0000549293,"about_ca_topic_score_gemma":0.000117775584,"teacher_disagreement_score":0.03421569,"about_ca_system_score_codex":0.000023506105,"about_ca_system_score_gemma":0.000055876342,"threshold_uncertainty_score":0.9997824},"labels":[],"label_agreement":null},{"id":"W4388705647","doi":"10.1097/yic.0000000000000521","title":"The impact of mild behavioral impairment on the prognosis of geriatric depression: preliminary results","year":2023,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute on Aging; Canadian Institutes of Health Research; Neuraxpharm; H. Lundbeck A/S; Fondation Brain Canada; Johns Hopkins University; Biogen; Sanofi; Consortium canadien en neurodégénérescence associée au vieillissement; Alzheimer's Drug Discovery Foundation","keywords":"Depression (economics); Medicine; Psychology; Psychiatry","score_opus":0.10248921758814952,"score_gpt":0.5292276529264274,"score_spread":0.4267384353382778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388705647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984028,0.00006693503,0.000002633308,0.009965286,0.0011067326,0.0009315998,0.000082599116,0.000026998625,0.0037892435],"genre_scores_gemma":[0.99715877,0.0006480587,0.000015996322,0.00028248105,0.0003513497,0.00018702564,0.00003991376,0.0000130947,0.0013033015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997571,0.00035273092,0.0009176665,0.00029169122,0.0005991074,0.00026781042],"domain_scores_gemma":[0.99625105,0.0026475927,0.0003350225,0.0002409102,0.00040853786,0.0001169179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001918778,0.00012762166,0.00025135704,0.00016165878,0.00008470368,0.000010502952,0.000423289,0.00009717762,0.0005988725],"category_scores_gemma":[0.00049986894,0.000063359934,0.00046660594,0.00036284435,0.00035002688,0.000031977546,0.00016902311,0.00040732487,0.0000977531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06271674,0.0051156664,0.65673995,0.000020207974,0.0010814987,0.000070693095,0.00009913011,0.00002876472,0.0030290321,0.000060366125,0.23925248,0.031785488],"study_design_scores_gemma":[0.0060436917,0.009141087,0.98029286,0.000055484816,0.00010974038,0.000009136004,0.00006865106,0.0005259631,0.0018405878,0.00019751869,0.0016579055,0.00005740639],"about_ca_topic_score_codex":0.000035305373,"about_ca_topic_score_gemma":0.0000011370807,"teacher_disagreement_score":0.3235529,"about_ca_system_score_codex":0.000049369683,"about_ca_system_score_gemma":0.00014848729,"threshold_uncertainty_score":0.6557234},"labels":[],"label_agreement":null},{"id":"W4391991450","doi":"10.1097/yic.0000000000000543","title":"Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder","year":2024,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Brain and Cognition Discovery Foundation; University Health Network","funders":"Center for Clinical and Translational Research; Universidad El Bosque","keywords":"Young Mania Rating Scale; Quetiapine; Psychology; Bipolar disorder; Psychiatry; Bipolar I disorder; Rating scale; Mania; Mood; Clinical psychology; Internal medicine; Medicine; Schizophrenia (object-oriented programming)","score_opus":0.0589141435056021,"score_gpt":0.437330468623192,"score_spread":0.37841632511758994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391991450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98964626,0.002742989,0.00009423144,0.0020018914,0.0010422004,0.0020191844,0.00009271531,0.000063541374,0.0022969816],"genre_scores_gemma":[0.9975675,0.0011465811,0.00012204066,0.00013819456,0.00009566618,0.00035465142,0.000053420383,0.00002922292,0.0004927269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979192,0.00018509831,0.00078047323,0.00057681894,0.00029748183,0.00024091279],"domain_scores_gemma":[0.998935,0.00046885505,0.00012218284,0.00021232062,0.0001486308,0.00011305048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017949723,0.00026678384,0.0006135865,0.0002737803,0.000031788124,0.000016762002,0.0001771172,0.00005921474,0.00044255168],"category_scores_gemma":[0.000024318848,0.00018237456,0.000104647756,0.00030057994,0.00023259243,0.00009227478,0.00003614165,0.00036920188,0.0000538466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006358893,0.042401336,0.93751585,0.000062082465,0.0020088283,0.00008759576,0.0018333315,0.00010000218,0.00011982356,0.00027922707,0.00012785189,0.009105179],"study_design_scores_gemma":[0.0199092,0.0376094,0.93394506,0.00014662644,0.00031742823,0.000026582085,0.001665167,0.00081493537,0.000022489552,0.0001441699,0.0052301795,0.00016875693],"about_ca_topic_score_codex":0.0015325858,"about_ca_topic_score_gemma":0.024039146,"teacher_disagreement_score":0.02250656,"about_ca_system_score_codex":0.00017117053,"about_ca_system_score_gemma":0.00012467825,"threshold_uncertainty_score":0.9937696},"labels":[],"label_agreement":null},{"id":"W4391993082","doi":"10.1097/yic.0000000000000538","title":"Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders","year":2024,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Polypharmacy; Schizoaffective disorder; Antipsychotic; Metabolic syndrome; Medicine; Schizophrenia (object-oriented programming); Bipolar disorder; Internal medicine; Olanzapine; Psychiatry; Psychosis; Pediatrics; Obesity","score_opus":0.03241707496823191,"score_gpt":0.4324719068644379,"score_spread":0.400054831896206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391993082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96336573,0.017153757,0.000056435398,0.015854845,0.0022883858,0.0008945282,0.00003181586,0.00008121488,0.00027329463],"genre_scores_gemma":[0.9845271,0.012985762,0.0006910309,0.0010639988,0.00032959125,0.00011057072,0.000018927583,0.000031306066,0.00024168046],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979665,0.00022533746,0.0005239781,0.0007004416,0.00028594697,0.00029776973],"domain_scores_gemma":[0.99835885,0.0009855543,0.00004597413,0.00011270188,0.00006463783,0.0004323042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006008149,0.0002077107,0.00039311178,0.0007370418,0.00004770516,0.000050601262,0.00012097393,0.00013474039,0.00034112096],"category_scores_gemma":[0.0003401589,0.00018141662,0.00011372416,0.00041892324,0.00011256718,0.00020138326,0.00009052886,0.00068137114,0.0002898952],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07930532,0.0022339385,0.26738715,0.00022276367,0.0033060077,0.0022037188,0.0002886465,0.000024570103,0.0074027963,0.019545464,0.0020667838,0.6160129],"study_design_scores_gemma":[0.014130236,0.0007976243,0.9680295,0.00016408414,0.00015918251,0.00043466425,0.000010360904,0.003742093,0.00008805708,0.0033213827,0.008940708,0.00018208817],"about_ca_topic_score_codex":0.000035809528,"about_ca_topic_score_gemma":0.00008250515,"teacher_disagreement_score":0.7006424,"about_ca_system_score_codex":0.000065042215,"about_ca_system_score_gemma":0.00014076845,"threshold_uncertainty_score":0.7397955},"labels":[],"label_agreement":null},{"id":"W4396798286","doi":"10.1097/yic.0000000000000553","title":"Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting system","year":2024,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Tetrabenazine; Parkinsonism; Adverse Event Reporting System; Odds ratio; Medicine; Adverse effect; Suicidal ideation; Psychiatry; Internal medicine; Pharmacology; Poison control; Suicide prevention; Emergency medicine","score_opus":0.08102644478716838,"score_gpt":0.4408891582959155,"score_spread":0.35986271350874716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396798286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967063,0.00003583192,0.0000468625,0.0047082114,0.0045744563,0.00043826282,0.00008263835,0.000110021814,0.00033309864],"genre_scores_gemma":[0.998296,0.00024225046,0.000037808204,0.0010571948,0.0002182302,0.000052273703,0.000009975243,0.000020136966,0.00006611469],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99589515,0.0007260791,0.0020761897,0.000715677,0.0004047606,0.00018214794],"domain_scores_gemma":[0.9960705,0.0023012166,0.0012045526,0.00021313035,0.00009628685,0.00011428217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025839992,0.00017497492,0.00025534668,0.0001514428,0.00011524297,0.00006056014,0.00022690457,0.00008861139,0.00004776296],"category_scores_gemma":[0.001551386,0.0001323576,0.00014354142,0.00019975934,0.0004299306,0.000117614065,0.00007266524,0.0006202004,0.000011882054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007658408,0.003208785,0.6398952,0.0011984783,0.0010739358,0.0095778005,0.0037560256,0.0011852529,0.23457746,0.016489536,0.016674265,0.06470484],"study_design_scores_gemma":[0.008838984,0.004276003,0.29857433,0.0016284505,0.0011749637,0.0067414786,0.002600766,0.022983683,0.45273736,0.003521789,0.19526665,0.0016555346],"about_ca_topic_score_codex":0.00005713567,"about_ca_topic_score_gemma":0.000009204203,"teacher_disagreement_score":0.34132087,"about_ca_system_score_codex":0.00004754147,"about_ca_system_score_gemma":0.00005530967,"threshold_uncertainty_score":0.5397386},"labels":[],"label_agreement":null},{"id":"W4400411923","doi":"10.1097/yic.0000000000000556","title":"Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis Registry","year":2024,"lang":"en","type":"article","venue":"International Clinical Psychopharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; McGill Pain Questionnaire; Adverse effect; Brief Pain Inventory; Observational study; Quality of life (healthcare); Physical therapy; Anxiety; Internal medicine; Clinical trial; Chronic pain; Visual analogue scale; Psychiatry","score_opus":0.028858942112115014,"score_gpt":0.4776365398539525,"score_spread":0.44877759774183745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400411923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95027035,0.0002488236,0.000084584426,0.044381622,0.0030124746,0.00040552675,0.00016531537,0.00002835101,0.0014029735],"genre_scores_gemma":[0.9925959,0.0004865012,0.00010534788,0.0041725766,0.00084750284,0.00008663112,0.00014779333,0.000020766392,0.0015369818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952617,0.00046294657,0.00197621,0.00062576274,0.0014075118,0.00026585403],"domain_scores_gemma":[0.9976712,0.0009368093,0.00025375228,0.0004056746,0.00040820058,0.00032435998],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002619152,0.0001809837,0.00087266037,0.00026990063,0.000028043487,0.000031245894,0.0005425997,0.0003296072,0.0058110873],"category_scores_gemma":[0.0012496948,0.000110588386,0.0006567533,0.0005091401,0.0006874693,0.000058569396,0.00014757203,0.0015926823,0.000025328596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011297854,0.0008489479,0.9126218,0.000013388266,0.003543201,0.00024062827,0.000019053243,0.000012011315,0.0000028742204,0.0002053879,0.07015759,0.011205318],"study_design_scores_gemma":[0.007207449,0.00043392472,0.95900965,0.00011500433,0.00034945487,0.0000029669466,0.00002324157,0.0010840048,0.0000012746581,0.000090267815,0.031579144,0.000103634266],"about_ca_topic_score_codex":0.00036239187,"about_ca_topic_score_gemma":0.0009847018,"teacher_disagreement_score":0.046387818,"about_ca_system_score_codex":0.000098570184,"about_ca_system_score_gemma":0.0011241442,"threshold_uncertainty_score":0.99509776},"labels":[],"label_agreement":null}]}